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ABSTRACT
GENOMIC METHODS FOR STUDYING THE POST-TRANSLATIONAL
REGULATION OF TRANSCRIPTION FACTORS
Logan J. Everett
Sridhar Hannenhalli, Ph.D. Stephen R. Master, M.D., Ph.D.
The spatiotemporal coordination of gene expression is a fundamental process in
cellular biology. Gene expression is regulated, in large part, by sequence-specific
transcription factors that bind to DNA regions in the proximity of each target
gene. Transcription factor activity and specificity are, in turn, regulated post-
translationally by protein-modifying enzymes. High-throughput methods exist to
probe specific steps of this process, such as protein-protein and protein-DNA inter-
actions, but few computational tools exist to integrate this information in a princi-
pled, model-oriented manner. In this work, I develop several computational tools for
studying the functional implications of transcription factor modification. I establish
the first publicly accessible database for known and predicted regulatory circuits that
encompass modifying enzymes, transcription factors, and transcriptional targets. I
also develop a model-based method for integrating heterogeneous genomic and pro-
teomic data for the inference of modification-dependent transcriptional regulatory
networks. The model-based method is thoroughly validated as a reliable and accu-
rate computational genomic tool. Additionally, I propose and demonstrate funda-
mental improvements to computational proteomic methods for identifying modified
protein forms. In summary, this work contributes critical methodological advances
to the field of regulatory network inference.
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Chapter 1
Post-Translation Regulation of
Transcription Factor Proteins
1.1 Introduction
Changes in gene expression underlie many fundamental biological processes, includ-
ing development, metabolism, and response to environmental stress. Attempts to
understand these processes in terms of individual genes have been limited due to the
inherent complexity of cellular biology. Many genes interact, resulting in functions
that are largely dependent on the expression levels of other genes. Thus, multi-
genic expression programs must be coordinately regulated to achieve the intended
cellular state, and disruption of these programs is a major component of human
disease [12, 44].
The characterization of cellular behavior at the systems level—rather than at the
level of individual genes—is now a viable approach for the study of such complex-
ity, due to advances in high-throughput technology and the completion of genome
sequences [44, 113]. A prerequisite for any quantitative study of a cellular system is
1
a model of the underlying system structure, i.e., the direct physical and functional
interactions between sets of genes, typically represented as a network [113, 125].
In particular, the interactions between DNA-binding proteins and the gene tran-
script levels they regulate are of particular interest in the study of gene expres-
sion [12, 112, 199]. There is also a cellular sub-network of proteins and other
molecules involved in relaying, processing, and responding to signals from the cel-
lular environment, and many of these signals lead to coordinated changes in gene
expression programs [12]. A major challenge in the field of network biology is the
overlay of these two classes of networks, creating a comprehensive model of signal-
ing and coordinated transcriptional response in the nucleus [112]. Network models
of these regulatory interactions provide a foundation for understanding how cells
coordinate multigenic responses, and hold the potential to decipher systems-level
behavior in the cell [44, 125].
In this chapter, I review the basic biology of transcription and cell signaling,
and highlight recent methodological advances in the field of network inference. In
subsequent chapters, I present novel computational methods and related resources
for unraveling the complex regulatory network operating at the interface between
cell signaling and transcriptional regulation.
1.2 Gene Regulation by Transcription Factors
Transcription is the process of copying information from genomic DNA to RNA, and
is a critical step in the expression of all protein-coding genes. The precise transcript
level is tightly regulated for most genes in both space (e.g., different tissues) and time
(e.g., developmental programs). In a single organism, the same genome gives rise to
a variety of specialized cell types and states, as a result of differential gene expression
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regulated at the level of transcription initiation [12, 44]. Many functionally related
genes, including members of a pathway, biological process, or a protein complex,
tend to have similar spatiotemporal expression patterns [186, 192]. In eukaryotes,
transcription of protein-coding genes is performed by RNA Polymerase II (RNAPII),
and the rate at which RNAPII is recruited and activated at each transcription start
site (TSS) is a major determinant of gene expression levels [103, 115].
Transcription by RNAPII occurs in several regulated steps [60]. First, the TSS
region (also called the core promoter) must be cleared of other proteins, such as
histones, that would otherwise obscure RNAPII from binding to the DNA. RNAPII
and additional proteins can then assemble at the TSS, forming the pre-initiation
complex (PIC). The PIC proceeds with transcription for 5–6 bases before several
protein components must be released, a step referred to as promoter escape, or
transcription is aborted. After successful promoter escape, elongation of the nascent
transcript can then proceed, but is often paused at an upstream region proximal to
the TSS. Chemical changes to the RNAPII protein are typically required to escape
pausing and transcribe the rest of the gene (productive elongation). Thus, genes
can be silenced by blocking this core transcriptional machinery or, more commonly,
genes can be strongly induced by guiding RNAPII to specific genomic loci and
promoting the initiation and elongation steps of transcription [60, 158].
Sequence-Specific Transcription Factors (TFs) are proteins which bind to specific
DNA sequences and influence the rate of transcription at particular target genes,
thereby coordinating the expression of multiple genes to organize a coherent cellu-
lar state. Many genes are directly regulated via TF binding in the region of DNA
immediately upstream from the TSS - called the proximal promoter [48, 78]. In
higher eukaryotes, many TFs also bind distal regulatory regions, e.g., enhancers
and silencers, although these regions are especially challenging to annotate and link
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to specific target genes on a genomic scale [78, 103, 190]. TFs typically function in
combinatorial programs, with many TFs cooperating to regulate the transcription of
each target gene, and these programs can precisely regulate the quantity of mRNA
transcribed. The strength of physical interactions between a TF, its DNA binding
site, and its related protein partners (co-factors) at each regulatory region can cre-
ate differential gene regulatory effects. These interactions, and the protein level of
each TF, can be fine-tuned by the cell to produce distinct cellular states and ap-
propriate responses to intrinsic and extrinsic cues, e.g., stress, nutrient availability,
and hormonal signals [103].
The study of gene-specific transcriptional regulation is typically built on two ba-
sic components: (i) identification of specific TF binding sites in annotated genomic
regions, e.g., proximal promoters, and (ii) observation of TF-dependent changes in
gene expression [12]. For several decades, these components have been studied in
targeted (low-throughput) experiments designed to elucidate the details of regula-
tion at a few gene promoters at a time [112]. For the purposes of this work, I will
focus on briefly reviewing more recent methods applicable to genome-wide inference
of transcriptional regulatory networks1.
Inference of TF Binding Sites
A critical mechanism by which many TFs accomplish specificity for their target
genes is by preferential binding to specific DNA sequences, or motifs, present in the
promoters of target genes [78]. Hannenhalli and Levy have shown that functionally
related genes have similar sequence motifs in their proximal promoters, supporting
the idea that these DNA regions contain binding sites for specific TFs responsible
for coordinating multigenic biological processes [79].
1For a review of targeted methods, see refs. [48, 103]
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TF-DNA binding events can be detected in vivo using a method called Chro-
matin Immunoprecipitation (ChIP). In brief, the complex of proteins bound to
DNA—chromatin—is cross-linked in place and complexes containing a specific TF
are isolated through antibody binding. The cross-linking is then reversed and all
proteins are digested, leaving only the DNA from the sites where the TF of in-
terest was bound. This technique can be coupled to high-throughput methods for
characterizing the bound DNA by either hybridization to oligonucleotide microar-
rays (ChIP-chip) [77] or high-throughput sequencing (ChIP-seq) [151]. For example,
ChIP-chip has been used extensively to characterize TF binding sites in the yeast
Saccharomyces cerevisiae [81, 123]. Recent advances in these methods have allowed
for the in vivo detection of intergenic TF binding sites in higher eukaryotes, but
these binding sites are particularly difficult to link to specific target genes due to
the lack of annotations for distal regulatory elements, and are typically ignored by
current genome-scale network inference methods2.
Binding sites can also be predicted based on the sequence-specificity of the TF.
The most common model for representing this sequence-specificity is the Positional
Weight Matrix (PWM) [185], although other models exist [78]. PWMs provide a
probabilistic representation of TF binding sites in terms of the relative preference
for all four bases at each position [78]. These models can be trained from in vivo
binding sites identified through ChIP-chip/seq [81], or by in vitro binding to libraries
of sequences, such as the Systematic Evolution of Ligands by Exponential Enrich-
ment (SELEX) method [193]. More recently, DNA microarrays have been used
to quantitatively probe the in vitro specificity of TFs [142]. Databases of PWMs
2Note that additional genomic annotations of distal regulatory elements, such as those sought
by the ENCODE project [49], can be readily incorporated into the methods discussed in this work
whenever the annotated element can be linked to specific target genes. Proximal promoters simply
represent the easiest form of this problem, because they can generally be assumed to influence the
nearest gene.
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based on these experimental methods have been compiled, such as TRANSFAC [209]
and JASPAR [168]. Once trained, a PWM model can be used to scan proximal pro-
moter regions for likely binding sites, thereby inferring potential target genes for
each TF. However, TF binding sites are typically short and degenerate, and even
well-trained models are prone to high false positive rates. Therefore, PWMs should
be regarded with caution when applied to a large number of proximal promoter
sequences, and are generally not suitable for scanning the entire genome for distal
regulatory elements [78].
Inference of TF-Dependent Gene Expression
A complementary approach to inferring transcriptional networks is the inference of
TF-dependent expression patterns, typically measured in high-throughput by ex-
pression microarrays [172]. The most direct approach is to measure the differential
expression of genes when a particular TF is deleted or otherwise perturbed. For ex-
ample, Hu et al. experimentally determined the set of genes differentially expressed
in S. cerevisiae when each TF was systematically knocked down [90]. Differentially
expressed genes in these conditions typically include both direct and indirect (down-
stream) targets of the TF of interest. Hu et al. dealt with this problem by analyzing
the overall transcriptional network inferred from the knock-out compendium and re-
moving connections that appeared to be indirect, i.e., dependencies that are better
explained by one or more intermediate TFs. However, this requires a compendium
of all TF knock-outs in order to reliably detect indirect dependencies [90]. Cells can
also compensate for individual TF perturbations through redundant mechanisms or
feedback loops, further complicating the analysis of these experiments [68, 90].
Another method for characterizing transcriptional regulation is the analysis of co-
6
expression across multiple experimental conditions. Typical metrics of coexpression
include correlation coefficients [44, 54, 186], and mutual information [20, 40, 184].
Many compilations of expression data now exist, such as the Gene Expression
Omnibus (GEO) [9], and measures of coexpression typically gain power as the number
of expression samples increases [44]. Stuart et al. showed that coexpression patterns
are strongly conserved through evolution, and often correspond to co-regulated mod-
ules of genes with related functions [44, 186]. Basic patterns of coexpression can
arise from a number of different regulatory relationships. One gene in a coexpressed
pair may regulate the other, or both genes may be co-regulated by some other TF,
and in both cases this regulation can be direct or indirect.
Despite the limitations noted above, coexpression networks have been used in
many applications to successfully infer the structure of the underlying transcriptional
network. Magwene et al. developed the First-Order Conditional Independence
(FOCI) algorithm to filter an expression correlation network to the edges that are
independent of other edges, and likely to represent either direct regulatory interac-
tions or directly co-regulated genes [133]. Similarly, Margolin et al. developed the
Algorithm for the Reconstruction of Gene Regulatory Networks (ARACNE),
which first infers network edges based on mutual information, then filters indirect
edges by removing the weakest edge from each fully connected set of three genes
in the network, based on the data-processing inequality theory [134]. By focusing
on the network edges predicted by ARACNE surrounding TFs, Basso et al. accurately
predicted direct regulatory interactions, and modeled a transcriptional network in
B cells and related cancers [10]. Faith et al. developed the Context Likelihood of
Relatedness (CLR) algorithm, which is also based on mutual information, but filters
out indirect edges by applying local thresholds to each gene in the network. Faith et
al. used the CLR algorithm to accurately model the transcriptional regulatory net-
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work underlying a large compendium of Escherichia coli expression data [55]. Thus,
while simple coexpression metrics may primarily identify modules of co-regulated
or functionally related genes, more advanced algorithms can mine collections of ex-
pression data for evidence of direct regulatory interactions between TFs and target
genes.
Construction of Integrative Network Models
Given genome-wide data related to both TF binding sites and gene expression data,
a major goal in computational biology is the construction of a network model that ac-
curately describes the “circuitry” of TFs and their target genes [12, 44, 112, 125, 199].
The “gold standard” for identification of a direct TF-Gene network edge is evidence
for both TF binding in an annotated gene regulatory region and a TF-dependent
change in gene expression3 [190]. Proximal promoter regions can be automatically
annotated genome-wide based on known gene transcripts, and therefore are the pri-
mary focus of current methods. Thus, one common approach is to calculate the strict
overlap of genes near TF binding sites and genes that are differentially expressed in
a TF perturbation experiment, although this often yields surprisingly low overlap,
even in lower eukaryotes where distal regulatory elements are less common [68, 90].
It is possible that some TF binding sites do not regulate proximal genes, and as
previously noted, TF perturbation experiments are prone to indirect and compen-
satory effects. However, a substantial part of this problem is likely to originate from
noise in the individual experiments [68, 90], which is of even greater concern when
attempting to combine noisier prediction methods, such as PWMs and coexpression
3Promoter “bashing”, i.e., the direct manipulation of the regulatory sequences bound by par-
ticular factors to study their influence on putative target genes, could be considered the “platinum
standard” for TF-Gene network edges, especially with respect to distal regulatory elements, but
such methods currently are not feasible to do in high-throughput and therefore are outside the
scope of genome-scale network inference.
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networks. Therefore, more elegant solutions to integrating expression and binding
data have been developed.
For example, Lee et al. combined their initial genome-wide survey of TF bind-
ing in S. cerevisiae with a compendium of expression profiles to identify sets of
genes with highly correlated expression patterns and coordinated TF binding [123].
Tavazoie et al. developed a method in which genes are first clustered by coexpres-
sion, then a motif discovery algorithm is used to predict TF binding sites common to
each gene cluster [189]. Bar-Joseph et al. developed the Gene Regulatory Modules
(GRAM) algorithm to identify modules of genes with similar expression profiles and
a common set of TFs bound to their promoters [5]. Bussemaker et al. modeled
each gene expression level as an additive function of different TF binding site motif
occurrences in the gene promoters [19], and Gao et al. later extended this method
to use ChIP-chip data in place of sequence motifs [61]. These methods all have
the same primary goal of identifying regulons—modules of functionally related and
co-regulated genes—and the specific TFs that coordinate their expression.
Chen et al. developed a probabilistic framework—Clustering of Genes into
Regulons using Integrated Modeling (COGRIM)—for studying regulons by inte-
grating experimental TF binding data, predicted binding sites from PWMs, and ex-
pression data. In brief, COGRIM models the observed expression value of each target
gene as a linear function of the expression of TFs regulating each gene. Individual
TF-Gene edges in the network are given prior probabilities based on ChIP-chip TF
binding data and/or PWM analysis of the gene promoters. The network model
is then fit to an expression compendium, and used to infer posterior probabilities
of TF-Gene edges given the expression and binding site data. COGRIM also has the
option to include synergistic effects from pairs of TFs that functionally interact [22].
The methods reviewed above are focused on network interactions between TFs
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and target genes, such that expression of each gene transcript is viewed as a function
of TFs only. However, TF function is often dependent on co-factors, chromatin
structure, and changes to the TF protein catalyzed by modifying enzymes. There
is a broad need for methods that expand the scope of transcriptional regulatory
networks to include these additional components [12, 14, 112]. In this work, I
focus on the post-translational regulation of TFs, although many of the methods
applicable to this problem can also be adapted to study regulation via co-factors,
chromatin modification, and other sources of network dynamics. In the next section,
I introduce the general concept of post-translational regulation and discuss novel
developments in relevant experimental methods. I then review related methods for
the more general problems of inferring condition-specific connectivity in TF networks
and TF modulators, and discuss the potential for specifically applying these methods
to study post-translational TF regulation.
1.3 Signaling Pathways and Post-Translational
Modifications
Living cells constantly sense internal and external chemical states. The means by
which a cell coordinates a response to a particular stimuli typically involves a signal-
ing pathway—a series of molecular interactions that amplify a signal, and ultimately
coordinate the appropriate response, including changes in gene transcription [1]. Co-
valent chemical changes to the amino acids in proteins—called Post-Translational
Modifications (PTMs) [211]—are critical for the regulation of protein activities in
signaling pathways [101]. A typical example of a signaling pathway includes a
sequence of PTM reactions, with each modified form of a protein catalyzing the
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modification of the next protein in the sequence, and ultimately activating a set
of appropriate response proteins. Hundreds of distinct types of PTMs have been
reported [36, 62], including phosphorylation, acetylation, methylation, and glyco-
sylation. Many PTMs involved in signaling are reversible, and the proportion of
modified and unmodified forms is determined by opposing enzymes that catalyze
the forward and reverse PTM reactions, allowing for fine-scale regulation of signal
strength [1, 101].
Emerging “proteomic” technologies are now making it possible to study PTMs on
a near-global scale, resulting in a growing compendium of high-throughput data re-
lated to protein modifications. For example, protein microarrays [56] have been used
to identify novel substrates for protein kinases [157] and one acetyltransferase [128],
and can be applied to a much broader range of protein-modifying enzymes. Turk et
al. have developed a peptide library screening method for determining the specificity
of protein kinases [194] that is now broadening our understanding of phosphoryla-
tion substrate specificity [140]. Recent improvements to the sensitivity, accuracy,
and speed of mass spectrometers have made it possible to assay a much wider range
of PTM types [100, 210, 223]. These methods can be used to both monitor known
PTMs and discover novel modification sites.
Advances in the study of protein modifying enzymes and PTMs are driving im-
provements to computational methods for PTM prediction. High-throughput data
on the substrate specificity of a particular modifying enzyme now make it possible
to build powerful models that go beyond basic motifs [13, 140, 217]. Furthermore,
knowledge of which residues are modified in vivo makes it possible to apply predic-
tive models to a smaller set of biological sequences, rather than blindly searching
whole proteomes for possible PTM sites [129]. These collective breakthroughs in
PTM research represent a major opportunity to expand regulatory network models
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beyond the scope of simple TF-Gene interactions.
1.4 PTM-Dependent Transcriptional Regulation
Many signaling pathways relay information to the nucleus and induce changes in
the transcriptional state of the cell, often through the modification of TF proteins.
PTMs can alter many properties of a TF4, including the rate of nuclear trafficking,
the rate of DNA binding at specific sequences, the interactions with co-factors,
and the stability of the TF protein [11, 17, 110, 191]. Numerous types of chemical
modifications of TF proteins have been documented, including phosphorylation [86],
acetylation [59, 183], and methylation [120] (see Table 1.1). On one extreme, such
regulation can be simple and binary—i.e., PTMs that serve as “on/off” switches
for TF activity. More often, however, this regulation is highly complex [216], with
multiple signal inputs integrated into tightly regulated transcript levels, and each
TF-PTM potentially affecting each target gene in a manner dependent on the larger
promoter context [8]. In this way, TFs can act as molecular switchboards that map
multiple incoming signals to their appropriate multigenic expression responses [17,
110].
A canonical example of a regulatory TF-PTM is the phosphorylation of CREB
at Ser133 (Figure 1.1). This TF-PTM has long been characterized as a key event in
cyclic-AMP (cAMP) signaling. Protein kinase A (PKA) is activated by increased
levels of cAMP in the cell, and phosphorylates CREB at the Ser133 residue [11].
The Ser133 phosphorylation allows CREB to interact with its co-activator, CBP,
thereby recruiting the core transcriptional machinery and inducing the expression of
target genes. In some contexts, Ser133 phosphorylation acts a simple on/off switch,
4RNAPII and histone proteins are also regulated via PTMs, although these tend to be part of
general transcriptional mechanisms, rather than the coordination of specific gene modules [110].
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Modification Amino Acid(s) Example TF(s)
Phosphorylation Ser, Thr, Tyr CREB [11, 110, 138], Sp1, PU.1, SRF, c-Myc, ER,
Pax-6, p53, NF-κB [215], STATs [39]
Acetylation Lys CREB [110], p53 [97], STAT1 [117], c-Myb,
GATA-1, MyoD, E2F, EKLF, dTCF [183]
Methylation Lys, Arg p53 [91, 98], STAT1 [207]
Glycosylation Ser, Thr CREB [110], PDX-1, AP-1, Sp1 [219], Pax-6, c-
Myc, p53 [203], NF-κB, NFAT [70], Elf-1 [191]
Ubiquitylation Lys Spt23, Met4, Gcn4, LIM, p53, HIF1α,
SMAD2 [143], STAT1 [180]
SUMOylation Lys Lef1, Sp3, Myb, p53, AP-1 [143], STAT1 [163],
TCF-4, Ikaros, AR, Elk-1, Sp3, SMAD4, GR,
Gal4 [67]
Neddylation Lys p53, p73 [159]
Hydroxylation Pro, Asp HIFα [85]
Table 1.1: PTM types relevant to TF regulation, with known examples
but further experimentation has revealed that other kinases also activate alternate
transcriptional programs through this same TF-PTM [138]. Other PTMs that al-
ter CREB activity have also been discovered, including additional phosphorylations,
acetylations, and one O-linked N -acetyl glycosylation (O-GlcNAc) that antagonizes
the primary activating phosphorylation [110]. CREB exemplifies the potential com-
plexity of TF-PTM regulatory programs beyond simple “on/off” switches.
Few TFs have been studied as extensively as CREB, and numerous TF-PTMs
remain to be discovered. To investigate TF-PTM-mediated gene regulation at the
level of systems biology, we first need to identify the key regulatory connectivity
between modifying enzymes, TFs, and target genes, as well as the specific TF-
PTMs involved in transducing these signals. Inclusion of modifying enzymes and
higher-order dependency increases the complexity of the network inference problem
by several orders of magnitude. However, a variety of high-throughput data sources
can be exploited via computational methods to predict the most likely regulatory
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Figure 1.1: CREB is a well-studied TF that exemplies the complexity of TF-PTM regulatory
circuits. Canonical CREB regulation begins with phosphorylation of Ser133 by PKA, which facil-
itates interaction with the co-factor CBP to recruit RNAPII and promote transcription of target
genes such as SST. Other kinases can also regulate CREB through Ser133 and other phosphory-
lation sites. CBP can also regulate CREB through multiple acetylations, and glycosylation can
disrupt the activating effect of the Ser133 phosphorylation. Reprinted from Everett L, Vo A, and
Hannenhalli S “PTM-Switchboard—a database of post-translational modifications of transcription
factors, the mediating enzymes and target genes” Nucleic Acids Research 2009 37:D66–D71 under
the Creative Commons Attribution Non-Commercial License.
relationships and prioritize further experiments. For many TFs, the full cohort of
regulatory PTMs and the modifying enzymes responsible for catalyzing their ad-
dition and removal are not known. As previously discussed in Section 1.3, new
experimental techniques now provide additional clues for this level of regulation.
Given the importance of PTMs in determining TF activity and the eventual con-
trol of gene transcription, it is imperative that models of transcriptional regulatory
networks incorporate PTMs and the mediating modification enzymes.
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Genome-Wide Inference of TF-Modifiers
The network inference methods discussed in Section 1.2 only consider regulatory
interactions between TFs and target genes, and are therefore limited in terms of the
biological phenomena they can explain. Although TF protein concentration is often
the primary determinant of target gene expression, TF activity at each target gene
promoter is dependent on a number of other factors, including chromatin accessi-
bility and cellular signals [103]. Harbison et al. tested the genome-wide binding of
various TFs in S. cerevisiae under different experimental conditions and found that
many TFs bind different sites under different conditions. Therefore, TF activity at
each target gene promoter can, in fact, be specific to a particular subset of cellular
conditions, and the TF-Gene network can be dynamically re-wired by other classes
of regulatory factors. For this work, I define a modulator as any individual pro-
tein that influences TF activity post-transcriptionally, including influence on DNA
binding and interaction with the core transcriptional machinery. Many types of
molecules can act as TF modulators, including chromatin modifying enzymes, co-
factors, and TF modifying enzymes. A regulatory triplet constitutes a TF, a target
gene, and any modulator gene that influences the regulatory interaction between
the TF and target gene. A special type of regulatory triplet, of particular inter-
est in this work, includes as the modulator gene a modifying enzyme that directly
catalyzes a PTM on the TF protein. I refer to this type of regulatory triplet as a
Modifier-TF-Gene (MFG) triplet (Figure 1.2).
MFG triplets differ from other regulatory triplets primarily in the physical inter-
action between the modifying enzyme and the TF, which yields a covalent chemical
change in the TF protein. This has several important implications for specically
studying MFG triplets, including: (i) the possibility that the modifying enzyme
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Figure 1.2: Example MFG triplet: a factor (F) is unable to regulate the target gene (G) in its
initial state. Modication catalyzed by the enzyme (M) transitions F to a new state (marked by ∗),
at which point it is able to regulate G. Reprinted from Everett L, Vo A, and Hannenhalli S “PTM-
Switchboard—a database of post-translational modifications of transcription factors, the mediating
enzymes and target genes” Nucleic Acids Research 2009 37:D66–D71 under the Creative Commons
Attribution Non-Commercial License.
regulates transcription distally, i.e., prior to the TF-DNA interaction and/or out-
side the nucleus; (ii) the implication that transcript expression data alone may be
insufficient for studying MFG triplets, due to post-transcriptional regulation of both
the TF and the modifying enzyme; and (iii) a unique set of additional data involv-
ing the detection and modeling of enzyme-substrate interactions and PTMs can be
applied to the study of MFG triplets (see Section 1.3). In the remainder of this sec-
tion I review existing methods applicable to the computational prediction of MFG
triplets. Most of these methods are designed for the more general problems of infer-
ring TF modulators or condition-specific TF activity, and have inherent limitations
motivating the development of new methods as presented in subsequent chapters.
A number of computational methods have been developed to estimate condition-
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specific TF activity based on genome-wide expression data. For example, Vadi-
gepalli, Gonye et al. developed the Promoter Analysis and Interaction Network
Toolset (PAINT) to systematically scan the promoters of genes differentially ex-
pressed in specific experimental conditions, thereby predicting candidate TFs co-
ordinating the condition-specific response [71, 197]. McCord et al. ranked genes
by TF binding significance and differential expression in specific yeast microarray
experiments, then compared these rankings to predict associations between TF ac-
tivity and experimental conditions [139]. In a similar approach, Boorsma et al. used
TF binding data to first establish regulons of target genes for each TF [14], then
tested these regulons for differential expression in specific TF and modifying enzyme
knock-out experiments [15].
The condition-specific methods above can be used to infer TF modulators in cases
where the expression conditions correspond to specific molecular perturbations. To
infer the dependence of TF activity on histone modification enzymes, Steinfeld et al.
[182] analyzed the expression of TF regulons in S. cerevisiae samples where specific
histone modification enzymes were knocked out. Cheng et al. applied a similar
method in yeast strains with knockouts of particular kinases, thereby predicting
likely MFG triplets mediating changes in life span [25].
An alternate set of methods search for broader patterns of TF and target gene
expression across multiple conditions, by broadly dividing the conditions based on
certain biological information, and calculating the differential association of gene
pairs across subsets of the available samples. Hu et al. [89] have proposed a non-
parametric test to detect differentially correlated gene-pairs in two sets of expression
samples from different disease classes. In a different study, Hudson et al. [93] ana-
lyzed two expression data sets in cattle, one obtained from a less-muscular wild-type,
and the other from cattle with a mutation in the TF myostatin. They found that
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the coexpression of myostatin with another gene, MYL2, was significantly different
between the mutant and the wild-type sets of expression. This differential coexpres-
sion led them to detect a change in myostatin activity even though the expression
of myostatin gene itself was not significantly different between the mutant and the
wild type. Kim et al. developed an algorithm to predict sets of genes which appear
to be co-regulated in a subset of conditions within an expression compendium, and
uses addition TF binding site data to infer the TFs responsible for these condition-
specific regulatory programs [111].
This class of methods can be used to infer TF modulators by partitioning the ex-
pression data based on the expression profile of a potential modulator gene, followed
by prediction of specific regulatory pairs or regulons that appear to be dependent
on the modulator. Zhang et al. have proposed a method in which each gene with a
bimodal expression pattern across a compendium is considered as a potential modu-
lator (regardless of function). This bimodality is then used to partition the samples
in the expression compendium, and pairs of additional genes can then be tested for
a significant difference in correlation between the two partitions to infer regulatory
triplets. The regulatory triplets predicted by this method had only weak global
correlations, highlighting the difference between pair-wise and higher-order expres-
sion models [220]. Wang et al. proposed a similar algorithm, Modulator Inference
by Network Dynamics (MINDY), in which the expression compendium is partitioned
into equal sizes according to the highest and lowest expression values of a selected
modulator [204]. TF-Gene pairs are then tested for a significant difference in mutual
information [134] between the partitions. This method has been applied to infer the
kinases and other signaling molecules that directly or indirectly modulate activity
of the TF c-MYC in B cells.
Segal et al. [175] proposed a related approach in which multiple partitions are
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learned according to a decision tree combining TFs and signaling molecules, and each
partition is fit to a normal expression model for a particular module of genes. This
method was applied in yeast to infer modules of genes regulated by a combination of
TFs and upstream signaling genes. Another approach, termed Liquid Association,
explicitly tries to detect regulatory triplets (X, Y, Z) where the change in correlation
between X and Y varies continuously with the change in Z, bypassing the need for
any partition structure [126].
Limitations of Existing Methods
While many of the methods described above have been successful in elucidating con-
ditional or modulated TF activity in general, there remain a number of limitations
to overcome, especially with respect to the inference of TF modifying enzymes and
MFG triplets. Many of the methods for inferring TF activity in a single condition
rely on accurate TF binding data [15, 25, 182]. As shown by Harbison and colleagues,
TF binding patterns are also dependent on cellular conditions [81]. Therefore TF
binding data in one condition may not be fully informative when analyzing expres-
sion from another condition. Furthermore, these condition-specific methods can
only infer modulators of TF activity when applied to data in which specific genes
have been perturbed.
Methods which must exhaustively analyze many triplet combinations are gener-
ally inefficient when applied at a genome-wide scale. Zhang et al. only applied their
method to 1,000 human genes (less than 5% of known genes), and still needed to
analyze approximately 400 million potential triplets. It was impossible to compute
p-values with enough precision to overcome the multiple testing problem, even in this
limited case, and therefore Zhang et al. randomly split the expression compendium
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into equal sized training and test sets. The training set was used to rank the sig-
nificance of each possible triplet, and the top 10,000 triplets (less than 0.0001% of
triplets analyzed) were re-analyzed in the test set. Thus, the methodology of Zhang
et al. raises substantial concerns about sensitivity and scalability. Attempting to
apply this methodology to a larger number of genes, or a larger percentage of the
triplets analyzed, is likely to exacerbate the multiple testing problem. Furthermore,
the need to split the data into training and test sets means that only half the avail-
able data can actually be used to predict regulatory triplets [220]. MINDY has similar
limitations, although in this case Wang et al. chose to limit their analysis to a rela-
tively small number of modulators with known roles in cell signaling, and only TFs
of interest, rather than exhaustively searching all possible triplets [204].
In general, methods that attempt to infer network structure from expression data
alone cannot truly differentiate direct and indirect interactions, and often cannot
distinguish the direction of regulation [133, 134]. These problems are only exac-
erbated in the inference of regulatory triplets. Even when TF binding data are
introduced to support the directness and directionality of the TF-Gene interaction,
the effect of the inferred modulator can often be indirect [25]. The modulator genes
are also transcriptionally regulated, and often have expression profiles correlated
to other genes. Furthermore, expression levels for TFs and modulators, especially
modifying enzymes, are not a direct measure of activity. Methods for predicting
regulatory triplets from an expression compendium struggle to distinguish between
several candidate modulators that are coexpressed, and often cannot analyze reg-
ulatory triplets where the modulator is coexpressed with either the TF or target
gene [126, 204, 220]. Feedback loops and parallel signaling pathways are likely to
introduce such artifacts, and therefore present a challenge for many of the existing
methods. Ultimately, these problems limit the sensitivity of current network infer-
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ence methods, which translates into fewer hypotheses for experimental validation,
and an incomplete picture of network behavior. Thus, there is a critical need in the
network inference field for methods that can integrate and fully utilize a wide range
of available data.
1.5 Overview of Thesis Work
In this thesis, I have developed new methodologies specifically designed to ad-
dress the challenges discussed above. In Chapter 2, I first establish a database
for cataloging known examples, in order to provide a “gold set” for method vali-
dation. In Chapter 3, I introduce the Modification-dependent Network-based
Transcriptional Estimator (MoNsTEr) algorithm for modeling the synergistic ef-
fects of TF-Modifier pairs on putative regulons of target genes. MoNsTEr also incor-
porates additional physical evidence for direct TF-Gene and TF-Modifier interac-
tions to overcome the limitations of analyzing expression data alone. In Chapter 4,
I apply MoNsTEr to study the role of the TF STAT1 in human B cells. In Chapter 5,
I propose alterations to common proteomic methods that can improve the reliable
detection of PTMs by mass spectrometry. Finally, in Chapter 6, I suggest novel
ways in which these and related tools can be improved and combined to continu-
ally expand our knowledge of TF-PTM connectivity in regulatory networks. The
scope of this work is primarily limited to the regulation of target genes by TF pro-
teins binding to proximal promoter regions, and the PTMs occurring on these TF
proteins. This limitation is motivated by the currently available data, and the com-
plexity that results from considering multiple, interacting forms of gene regulation.
However, many of the methods presented here will be readily adaptable to other
mechanisms of regulation, when data becomes available at the appropriate scale.
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Chapter 2
PTM-Switchboard: a Database of
MFG Triplets
This chapter adapted from Everett L, Vo A, and Hannenhalli S “PTM-Switchboard—a database
of post-translational modifications of transcription factors, the mediating enzymes and target
genes” Nucleic Acids Research 2009 37:D66–D71 under the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/), available online
at: http://nar.oxfordjournals.org
2.1 Introduction
Many instances of TF-PTMs and their effect on gene regulation have been ex-
perimentally determined (see Table 1.1, e.g.), a systematic meta-analysis of these
examples has not been undertaken. Furthermore, while the current knowledge of
TF-PTMs is limited to a subset of TFs and modifying enzymes, it is nevertheless
highly valuable for the development and validation of computational models. Thus,
there is a need for a structured and machine-readable collection of experimentally
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derived regulatory triplets. The PTM-Switchboard database addresses this need by
cataloging known examples of MFG triplets (as defined in Chapter 1) in the model
system S. cerevisiae. In this critical aspect, PTM-Switchboard differs from previous
molecular pathway databases [29, 74, 106], which support only pair-wise relation-
ship between genes. The database currently includes a large sample of experimen-
tally characterized instances curated from the literature. In addition to providing
a framework for searching and analyzing existing knowledge, the collection as a
whole serves to benchmark computational methods, including those presented in
subsequent chapters of this work. Methods for predicting MFG triplets are in their
infancy and lack a “gold set” by which to gauge their performance. The database
currently contains a sufficient set to evaluate computational approaches and seed
further cataloging efforts.
PTM-Switchboard is also intended to seed a larger community effort to build
a more comprehensive database of MFG triplets, as they are extremely laborious
to search and curate from the literature. Text-mining approaches [170, 218] are
currently limited to identifying pair-wise interactions, and MFG triplets are rarely
studied together as part of a single paper. More commonly, the overall effects of
a PTM on a TF’s cellular localization, degradation or DNA-binding activity are
studied in one reference, while the gene targets of the TF are studied indepen-
dently of any PTMs in another reference. In some cases, MFG triplets can be
inferred from these references together, but only with careful consideration of the
molecular mechanisms involved—a task clearly beyond current text-mining meth-
ods. PTM-Switchboard links the two fields of cell signaling and transcriptional
regulation, and provides substantial opportunity to leverage the existing knowledge
bases in these fields.
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2.2 Database Overview
The primary unit of data used in PTM-Switchboard is a three-way interaction—
the MFG triplet—as described in Chapter 1 and illustrated in Figure 1.2. The
database currently contains 519 fully characterized and experimentally validated
MFG triplets. These triplets cover a total of 14 modifying enzymes and 15 TFs
(Table 2.2), targeting 212 genes in 17 cellular contexts, and are derived from 69
different literature and knowledge base references. Each MFG triplet is stored un-
der the data schema1 shown in Table 2.1. As noted in Chapter 1, the MFG triplet
representation allows the effect of a modifying enzyme to be defined for each of
a TF-Genes interaction individually, rather than uniformly across all TF targets.
Therefore, multiple triplets contained in the database may share one or two mem-
bers. For example, Hog1 regulates the overall transcriptional activity of Sko1 at a
set of target gene promoters, and a separate triplet is included for each target.
The schema shown in Table 2.1 includes descriptive biological information about
each MFG triplet, in addition to the identifiers for each gene member. The modifier
can either have a positive or negative effect on the activity of the TF, and likewise
the TF can be an activator or repressor of each target gene. In some especially
complex cases, such as Sko1, the TF can act as both an activator and a repressor,
depending on the activity of the modifying enzyme— in this case, kinase Hog1 [161].
To describe the behavior in such cases, the overall activity of the triplet is described
by the influence of the TF on the target gene (positive, negative or neutral) in both
the cases when the modifying enzyme is active and when the modifying enzyme
is inactive. For example, in Figure 1.2 the relationship between F and G is neu-
tral when M is inactive, and positive when M is active. Note that this is still a
1PTM-Switchboard is implemented using the MySQL database engine: http://www.mysql.com
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Field Description
mod name SGD official gene name for the modifying enzyme in the triplet
mod orfid SGD systematic ORF ID for the modifying enzyme
mod class Class/type of modifying enzyme, e.g., “Kinase”
tf name SGD official gene name for the TF in the triplet
tf orfid SGD systematic ORF ID for the TF
gene name SGD official gene name for the target gene
gene orfid SGD systematic ORF ID for the target gene
ptm ids List of individual PTM sites (Table 2.3) that have been mapped for this par-
ticular TF-Modifier interaction, each with indicator of whether the modifier
adds or removes the PTM.
context ids List of cellular contexts in which triplet is known to function
ref ids List of literature and external database references containing evidence for
this triplet
mod low Describes the interaction between the TF and target gene when the mod-
ifier activity is low. A ‘+’ value indicates the TF promotes target gene
expression, ‘-’ indicates the TF represses target gene expression, and ‘0’
indicates a disruption of the regulatory interaction between TF and target
gene.
mod high Describes the interaction between the TF and target gene when the modifier
activity is high. Possible values are the same as for mod low.
evidence Evidence codes (Table 2.4) indicating the types of evidence found in support
of the triplet from all references
Table 2.1: Schema for storing MFG triplets in PTM-Switchboard database. Each triplet record is
stored with all fields listed here.
simplification of complex dynamics, and is intended to serve as a primer for more
quantitative investigations.
PTM-Switchboard specifically focuses on MFG triplets involving a direct catal-
ysis of a TF-PTM by a modifying enzyme, and does not include other types of
regulatory triplets or cases that lack evidence for direct catalysis. Furthermore, the
PTM must be relevant to TF activity at the promoter of the included target gene.
This basic unit is an essential building block for more advanced studies of kinetics
and fine-scale regulation at both the transcriptional and post-transcriptional level.
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Modifiers
CDC34 FUS3 HOG1 HYR1 KSS1
MET30 OTU1 RSP5 SLT2 TPK1
TPK2 TPK3 UFD2 YPD1
Transcription Factors
FLO8 HOT1 MET4 MSN2 MSN4
OPI1 RLM1 SFL1 SKN7 SKO1
SMP1 SPT23 STE12 YAP1
Table 2.2: Unique Modifers and TFs included in PTM-Switchboard, listed by SGD gene symbols.
Field Description
ptm type The type of modification, e.g., phosphorylation
prot name The SGD official gene name for the protein that is modified
prot orfid The SGD systematic ORF ID for the protein that is modified
prot refseq The RefSeq accession of the translated protein sequence
ptm pos The position of the modified amino acid (in the official RefSeq sequence)
ptm res The single character abbreviation of the amino acid that is modified, e.g.,
‘Y’ for tyrosine
context ids List of contexts in which the PTM has been observed
ref ids List of literature and external database references containing evidence for
this PTM.
Table 2.3: Schema for storing PTMs in PTM-Switchboard database. Each record with this schema
corresponds to a unique modification site on a particular yeast protein.
Each unique PTM site (when mapped) is stored separately, according to the schema
in Table 2.3. This table records each PTM at a specific residue of a TF protein, but
independent of the modifying enzyme responsible. The same PTM can be involved
in multiple MFG triplets, and likewise an MFG triplet can involve multiple PTMs.
MFG triplets can involve both addition and removal of a chemical group. Even in
the well-studied cases, the exact positions of the PTMs often have not been mapped.
However, PTM-Switchboard provides a framework to store these PTMs as they are
identified or hypothesized.
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2.3 Supporting Evidence
PTM-Switchboard is also an exploratory tool for molecular biologists, and provides
a considerable amount of supporting data for the curated instances of the MFG
triplets, including links to external annotation resources [74, 156]. All genes are
recorded using both their official gene symbol and systematic ORF ID according to
the Saccharomyces Genome Database (SGD) [58], thus directly linking each gene to
its SGD annotation page. All information contained in PTM-Switchboard is derived
either from literature or other knowledge bases, and the sources used to derive this
information are continually tracked and annotated, as discussed in the next section.
The MFG triplets currently contained in PTM-Switchboard vary in their mech-
anistic complexity and are supported by heterogeneous experimental evidence. To
help the user assess each triplet, the database includes an extensive annotation of
the sources for each MFG triplet. The most convincing cases are those in which all
three genes are studied together—i.e., the effect of perturbing the modifying enzyme
is studied on both the TF and the target gene—using a combination of genetic and
biochemical techniques.
While MFG triplets identified through targeted biochemical experiments garner
the highest confidence in their accuracy, there is also a great deal of knowledge to
be gained from high-throughput and genetic experiments, even if these experiments
occasionally provide invalid MFG triplets. Genetic experiments alone can detect
MFG triplets, but cannot distinguish them from other forms of regulation and net-
work connectivity. For example, the modifying enzyme may be further upstream
from the TF in the signaling pathway, or likewise the known TF may target an-
other TF, which then targets the gene of interest. Many kinases are also known to
operate as co-factors, i.e., by binding TFs at promoters to help recruit, activate,
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Code Definition
C Supported by biochemical experiment
G Supported by genetic experiment
V Experimentally demonstrated in vivo
T Experimentally demonstrated in vitro
L Identified in low throughput experiment
H Identified in high throughput experiment
I Inferred from multiple sources
S Demonstrated in a single experiment
M Identified from literature by manual curation
X Identified from literature by text-mining
P Predicted by computational tool
O Identified by homology to a known triplet in another organism
Table 2.4: PTM-Switchboard evidence codes used to characterize the experimental evidence for
each PTM and MFG triplet.
or block the core transcriptional machinery [7, 152, 155]. Such mechanisms do not
qualify for inclusion in PTM-Switchboard, however any triplet is useful to include in
the database if the best model explaining the genetic evidence involves a TF-PTM.
Therefore, PTM-Switchboard has been designed to integrate current knowledge from
all available sources.
To address the potentially subjective nature of weighing different evidence types,
we have developed a system of tagging each triplet with a set of codes that briefly
and concisely describe the evidence contained in the literature. This allows the user
to quickly assess their confidence in individual triplets based on their own criteria
without having to examine each literature reference. I also included tags to catalog
MFG triplets predicted by text-mining and computational modeling approaches,
which may be useful for future content (see Chapter 6). Appropriate evidence codes
can be assigned to separate the gold set from computational predictions. A complete
set of the evidence codes currently used is shown in Table 2.4.
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Of particular interest is the ‘I’ evidence code, which indicates that the triplet
was inferred from a combination of literature references. For instance, one paper
may demonstrate that a modifying enzyme regulates a TFs overall activity under
a specific condition, e.g., by changing its nuclear import/export, while a second
paper may demonstrate that the TF is known to regulate a target gene under a
similar condition. Triplets marked with the ‘I’ code indicate that the experimental
conditions in the referenced papers were comparable enough to justify combining
their results. The ability to integrate multiple references is a major advantage of
expert curation.
In addition to the gold set of 519 fully characterized and experimentally vali-
dated MFG triplets, PTM-Switchboard also tracks incomplete MFG triplets where
computational predictions may be of the most immediate value to molecular biol-
ogists. These typically occur in the literature when perturbation of a modifying
enzyme leads to a significant change in another genes transcript level, but the TF
transducing the signal is unknown. Likewise, a PTM may be known to influence the
activity of a TF, but the enzyme catalyzing the addition or removal of this PTM
may be unknown. These entries are marked with the evidence code ‘U’ to mark
them as having exactly one unknown member and they are excluded from the “gold
set” for validating prediction algorithms.
2.4 Guidelines for Literature Curation
The current content of PTM-Switchboard was obtained through careful curation
of primary literature. Text-mining approaches [170, 218] are currently limited to
identifying pair-wise interactions from individual articles. MFG triplets are rarely
studied together as part of a single paper, and therefore require the integration
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of knowledge from multiple literature sources. Therefore, this process currently
requires a curator with knowledge of basic molecular biology to understand the
various subtleties involved in drawing inferences from multiple experiments. As such,
there is no strict algorithm for extracting an MFG triplet from literature sources,
but the following steps provide a general guideline for the annotation process:
1. Given one or more related papers, e.g., starting from a review of a particular
TF or signaling pathway, identify the genes explicitly tested and discussed, as
well as the connectivity between these genes to infer appropriate triplets.
2. Identify the relevant contexts, i.e., cellular or experimental perturbations, un-
der which each triplet was studied. This is specific only to the type of pertur-
bation, such as “osmotic shock” rather than the exact details of the reagents
and conditions used. If a similar context is already present in the database,
the vocabulary is kept consistent. If multiple papers are being used to infer a
single triplet, the contexts are checked for consistency across all papers.
3. Assess the types of evidence present in the papers and annotate with the
relevant evidence codes, as described in Section 2.3.
4. Identify other relevant papers in PubMed2 and SGD [58]. If the initial paper
is a review, references to the original experimental papers are followed. If
biochemical, in vivo, or low-throughput evidence is lacking for a triplet, an
attempt is made to find other papers that contain such evidence. If no in-
formation has been found on the positions of relevant PTMs, an attempt is
made to find papers mapping these PTMs. For PTMs that broadly regulate
TF activity, e.g., via nuclear trafficking or degradation, a search is also made
2Available online at: http://www.ncbi.nlm.nih.gov/pubmed
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for papers that identify other targets of the same TF in the same contexts, in
order to identify partially overlapping triplets. Steps 1–3 are repeated on all
additional papers.
5. Resolve gene identity and PTM ambiguities. Gene names are translated to
their official SGD symbols before being entered in the database. The positions
of all PTMs are resolved against the official reference sequence in RefSeq [156]
using sequence match.
2.5 Case Study: The FUS3/STE12/FUS1 Triplet
Here, I present one example of PTM-mediated transcriptional regulation included
in PTM-Switchboard that highlights the mechanistic complexity of this process and
thus the value of expert curation. Additionally, this case study illustrates the guide-
lines for inclusion of a MFG triplet in the database and the benefit of using evidence
codes. Activation of the mitogen-activated protein kinase (MAPK) Fus3 is known
to up-regulate the transcription of many genes, including FUS1, via activation of the
TF Ste12 at pheromone response elements in gene promoters [76]. Yeast mating fac-
tors trigger this response via a well-studied signal transduction pathway culminating
in this MFG triplet [6, 24, 45].
On the surface this appears to be a straightforward MFG triplet, with the sim-
plest model suggesting that Fus3 activates Ste12 via phosphorylation. However,
a closer inspection of the literature reveals alternative regulatory mechanisms, in-
cluding inhibitory phosphorylation of the Ste12 repressors Dig1 and Dig2 [24] and
direct repression of Ste12 protein by inactive Fus3, which is lifted upon Fus3 acti-
vation [7, 38]. Most experiments focused on this triplet are genetic in nature, and
cannot distinguish between these mechanisms. A small fraction of the published
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research articles contain biochemical evidence demonstrating that active Fus3 also
phosphorylates Ste12 [47] in a way that promotes target gene expression [94, 179].
Therefore, this MFG triplet was included in the database, but without such evidence,
the triplet would not have been included. Furthermore, triplets involving Dig1 and
Dig2 as modulators of Ste12 do not meet inclusion guidelines for the database re-
gardless of evidence, because these triplets do not involve direct catalysis of Ste12
modification.
In a similar case, there is genetic evidence for activation of Ste12 by another
MAPK, Kss1 and the most widely accepted model for this evidence includes phos-
phorylation of Ste12 by Kss1 [7]. In this case, a set of KSS1/STE12 triplets is in-
cluded in PTM-Switchboard, but assigned a different set of evidence codes to reflect
the lack of biochemical experiments. The FUS3/STE12/FUS1 triplet highlights the
need to separate biochemical and genetic evidence to study PTM-dependent regula-
tion because genetic evidence can often mask more complex mechanisms. The basic
knowledge that a modifying enzyme activates or represses a TF cannot be assumed
to involve a PTM in all cases.
2.6 Discussion
In this chapter, I described a new kind of database—PTM-Switchboard—to catalog
TF-PTM mediated regulation of gene transcription. As illustrated by the case of
the FUS3/STE12/FUS1 triplet, curating known MFG triplets currently requires an
expert examination of literature. I have curated over 500 complete MFG triplets,
thus establishing the groundwork for continued efforts. The database provides a
focused and structured platform to leverage other regulatory network and signaling
pathway resources for this multi-faceted task.
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The first version of PTM-Switchboard is meant as the starting point towards a
comprehensive database, but can also serve several more immediate purposes. For
the molecular biologist studying a particular gene or pathway, PTM-Switchboard
is available as a repository of structured MFG triplet data that is otherwise te-
dious to extract from the literature. Indeed, specific protein and transcription factor
databases such as the Universal Protein Resource (UniProt) [3], TRANSFAC [209],
and dbPTM [122] include information relevant to MFG triplets. However, integration
of these resources to extract consistent information needed for MFG triplet ascer-
tainment is not straightforward. For the computational biologist, the entirety of
the database—or a subset filtered by an appropriate evidence code—can serve as
an ideal “gold set” for training and testing computational methods, such as those
reviewed in Chapter 1. In fact, PTM-Switchboard has been critical in validating the
computational method presented in Chapter 3, and has also been used to validate
the Mimosa algorithm [80]. Moreover, the computational predictions can be conve-
niently compiled in PTM-Switchboard and made accessible to molecular biologists
for experimental validation.
The collection is also immediately useful to researchers interested in the ap-
proximately two-dozen modifying enzymes and TFs included in the database (Ta-
ble 2.2), or as a resource for studying the regulation of over 200 target genes.
PTM-Switchboard provides extensive connectivity to other data repositories, making
it an ideal portal for researchers studying transcriptional regulation or cell signaling
in S. cerevisiae. The knowledge catalogued in PTM-Switchboard will be immediately
helpful in designing further validation experiments and to place these experimental
observations in a broader context of cell signaling. The database can also serve as a
platform to catalog further literature curation, text-mining results, and predictions
from computational models (see Chapter 6).
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Investigation of transcriptional networks based entirely on genomic and tran-
scriptomic information, as is the current practice, is limited. This collection is
designed to encourage more integrative computational approaches based on post-
transcriptional data sources, such as the method described in Chapter 3. By cat-
aloging known instances of TF-PTM mediated regulation of gene transcription,
PTM-Switchboard bridges the current resources in the fields of cell signaling and
transcriptional regulation to facilitate a broader understanding of regulatory net-
works.
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Chapter 3
MoNsTEr: An Integrative Model
of Transcriptional Regulation via
TF-Modifying Enzymes
3.1 Introduction
As noted in Chapter 1, the inference of TF modulators specifically acting through di-
rect catalysis of TF-PTMs can be aided by additional types of high-throughput data.
I therefore propose a principled computational model of gene transcription that ex-
plicitly incorporates interactions between modifying enzymes and TFs, allowing for
the integration of heterogeneous genomic and proteomic data. This model provides
the framework for a new network inference method, called Modification-dependent
Network-based Transcriptional Estimator (MoNsTEr), which combines an ex-
pression compendium (in this work, defined as steady-state mRNA levels measured
by microarray in multiple experiments) with other data sources indicative of physi-
cal protein-DNA and protein-protein interactions to simultaneously infer the target
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genes and upstream modifiers of each TF.
In this chapter, I formally define the probabilistic model of gene expression un-
derlying this method. The necessary complexity of this model motivates the develop-
ment of a novel heuristic algorithm for fitting the model parameters to the available
data in a robust and efficient manner. I then use simulated data to demonstrate that
the model and parameter estimation procedure are robust against noise from a va-
riety of sources. Next, I use a well-studied stress-response regulatory network in the
model system S. cerevisiae to demonstrate the accuracy of MoNsTEr on experimental
data.
3.2 The Integrative Network Model
The computational problem addressed in this chapter is the inference of a regulatory
network model that incorporates: (i) interactions between TFs and gene regulatory
regions, and (ii) interactions between TFs and their modifying enzymes. In this sec-
tion, I introduce and explain the underlying mathematics of the model (represented
graphically in Figure 3.1), and introduce a novel heuristic approach to efficiently
estimate the model parameters. Individual variables are denoted in italics and the
corresponding vectors and matrices of variables are denoted in bold. See Tables 3.1
and 3.2 for a guide to the notation used in this chapter.
Primary Model Equations
The model used here is an extension of the variable-selection linear regression model
first described by Chen et al. [22], and is described concisely by the following equa-
tions and notation. Given potential target genes indexed by i from 1 to N , TFs of
interest indexed by j from 1 to J , and modifiers of interest indexed by k from 1
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Figure 3.1: Conceptual diagram of network model with relationships to model equations. Input
data is shown in green and model parameters are shown in blue. Expression matrices g, f , and h
correspond to samples t for genes i, TFs j, and enzymes k respectively. Prior matrices b,m, a, and
s are derived from TF binding data, TF motif data, protein-protein interaction data, and protein
motif data, respectively. Model parameters include TF-Gene edges C and TF-Modifier edges D,
TF activities β, TF-Modifier synergy effects γ, TF-specific prior weights w, and modifier-specific
prior weights u.
to K, with expression measured under conditions indexed by t from 1 to T : let g
denote the N × T expression matrix for target genes with values git; let f denote
the J × T expression matrix for TFs with values fjt; and let h denote the K × T
expression matrix for modifiers with values hkt. Thus, the first step of the modeling
procedure is the selection of an appropriate set of candidate TFs, modifiers, and
target genes for the network of interest. In particular, the target genes i should not
overlap with the TFs j or modifiers k, and therefore i can include all other genes
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for which there is sufficient data after selecting j and k, or a subset thereof. The
model defines each target gene expression value git as a function of four additive
components: (i) basal expression, (ii) direct influence from regulating TFs, (iii) syn-
ergistic influence from specific TF-Modifier pairs, and (iv) an error component εit
encompassing technical and biological noise. These components are formally defined
in the following equation:
git = αi +
J∑
j=1
βjCijfjt +
J∑
j=1
K∑
k=1
γjkCijDjkΦ(fjt, hkt) + εit (3.1)
Eq 3.1 is applied to all genes i from 1 to N and all samples t from 1 to T . The
term αi represents a baseline expression value for gene i independent of condition.
The term βj is a scaling factor for TF j to describe its linear influence on all target
genes in all conditions. The terms Cij, denoted collectively by the N × J matrix C,
are binary variables indicating whether each TF j regulates the expression of each
gene i. By definition, Cij = 1 implies that TF j is a predicted regulator of gene
i (Cij = 0 otherwise). Thus, in this model, TF j only directly affects the subset
of genes i where Cij = 1. Modifiers differ from TFs in the model in that they do
not influence target gene expression directly, but rather indirectly by modulating
TF activity. Each TF-Modifier pair (j, k) has an influence parameter γjk and an
edge indicator variable Djk, analogous to the βj and Cij variables respectively, i.e.,
Djk = 1 if modifier k has a synergistic effect on the target genes of TF j. The
nature of these synergistic effects are described in general as a function Φ of TF and
modifier expression values, discussed in more detail below. The term εit corresponds
to the residual error of the model fit for each git. This term captures technical and
biological noise as well as non-model behavior and is sampled from the normal
38
Symbol Description
N Number of target genes in input data
J Number of TFs in input data
K Number of modifiers in input data
T Number of expression samples in input data
i Index over target genes in input data, range (1, N)
j Index over TFs in input data, range (1, J)
k Index over modifiers in input data, range (1,K)
t Index over samples in input data, range (1, T )
g Matrix of target gene expression values for all genes i and all samples t, size N × T
f Matrix of TF expression values for all TFs j and all samples t, size J × T
h Matrix of modifier expression values for all modifiers k and samples t, size K × T
b TF-Gene prior matrix based on experimental binding data for all genes i and TFs j,
size N × J
m TF-Gene prior matrix based on promoter motif analysis for all genes i and TFs j,
size N × J
a TF-Modifier prior matrix based on protein-protein interaction data for all modifiers
k and TFs j, size J ×K
s TF-Modifier prior matrix based on substrate profile analysis for all modifiers k and
TFs j, size J ×K
Ξ The set of all input data matrices, (g, f ,h,b,m,a, s)
Table 3.1: Summary of notation representing components of input data for MoNsTEr network model
distribution with model-wide variance parameter σ2:
εit ∼ N(0, σ2) ∀i, t (3.2)
The interaction function Φ is, generally speaking, intended to be a non-linear
representation for synergistic TF-Modifier interaction effects on target gene expres-
sion. The function can be computed prior to model-fitting, and therefore different
functions do not alter the complexity of the model or the computations discussed
in subsequent sections. In this work, I used a sign-corrected product in order to
capture a synergistic effect that is positive only when both input expression values
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are positive, and negative in all other cases:
Φ(fjt, hkt) = sign(min(fjt, hkt))|fjt ∗ hkt| =
{
fjt ∗ hkt iff fjt, hkt > 0
−|fjt ∗ hkt| otherwise (3.3)
This function is intended for normalized expression profiles with mean 0 (as enforced
by expression normalization, see Section 3.3), and has the preferable behavior that
it returns positive values only when fjt and hkt are both positive (corresponding to
high expression).
The model also allows the consideration of other types of high-throughput data,
in addition to expression by defining prior probabilities for the edge variables C
and D. Let b and m denote two N × J matrices of prior probabilities for TF-
Gene interactions based on different types of biological data regarding protein-DNA
interactions. In the applications presented here, bij is the prior probability that TF
j binds the proximal promoter of gene i based on a ChIP-seq binding experiment.
Similarly, mij is a prior probability derived from scanning the promoter of gene i
with a PWM describing the preferred binding sequence for TF j. Priors for TF-
Modifier interactions are derived from additional J × K matrices a (derived from
protein-protein interaction data) and s (derived from PWMs describing modifier-
specific substrate recognition motifs). Thus, the variable matrices C and D in the
model are given prior probabilities based on a weighted mixture of all available
biological priors, as follows:
P(Cij = 1) = b
wj
ij m
(1−wj)
ij (3.4)
P(Djk = 1) = a
uk
jk s
(1−uk)
jk (3.5)
The weight variables in the above equations, denoted collectively as w and u,
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each range from 0 to 1 and are also estimated as part of the model-fitting procedure.
Thus, no assumptions need to be made about the relative quality of each prior
source. Note that there are separate weight variables wj and uk for each TF j and
modifier k respectively. This was chosen because the quality of a given PWM or
ChIP-chip result set will typically vary more widely by TF, rather than by target
gene. Likewise, the PWM or interaction data for a modifier is also assumed to vary
more widely by modifier, rather than by substrate or interaction partner. Note that
when only a single type of prior is available for either C or D, then Eq 3.4 or 3.5,
respectively, simplifies to an unweighted use of the available prior. In other words, if
no PWM data is available for a particular TF j, then wj = 1, and P(Cij = 1) = bij
for all genes i.
Also note that given any full instantiation of values for C and D, Eq 3.1 be-
comes a linear regression and can be solved using a standard closed-form solution.
Although this problem can be solved as a linear regression, the relationship between
target gene, TF, and modifier expression values is non-linear because of the synergy
function Φ (Eq 3.3).
Model Estimation Method
The goal of this computational method is to estimate the posterior probabilities for
all model parameters, given the expression data and the priors. Once estimated, the
posterior probabilities of C and D can be used to probabilistically infer a network
with connectivity between target genes, TFs, and modifying enzymes. In addition,
the best-fit values of other parameters such as β and γ can be used to infer the
strength and directionality of these interactions. Let Θ denote the set of model
parameters {α,β,γ, σ,w,u}, excluding C and D. Let Ξ denote the complete set
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Symbol Description
α Vector of basal expression values for target genes, length N
β Vector of TF influence parameters, describing linear effect of TF on all target genes,
length J
γ Matrix of TF-Modifier synergy parameters, describing the sign and magnitude of
TF-Modifier synergy terms, size J ×K
C Matrix of indicator variables describing TF-Gene network connectivity, size N × J
D Matrix of indicator variables describing TF-Modifier network connectivity,
size J ×K
Φ General synergy function mapping expression values (fjt, hkt) to synergistic effect
of interaction between TF j and modifier k
εit Residual error for observed expression of gene i in sample t
σ2 Model-wide variance of residual errors
w Vector of weight variables to apply to b and m for each TF, length J , values in
range (0, 1)
u Vector of weight variables to apply to a and s for each modifier, length K, values
in range (0, 1)
τα Hyperparameter for the standard deviation of normal prior for all members of α
τβ Hyperparameter for the standard deviation of normal prior for all members of β
τγ Hyperparameter for the standard deviation of normal prior for all members of γ
Θ The set of all non-edge model parameters, (α,β,γ, σ2,w,u)
Table 3.2: Summary of notation representing parameters in the network model.
of biological data sources {g, f ,h,b,m, a, s}. Thus, the model can be completely
described by the set {Ξ,Θ,C,D}. The relative posterior probability of a model
configuration {Θ,C,D}, given a set of biological data Ξ is:
P(Θ,C,D|Ξ) ∝ P(g|f ,h,C,D,Θ) ∗ P(C|m,b,w) ∗ P(D|a, s,u) ∗ P(Θ) (3.6)
In other words, the posterior probability of a model given input data is pro-
portional to the product of the gene expression likelihood, the edge priors, and the
remaining parameter priors. The priors on all model parameters in Θ are the same
as in ref. [22]. Specifically, α, β, and γ are assumed to have normal priors with
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standard deviations τα, τβ, and τγ respectively. The τ hyperparameters are set to a
large value, e.g., 10,000, to make the parameter priors uninformative. The model-
wide variance, σ2, is assumed to have a prior defined by the χ2ν distribution with
ν = 2. The weight variables w and u are given uniform priors in the range (0, 1).
See Appendix A.1 for full derivations of these posterior distributions.
Solving for the full posterior distribution (Eq 3.6) analytically is an intractable
problem. However, it is possible to compute an “individual posterior” on each model
parameter given the biological data and fixed values for all other model parameters.
These equations form the basis for iterative approaches to estimating the model
parameters, and are derived in Appendix A.1.
The full posterior (Eq 3.6) can therefore be estimated in a standard iterative
framework, such as Gibbs Sampling [65] or hill-climbing. However, the posterior
distributions relevant to this model are typically highly multi-modal. This results
in many regions of the parameter space that are “locally good”, i.e. they are con-
siderably more likely than similar model configurations. In other words, there are
often multiple solutions for fitting the model to a given set of input data, which are
substantially different and roughly equal in their “goodness of fit”. This presents
a problem for normal statistical learning techniques, as maximization-based tech-
niques are only guaranteed to find local optima, and sampling techniques require an
impractical number of iterations to fully explore such a parameter space.
I present here a heuristic framework that combines several statistical learning
approaches to produce a good fit of the network model to the input data, with
partial or local estimates for key variables of interest. In short, a local estimation
algorithm is run in 3 phases, described in greater detail in Appendix A.2. In the first
phase, a fixed starting network is selected and other model parameters are fit to this
network using a closed form solution. In the second phase, all model parameters,
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including network edges, are iteratively maximized until sufficient convergence at
a local optimum. In the third phase, model parameters of interest are iteratively
resampled a fixed number of times to provide a more robust estimate around the
local optimum. Marginalized posterior distributions for each parameter of interest
are derived in Appendix A.3.
In order to robustly estimate the posterior probabilities, the local estimation
algorithm should be run multiple times. While the results of individual runs may
be of interest, there is a need to summarize across multiple results in order to score
each network edge in terms of how likely it is overall given the results of multiple
runs. In this work, I summarize multiple runs by averaging together the expected or
fixed value of each parameter in Θ and averaging together the estimated posterior
probabilities for each edge variable in {C,D} (see Appendix A.3).
The averaging method is only valid under the assumption that all individual
result sets are similar, i.e., that each run is an estimate around the same mode of
the solution space. To assess the validity of this assumption, I performed hierar-
chical clustering [82] of the individual network models returned by each run of the
algorithm. I used the vector of posterior probabilities assigned to all edge variables
(C,D) to represent each model and then compute the Euclidean distance between
all pairs of models. From this distance matrix, I performed complete hierarchical
clustering as implemented in R [66] and visually inspect the resulting tree. If the
overall tree structure does not show any clearly delineated clusters, then the com-
puted network models most likely represent estimates of the same solution mode
and can be averaged together for a more robust estimate. The clustering results in
the yeast application exemplify this criteria (see Section 3.5).
Conversely, if the tree shows several well-separated clusters, then the computed
network models were most likely sampled from multiple divergent solution modes.
44
The model is generally over-parameterized relative to the available data, and it
is therefore possible, but not necessarily incorrect, for subsequent runs to return
parameters that encompass substantially different networks. It is possible that the
underlying or “true” network that produced the input data cannot be completely
captured by this model, e.g., due to a mixture of cell types or genetic backgrounds
with different underlying networks included in the input data1. In this case, each
mode may capture a different view of the underlying network. At this time I do not
have a solution for summarizing over multiple modes, and prefer instead to analyze
the biological significance of each cluster individually. Whenever the dendrogram
indicated multiple modes, I selected an appropriate height cut-off for clustering the
models, and then averaged together and performed biological inference separately
within each cluster. The clustering results from the human B cell application in
Chapter 4 appear to be multi-modal based on this criteria (see Figure 4.2).
3.3 Data Sources and Pre-Processing
I initially applied MoNsTEr to simulated data and a well-studied network in S. cere-
visiae in order to demonstrate the accuracy of the model and estimation method.
In this section, I describe all procedures used to prepare input data for these appli-
cations.
In general, when defining the expression matrices, the genes used as TFs and
modifiers for a particular model application are always completely excluded from the
set of target genes. This is necessary because regulator expression data is used as
a proxy for regulatory activity, and attempting to simultaneously model their tran-
1The phenomenon of multi-modality can also occur due to violations of model assumptions, i.e.
a TF acting as activator for one set of genes and repressor for another. Thus, considering multiple
modes in the parameter space allows us to overcome these model limitations.
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scriptional regulation would more likely result in false positive connections. How-
ever, this limitation could be overcome if both protein-level and transcript-level
concentration measurements were available for TFs and modifiers in all conditions.
In order to derive PWM-based priors of any kind, the PWM is scanned along
a DNA or protein sequence to compute a score at each possible PWM-sequence
alignment. Each score can be converted to a p-value by comparing it to a distribution
of scores computed for some set of background sequences, e.g., random genomic
or protein sequences. This procedure is described in more detail in ref. [124]. A
conversion from p-values to prior probabilities was first introduced in ref. [22], and
is reviewed or adapted here where applicable. Also, as noted in ref. [22], all priors
(PWM-based or otherwise), must be “trimmed” so that they do not include extreme
values of 0 or 1, as these values prevent further estimation of posteriors by the model.
I limited the range of all priors to (0.05, 0.95) for all applications presented in this
work.
Simulated Data
Simulated data was primarily generated to test the accuracy of the model-fitting
method described in Section 3.2, and is not intended to demonstrate the biological
relevance of the underlying model or the simulated network properties. All input
data matrices in Ξ were initially simulated for a network containing N = 200 target
genes, J = 10 TFs, and K = 100 modifiers measured under T = 100 conditions.
This is a network of sufficient size to reliably assess the accuracy of estimated model
parameters without requiring substantial computing time. The expression values for
all TFs and modifiers in all conditions (f and h) were randomly sampled from the
normal distribution N(0, 1). The edge indicator variables Cij and Djk were selected
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at random with the following constraints:
• Each TF regulates 50–100 genes: 50 ≤
[∑N
i=1 Cij
]
≤ 100 ∀j
• Each TF is targeted by 1–20 modifiers: 1 ≤
[∑K
k=1 Djk
]
≤ 20 ∀j
• Each modifier targets 1–3 TFs: 1 ≤
[∑J
j=1 Djk
]
≤ 3 ∀k
Each parameter βj was randomly sampled from the normal distribution N(0, 0.3),
but was resampled whenever |βj| < 0.05. Each parameter γjk for which the corre-
sponding Djk = 1 was randomly sampled following the same procedure used for the
βj variables. The prior matrices {b,m, a, s} were all randomly sampled using the
standard Beta distribution to generate priors that are correlated to the intended net-
work, but also contain a substantial amount of noise. Each prior value was sampled
as follows:
bij,mij ∼ B(z, 1) ∀(i, j) : Cij = 1
bij,mij ∼ B(1, z) ∀(i, j) : Cij = 0
ajk, sjk ∼ B(z, 1) ∀(j, k) : Djk = 1
ajk, sjk ∼ B(1, z) ∀(j, k) : Djk = 0
Note that in the equations above, ‘B’ denotes a standard probability distribution
(the “Beta” distribution) and should not be confused with the prior matrix b or
the model parameters β. The variable z is randomly sampled from the uniform
distribution U(1.2, 1.5) independently for each column of each matrix, in order to
vary the relative quality of priors for each TF and each modifier.
The expression values for all target genes in all conditions (matrix g) were com-
puted according to Eq 3.1 with all residual error terms εit initially set to 0. Addi-
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tional versions of g were calculated with residual errors randomly sampled according
to Eq 3.2 using increasing values of σ2 = 0.05, 0.1, . . . , 1, denoted gσ2=0.05, etc.
For subsequent simulations, the input data was expanded to include other types
of noise, in the form of either additional, uninformative target genes, or additional,
uninformative conditions. In both cases, the matrix gσ2=1 was used as a starting
point, so these subsequent simulations also include a considerable amount of noise
in the informative target genes and conditions.
To add additional, unregulated target genes, the model was expanded to include
N = N0 +N
′ target genes, where N0 = 200 for the original, regulated target genes,
and N ′ = 20, 40, . . . , 200 for the additional, unregulated genes. All unregulated ex-
pression values were randomly sampled from N(0, 1). In other words, each additional
gene profile was completely random and unregulated by the TFs and modifiers in
the network.
To add additional, uninformative conditions, the simulated data was expanded
to include T = T0 + T
′ conditions, with T0 = 100 for the original, informative con-
ditions, and T ′ = 10, 20, . . . , 100 for the additional, uninformative conditions. All
expression values in the uninformative conditions were sampled from the distribu-
tion N(0, 1). In other words, each additional condition contained completely random
expression values, with no information related to network structure.
Yeast Network Input Data
I also applied MoNsTEr to a stress-response network in S. cerevisiae based around
a large number of MFG triplets catalogued in PTM-Switchboard (Chapter 2). The
network model encompasses N = 80 target genes, J = 2 TFs (MSN2 and MSN4),
and K = 81 modifiers (kinases). The data sources used for this application are
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Variable(s) Summary Data Type Source
g, f ,h Compendium of yeast microarray
experiments
Gene expression (mRNA) ref. [22]
m MSN2/4 binding sites PWM ref. [81]
a Yeast kinase substrate profiles PWM ref. [171]
Table 3.3: Data sources used as input for MoNsTEr application to yeast stress response network,
organized by model variable. All relevant literature citations are shown in the “Source” column.
summarized in Table 3.3.
Yeast Expression Compendium
I derived the expression matrices g, f , and h from an expression compendium,
previously compiled and normalized by Chen et al. [22]. This compendium includes
T = 314 samples compiled from 18 studies covering a diverse set of conditions
such as cellular stresses and cell cycle phases. The matrix f contains expression
profiles for the TFs MSN2 (YMR037C) and MSN4 (YKL062W). Matrix h contains
the available expression profiles for 81 kinases. Table 3.4 lists the known target
genes, decoy target genes, and kinases included in the network model. The matrix
g contains: (i) expression profiles for 40 known targets of MSN2/4, compiled in
PTM-Switchboard (Chapter 2), and (ii) 40 additional decoy target genes selected at
random from the remaining expression data, ensuring that no decoy gene had any
Gene Ontology (GO) [4] annotation suggesting involvement in stress response.
All rows (expression profiles) are further normalized to have mean 0 and variance
1, by applying the z-score transformation, for example:
git =
g
(raw)
it − µ(raw)i
σ
(raw)
i
∀i, t (3.7)
Similar transformations are also applied to expression profiles in matrices f and
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Known MSN2/4 Target Genes
APJ1 ECM4 GRX2 HSP42 NTH1 RAS2 TPS3 YGL036W
CPR1 GAC1 GSY2 HSP78 PIL1 SPS100 TRX2 YML131W
CTT1 GLK1 HSP104 HXK1 PNC1 SSA4 TSA2 YMR090W
CYC7 GPH1 HSP12 LAP4 PRX1 TPS1 TSL1 YMR315W
DDR48 GRE2 HSP26 MDJ1 PTP2 TPS2 YDL124W YNL134C
Decoy Target Genes
AAT2 CUE1 ILV1 LYS9 PIB1 RIX7 RPS6B VPS41
ASK1 EDC2 IML2 MEF1 PTM1 RPN1 RPT3 VPS62
CAR1 EMI5 KAR4 MPP10 PUS7 RPS14B SMY2 VRG4
CCT4 FMP52 LAG1 NAT1 RCR2 RPS29B THI20 YLF2
CTF3 HXT5 LEA1 NIP100 RIM4 RPS4A TRM10 YLH47
Kinase Genes
AKL1 CTK1 HSL1 KIN82 PKH2 RIM15 STE11 YCK2
ARK1 DBF2 IKS1 KNS1 PKH3 SAK1 STE20 YCK3
ATG1 DUN1 IME2 KSP1 PKP2 SAT4 SWE1 YGK3
BCK1 ELM1 IPL1 KSS1 PRK1 SKM1 TDA1 YPL150W
CDC15 FMP48 IRE1 MCK1 PRR1 SKS1 TOS3
CDC28 FRK1 KCC4 MEK1 PSK1 SKY1 TPK1
CDC5 FUS3 KIN1 MKK1 PTK2 SLT2 TPK2
CKA1 GIN4 KIN2 MPS1 RAD53 SNF1 TPK3
CLA4 HAL5 KIN28 NNK1 RCK1 SPS1 VHS1
CMK1 HRK1 KIN3 PBS2 RCK2 SSK22 YAK1
CMK2 HRR25 KIN4 PHO85 RIM11 SSN3 YCK1
Table 3.4: All target genes and kinases used as input for yeast MoNsTEr application, listed by SGD
gene symbol.
h. The z-score normalization strengthens the model assumption that residual er-
ror terms follow a normal distribution with 0 mean and uniform model-wide error
variance (Eq 3.2).
MSN2/4-Target Gene Priors from PWMs
In the yeast application, I derived a single matrix m for TF-Gene priors, using
previously published PWMs for MSN2 and MSN4 [81]. For each TF-Gene pair (i, j),
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I scanned both strands of the 700bp upstream region for each gene i, and recorded
the best (maximum) PWM score, denoted as Sij. I then scanned the same PWMs
against random genomic sequences to generate a background score distribution for
each PWM, thereby allowing conversion of each score Sij to a p-value Pij, using the
method in ref. [124]. I then converted each p-value to a prior probability following
the same equation used in ref. [22]:
mij = (1− Pij)2[`−Wj+1] (3.8)
In this case, ` = 700 is the fixed promoter length, and Wj is the width (in bases) of
the PWM corresponding to TF j.
Kinase-Substrate Priors from PWMs
I generated a single matrix s of priors for TF-Kinase connectivity by scanning each
TF protein sequence with a PWM describing the predicted substrate specificity of
each kinase. I first acquired the protein sequence of each known kinase present in
the expression compendium from SGD2 [58]. I then submitted each sequence to the
Predikin v2.0 web server3 [171].
Briefly, Predikin takes a kinase protein sequence as input, and constructs a
predicted substrate profile, as a PWM, from the known substrates of related kinases
with high accuracy (see ref. [171] for further details). Thus, for each kinase protein
sequence, Predikin returns a predicted PWM describing the most likely protein
sequences to be targeted by that kinase. The primary advantage of Predikin over
similar tools is its ability to generate a PWM for a wider range of kinases, although
the Predikin server failed to predict a PWM for a few kinases, and these were
2Accessed at: http://www.yeastgenome.org on 7/28/08
3Accessed at: http://predikin.biosci.uq.edu.au on 8/6/08
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discarded from the input set (not included in K = 81).
Next, I obtained the protein sequences for the TFs MSN2 and MSN4, also down-
loaded from SGD2. I scanned the PWM for each kinase k against the protein sequence
for each TF j, and recorded the maximum PWM score, denoted as Sjk. I also gener-
ated and scanned randomized protein sequences to create an appropriate background
score distribution for each kinase k. For each k, I used the background distribution
to transform all corresponding scores Sjk to p-values, denoted Pjk. These p-values
were then converted to prior probabilities, adapting Eq 3.8 above:
sjk = (1− Pjk)`j−Wk+1 (3.9)
In this case, `j is the length of the protein sequence for TF j, and Wk = 7 for all
kinase PWMs generated by Predikin. Ultimately, these priors represent a proba-
bilistic estimate of the biochemical constraints on the TF-Modifier network edges.
3.4 Analysis of Simulated Data
MoNsTEr was first applied to simulated input data to estimate the accuracy of the
model-fitting method described in Section 3.2. Initially, data was simulated from
a network of K = 100 modifiers, J = 10 TFs, and N = 200 target genes over
T = 100 conditions, with noisy priors but no noise in the expression data (σ2 = 0)
as described in Section 3.3. The model-fitting algorithm was run for 10 replicates,
and each run was initialized by randomly selecting each network edge according
to the geometric mean of the corresponding priors. This initialization procedure
is fairly stochastic, representing wide coverage of the possible solution space, and
is suitable for smaller networks. The results from all 10 runs of the model-fitting
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algorithm were then averaged together to compute posterior probabilities for the
edge parameters C and D.
To visualize the performance of the model-fitting method, I plotted a Receiver
Operating Characteristic (ROC) curve for the posterior probabilities C and D com-
pared to the known network structure used to simulate the data (Figure 3.2A,B).
For comparison ROC curves are also shown for each individual type of prior prob-
ability, and for TF-Gene expression correlations. The performance observed on the
ROC curves can be quantified by computing the Area Under the Curve (AUC)
metric. This metric indicates that MoNsTEr perfectly recovered the TF-Gene edges
(AUC = 1, solid blue line in Figure 3.2A). I evaluated the relative advantage of the
full model, as compared with using either the priors b or m alone, or expression
correlations between TFs and target genes, to predict the TF-Gene edges. These
alternatives all performed with lower accuracy than the full model, resulting in AUC
values < 0.75 (dotted and dashed blue lines in Figure 3.2). TF-Modifier edges were
substantially harder to infer, owing to their indirect effect in the expression model
(AUC = 0.78, solid green line in Figure 3.2B). However, MoNsTEr predicted these
edges with better accuracy than either simulated prior type alone (AUCs < 0.7,
Figure 3.2B). These results demonstrate that the observed performance of MoNsTEr
cannot be reproduced by simpler analyses of the individual data sources.
Simulated Sources of Noise
To further assess the effect of various types of noise on the accuracy of MoNsTEr,
three possible sources of noise were simulated: (i) individual expression errors εit,
(ii) the inclusion of additional genes unconnected to the network, and (iii) the in-
clusion of additional, uninformative expression samples (see Section 3.3). Also note
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Figure 3.2: Accuracy of MoNsTEr using simulated data, measured separately for posterior proba-
bilities of TF-Gene connectivity (solid blue lines) and TF-Modifier connectivity (solid green lines),
by the area under the ROC curve (AUC) for each network model. The accuracy of network priors
(dotted blue and green lines) and TF-Gene expression correlation (dashed blue lines) are shown for
comparison. A. ROC curves for TF-Gene edges with no expression noise. B. ROC curves for TF-
Modifier edges with no expression noise. C. Accuracy (AUC) for increasing model-wide variance
of gene expression residual errors. D. Accuracy (AUC) for increasing percentage of uninforma-
tive genes as compared to the number of informative genes. E. Accuracy (AUC) for increasing
percentage of uninformative expression samples as compared to the number of informative samples.
that the priors are consistently noisy throughout this analysis. For each set of noisy
input data, the model-fitting algorithm was run 30 times, using the same stochastic
initialization procedure as the previous analysis, and the model estimates were av-
eraged within groups of 10 runs, in order to also assess the variability of algorithm
performance. For each group of 10 runs, the average posterior probabilities for C
and D were used to recompute the AUC as in the previous analysis above. This
resulted in 3 AUC values for each analysis (1 for each group of 10 runs), which
were used to plot median performance as a function of different noise sources. “I-
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bars” are also drawn, spanning the min and max AUC values at each noise level
(Figure 3.2C-E).
Noise within the gene expression values was simulated by gradually increasing
the model-wide variance σ2 from 0 to 1 (matrices gσ2=0 thru gσ2=1 from Section 3.3).
Figure 3.2C shows that algorithm performance is unaffected by noise in the individ-
ual expression values, up to a degree of noise equivalent to the expression variance
for each regulator (TF or modifier). Note that this limit is essentially guaran-
teed in other applications by the z-score transformation applied to real expression
data (Eq 3.7).
For subsequent analyses, the value of σ2 = 1 was kept constant, and further noise
was added in the form of either additional gene profiles, or additional expression
conditions, neither of which contain any information relevant to the original network.
The motivation for this analysis is that real expression compendia will contain target
genes that are not targeted by any of the TFs of interest, and may also contain
expression samples in which the underlying network is disrupted due to non-model
elements, e.g., samples from a different cell-type. As described in Section 3.3, I
added either N ′ uninformative genes, or T ′ uninformative conditions. Figure 3.2D
shows the results for increasing numbers of unregulated genes, represented as a
percentage of the number of regulated genes (N0 = 200). Again, performance is
essentially constant. Similarly, Figure 3.2E shows the results for increasing numbers
of uninformative samples, plotted as a percentage of the number of informative
samples (T0 = 100). In this case, the inference of TF-Modifier connections were
negatively affected by this type of noise, but still out-performed individual prior
sources. Based on these detailed simulation studies, I conclude that the model-
fitting method can reconstruct an underlying network model despite substantial
noise, and with greater accuracy than the individual input data sources.
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3.5 Analysis of Yeast MSN2/4 Network
To assess the utility of this model for biological inference from experimental data, I
applied MoNsTEr to a well-studied stress response network in S. cerevisiae. I chose a
network based around the TFs MSN2 and MSN4 in order to validate against existing
knowledge of target genes [141] and upstream signaling components [137, 178] for
these two TFs, previously cataloged in PTM-Switchboard (Chapter 2). MSN2 and
MSN4 function redundantly to regulate a core transcriptional response to most
cellular stresses [21, 64]. Both TFs are regulated primarily at the post-translational
level, with various kinases controlling their nuclear localization [137, 178]. The yeast
input data set was prepared from the sources listed in Table 3.3, and includes data
for TFs MSN2/4, all yeast kinases for which sufficient data was available, 40 known
MSN2/4 target genes, and 40 decoy target genes (see Section 3.3).
The MoNsTEr model-fitting algorithm was run 100 times to fit all model param-
eters to the network of N = 80 target genes, J = 2 TFs, and K = 81 modifiers.
In each run, the algorithm was seeded using the same stochastic method as for the
simulated data analysis (see Section 3.4). A substantially larger number of runs
were used here as compared to the simulated data because fewer separate sets of
input data were analyzed, and therefore more run time could be dedicated to each
set of input data. There was also a clear increase in accuracy using a larger number
of runs in this case (data not shown). The 100 individual network model estimates
were hierarchically clustered as described in Section 3.2 (Figure 3.3A). In the ob-
served dendrogram, the clusters are not well-separated (most of the tree height is
within these clusters). This meets the criteria for a single solution mode, although
there is clearly some variability between individual model estimates. Therefore, the
parameter estimates for all 100 replicate models were averaged together to produce
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Figure 3.3: Hierarchical clustering of individual yeast models from 100 runs of the model-fitting
algorithm for: (A) the full model and (B) the TF-only model. In both model sets, there are no
well-separated clusters to indicate distinct solution modes.
a single estimate of model parameter values and posterior probabilities for C and
D. This entire model-fitting procedure was also repeated for a network model con-
taining only TFs and target genes, but no modifiers (see below), with hierarchical
clustering results shown in Figure 3.3B. Although the scale of this dendrogram is
altered due to the smaller number of edges in the TF-only model, there is a similar
lack of separation between clusters, and again all 100 model estimates were averaged
together.
Accurate Prediction of MSN2/4 Modifiers and Target Genes
I first assessed the accuracy with which MoNsTEr predicted known target genes for
MSN2/4. A ROC curve measuring the overall separation of true and decoy target
genes was constructed using the posterior edge probabilities estimated for C. For
comparison, additional ROC curves were constructed using the PWM-based prior
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Figure 3.4: ROC curves of MSN2/4 target gene selection in yeast network models. Curves are
drawn by computing the sensitivity and specificity from known and decoy target genes at all
possible thresholds for: (i) the magnitude of correlation between TF and target gene expression
profiles (dashed blue lines, AUC = 0.63); (ii) the prior probabilities m derived from PWMs (dotted
blue lines, AUC = 0.73); (iii) the posterior probabilities from MoNsTEr with no kinases (solid blue
lines, AUC = 0.82); (iv) the posterior probabilities from MoNsTEr with TF-kinase synergy terms
(solid green lines, AUC = 0.87). The difference between the AUC values for the MoNsTEr models
with and without kinases is significant with p-value = 0.0018 based on bootstrap tests.
probabilitiesm and the TF-Gene expression correlations as possible selection criteria
(Figure 3.4). The posterior edge probabilities estimated by the model had the
highest AUC (0.87), indicating the best separation of true and false TF-Gene edges.
In particular, there was a substantial gain in sensitivity at low false positive rates
appropriate for subsequent experimental design or network analysis. For example,
at a fixed false positive rate of 10%, MoNsTEr selected TF-Gene edges with a true
positive rate of 77.5%, while the PWM priors and expression correlation alone had
true positive rates of only 37.5% and 18.75% respectively.
I next assessed the accuracy with which MoNsTEr identified known modifiers of
TF activity. MSN2/4 are regulated in response to a wide range of cellular conditions
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Known Kinases MoNsTEr Results Prior
Symbol Ref. Role TF P (Djk = 1) γjk Rank Prob Rank
TPK1 [63, 72, 178] - MSN2 0.59 0.10 30 0.81 35
TPK2 [63, 72, 178] - MSN4 0.97 -0.13 7 0.82 35
TPK3 [63, 72, 178] - MSN4 0.90 0.07 14 0.82 35
SNF1 [137] - MSN2 0.73 0.07 22 0.95 10
RIM11 [84] + MSN4 1.00 0.22 1 0.85 32
SSN3 [26] - MSN2 0.54 0.06 34 0.85 10
YAK1 [121] + MSN4 0.58 0.09 31 0.58 60
Table 3.5: Kinases known to regulate MSN2/4 with corresponding results from MoNsTEr applied
to yeast input data. MoNsTEr results are reported for the TF with the highest posterior of con-
nectivity to each kinase. Results include the posterior probability P (Djk = 1), the associated
influence parameter γjk, and the rank of the posterior among all kinase connections to the TF.
For comparison, the prior probability and associated rank are shown in the right-most columns.
[64, 137], and many of the kinases in the input data are likely to have some indirect
effect on MSN2/4 activity. However, there is a small set of kinases in the input
data that have experimental evidence for direct regulation of MSN2/4 proteins,
specifically PKA [63, 72, 178], SNF1 [137], RIM11/GSK3 [84], SSN3 [26], and YAK1
[121] (Table 3.5). MoNsTEr estimated significantly higher posterior probabilities
D and influence parameters γ for these known kinases, as compared to all other
input kinases (Mann-Whitney test p-value = 0.007 for D, p-value = 0.047 for |γ|).
By comparison, prior probabilities sjk alone do not significantly favor the known
kinases modifying MSN2/4 activity. Furthermore, the ranks of known kinases in
the MoNsTEr network are significantly higher than those based on prior probabilities
sjk (Table 3.5, “Rank” columns, Mann-Whitney test p-value = 0.047).
To specifically assess the contribution of TF-Modifier synergy terms (Eq 3.3)
to target gene expression prediction, I repeated the model fitting procedure on a
network containing only the N = 80 target genes and J = 2 TFs, but no kinases
(K = 0). I found that the TF-only model had a lower AUC than the full model
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(see Figure 3.4), and a lower sensitivity (37%, interpolated from the ROC curve) at
a fixed 10% false positive rate.
Significance Analysis of ROC Curves
In order to assess the significance of the ROC curves in Figure 3.4, I performed
additional statistical analyses. Permutation tests [54] were performed for each indi-
vidual ROC curve, to determine the significance of the computed AUC values. In
this test, the edge discriminants, e.g., the posterior estimates C, are randomly per-
muted relative to the known true/false labels on these same edges. The AUC value
is recomputed for each permutation, and the p-value is the proportion of permu-
tations in which the randomized AUC value is higher than the originally observed
AUC value. I performed 10,000 permutations for the AUC values corresponding to
the following discriminants: full model posteriors C(+), TF-only model posteriors
C(−), PWM-based priors m, and the magnitude of expression correlation between g
and f . The resulting p-values are summarized in Table 3.6 (3rd column). All AUC
values were significant according to this test, indicating that each discriminant per-
forms significantly better than random selection of edges. In other words, none of
the AUC values in Table 3.6 are expected to occur by chance.
To assess the significance of the apparent improvement in AUC observed for the
Bootstrap: < C(+)
Discriminant AUC Permutation P-value 95% Conf. Int.
C(+) 0.87 < 10−5 - -
C(−) 0.82 < 10−5 0.0018 (0.015, 0.095)
m 0.73 < 10−5 0.00458 (0.035, 0.25)
|cor(g, f)| 0.63 0.00229 < 10−5 (0.16, 0.33)
Table 3.6: Significance of yeast application AUC values.
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full model posteriors C(+) as compared to other observed AUC values, I performed a
bootstrap analysis [54], as follows. For each of 10,000 bootstrap samples, I randomly
sampled 160 TF-Gene edges from the actual network with replacement and with
all assigned posteriors, priors, etc. Thus, for each individual bootstrap sample,
some edges may be ignored, and other edges may count multiple times, although
the overall sample size remains constant. If the observed improvement in AUC is
based on a small percentage of the overall network, then this apparent improvement
should disappear in many of the bootstrap samples. Thus, the p-value based on
bootstrap analysis is the proportion of bootstrap samples in which the AUC for the
full model, C(+), is no longer greater than another comparative AUC value (e.g.,
C(−), the posteriors from the TF-only model). These p-values are reported for each
of the AUC values as compared to the full model AUC (Table 3.6, 4th column). For
each bootstrap sample, I also computed the exact difference in AUC values between
C(+) and each other discriminant, and summarized these values as a 95% confidence
interval (Table 3.6, 5th column). All bootstrap p-values were significant, and all
differences in AUC had positive confidence intervals, indicating that the apparent
improvement in accuracy observed in the full model compared to all other tested
discriminants is unlikely to occur by chance.
Thus, in predicting the TF-Gene network, MoNsTEr provides a significant im-
provement over each individual data source used as input (bootstrap p-value =
0.00458). Furthermore, inclusion of kinases in the model resulted in a significant
improvement to the overall accuracy of MSN2/4 target selection (Figure 3.4, solid
lines, bootstrap p-value = 0.0018). Overall, the inclusion of modifiers in MoNsTEr
improves the model of MSN2/4 regulation of target genes, and enables the prediction
of upstream components for the transcriptional program.
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3.6 Discussion
In this chapter, I have presented a novel model-based method to infer regulatory
networks, MoNsTEr, that simultaneously predicts TF-Gene and TF-Modifier inter-
actions by integrating heterogeneous data types in a probabilistic framework. Sim-
ulation studies show that MoNsTEr is robust against a variety of noise sources. I
have further demonstrated the validity and usefulness of this method through an
application to the stress response network in S. cerevisiae mediated by MSN2/4.
Development of the Heuristic Model-Fitting Framework
A fundamental challenge in computational biology is the construction of models
that are both biologically comprehensive and computationally tractable. The TF-
Modifier interactions capture a critical and often ignored aspect of transcriptional
regulatory networks, but also render the model highly parameterized. As a result,
the exploration of possible models presents a computational and statistical challenge.
Chen et al. used a similar—but simpler—model [22] and were able to estimate
the joint posterior distribution over all parameters using standard Gibbs Sampling
[65]. The extended model presented in this chapter is substantially more complex
due to the additional network layer of TF-Modifier connectivity, and tends to result
in multi-modal distributions not easily traversed by the Markov Chain approach
used in Gibbs Sampling. As evidence of this, I initially attempted to estimate the
posterior of the MoNsTEr model using Gibbs Sampling. Reliable estimation using
Gibbs Sampling requires the sampling algorithm to reach convergence, which is
typically assessed by running several parallel runs (called chains) of the sampling
algorithm, and measuring a convergence statistic, Rˆ, based on observed parameter
values within and between chains [18]. It is not valid to begin drawing samples from
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the Markov Chains until they have converged, indicated by an Rˆ value close to 1 for
all parameters. I was unable to reach a satisfactory value of Rˆ for many parameters
after a substantial number of iterations—in some cases greater than 50,000—even
for a small network (data not shown). On the contrary, attempting to fit a model
with only TF regulators (no modifiers) via Gibbs Sampling converged in less than
5,000 iterations. Thus, I concluded that the convergence problems were specific to
the extended model.
As a practical alternative, I fit the model parameters using a heuristic that
identifies a sufficiently good solution for biological inference in the cases studied here.
In general terms, MoNsTEr leverages the prior knowledge of network structure, and
combines the merits of both maximization and sampling approaches. The accuracy
of MoNsTEr is improved by combining multiple independent runs of the model-fitting
procedure, given that each run estimates a similar network model, as demonstrated
by the results in this chapter.
Interpreting the TF-Modifier Influence Parameter
In addition to assigning a posterior probability for each TF-Modifier interaction, I
also estimate an influence parameter γjk. The magnitude of this parameter can be
used as an additional filter for the inference of TF-Modifier interactions that affect
gene transcription. In the yeast application, the magnitudes of γjk parameter for the
known MSN2/4-regulating kinases were all greater than 0.05, and were significantly
larger compared to the other kinases (Table 3.5, p-value = 0.047).
The sign of each γjk parameter potentially provides information on whether the
modifier up- or down-regulates the activity of the target TF. For example, in the
yeast application, the γjk values associated with several known modifiers are con-
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sistent with their known inhibitory or activating roles (Table 3.5). On the other
hand, the model is fit to steady state expression values, and therefore cannot cap-
ture any feedback loops that may alter the observed relationship between modifier
and TF. This suggests that while MoNsTEr accurately infers TF-Modifier edges, the
dynamics of these regulatory relationships need to be further explored under specific
experimental conditions.
Additionally, the function Φ (Eq 3.3) used to represent these interactions is based
on the biological intuition that synergistic effects only occur when both members are
sufficiently expressed, and has been successful in the applications tested. However,
this function does not have a symmetric intuition for negative synergistic effects,
i.e., when γjk < 0, this intuition may be lost. Ideally, a non-linear function that is
also monotonic in both fjt and hkt, and which fits the biological intuitions for both
positive and negative values of γjk could be developed. I leave the identification of
such a function for future work, but also note that it is trivial to implement new
interaction functions into the overall methodological framework.
Additional Data Available for Yeast
The yeast input data set used in this chapter lacks a TF-Gene prior matrix b
based on ChIP experiments. While there is publicly available ChIP-chip data for
the factors of interest, these experiments were performed in the absence of any
environmental stress [123]. The TFs MSN2 and MSN4 are primarily controlled
at the level of nuclear transport, and in the absence of stress, these factors are not
present at high concentrations in the nucleus. Unsurprisingly, few binding sites were
identified for these particular factors in normal growth conditions. I attempted to
derive a prior probability matrix b from this data set, but found that it resulted in
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an overly sparse network with lower performance (data not shown).
There is also publicly available data for yeast kinase substrates identified in vitro
through the use of protein microarrays [157]. I attempted to use this data set to
derive the prior matrix a, but ultimately rejected it for several reasons. For one,
quantitative data was not made public, and so I could only assign a general “high”
prior probability (e.g., 0.9) to their predicted kinase-substrate connections, and a
general “low” prior probability (e.g., 0.1) to all other interactions. This data set
was also especially sparse for the TFs of interest, and in particular none of the 81
kinases were predicted to phosphorylate MSN2. I also attempted to derive priors
from STRING [99], but once again, this resulted in an overly sparse network with
lower performance (data not shown).
Taken together, these unsuccessful attempts to include additional data sources
suggest that the use of multiple network priors is only beneficial when the priors are
of a sufficient density. From a theoretic perspective, I expect the method described in
this chapter to be more effective for filtering potential network structures suggested
by noisy prior knowledge, rather than for discovering completely novel interactions
with no prior evidence. This expectation is further supported by results in the next
chapter, where I apply MoNsTEr to a network mediated by the TF STAT1.
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Chapter 4
Analysis of the STAT1-Mediated
Network in Human B Cells
4.1 Introduction
I applied MoNsTEr (Chapter 3) to decipher the complex regulatory network medi-
ated by the TF STAT1 in human B cells. B cells play a critical role in the adaptive
immune response, and dysregulation of B cell networks can lead to a number of
human diseases including autoimmune disorders [201], leukemias [127], and lym-
phomas [176]. STAT1 is a pleiotropic and critical mediator of cellular responses to
a broad range of cytokines and growth factors, as well as B cell development and
function. STAT1 is subject to complex post-translational regulation, and improper
activity is implicated in human immune disorders and cancers [16, 39, 154, 177]. For
example, STAT1 is the primary regulator of IFN-γ signaling, which is essential for
anti-bacterial immune responses. IFN-γ signaling has both STAT1-dependent and
STAT1-independent components, but the role of each component and the amount
of cross-talk between downstream pathways remain unknown [73]. To gain a better
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mechanistic understanding of STAT1’s pleiotropic function, additional knowledge
is needed regarding the modifying enzymes and other modulators targeting STAT1
and their influence on the expression of specific STAT1 target genes.
The STAT1-mediated regulatory network is a particularly attractive applica-
tion for integrative methods, due to the availability of a variety of relevant high
throughput data (summarized in Table 4.1). Basso et al. previously generated a
compendium of 336 expression microarray samples from 62 different human B cell
sources, including cord blood, tumor samples, and 39 different cell lines [10]. STAT1
binding has been characterized by multiple groups, resulting in several high-quality
PWMs [209] and genome-wide ChIP-seq data [165]. Thus, there is sufficient data to
study the transcriptional regulatory network mediated by STAT1 in human B cells
using the integrative model-based method developed in Chapter 3. In this chapter,
I demonstrate how the network model can elucidate coordinated cellular responses
relevant to human physiology and disease. MoNsTEr predicts a module of STAT1
target genes and modifying enzymes active in B cells that is well-supported by the
STAT1 literature, but also includes novel hypotheses about the role of STAT1 in
specific signaling pathways.
4.2 Materials and Methods
Human B Cell Expression Compendium
I downloaded the expression compendium of T = 336 Affymetrix HGU95A microar-
ray samples of human B cell from ref. [10] in RAW format from GEO2 [9]. I processed
the raw data with RMA [96] in BioConductor [66], which outputs normalized expres-
2Accessed at http://www.ncbi.nlm.nih.gov/geo/ on 4/5/07, accession #GSE2350
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Variable(s) Summary Data Type Source
g, f ,h Human B cells, B cell-derived
cancers, and cell lines
Affymetrix HGU95A
gene expression
GEO: GSE2350,
ref. [10]
b STAT1 ChIP-seq in IFN-γ
treated HeLa S3 cell line
Illumina DNA
sequence reads
GEO: GSE12782,
ref. [165]
m STAT1 binding sites in
response to IFN-α/β (ISRE)
PWM TRANSFAC: M00258,
ref. [209]
m STAT binding sites in
response to IFN-γ (GAS)
PWM ref. [162]
a STRING Database,
“experimental” and
“pathway” channels1
Protein-protein
interactions
ref. [99]
Table 4.1: Data sources used as input for MoNsTEr application in human B cells, organized by
model variable. All relevant literature citations and database accessions are shown in the “Source”
column.
sion values on the log2-scale. I then filtered out all probe sets with low expression in
all conditions (max expression < log2(100)), or insufficient perturbation across the
samples (variance < 0.03). As for the S. cerevisiae data used in Chapter 3, each
remaining gene expression profile was further normalized to have mean of 0 and
standard deviation of 1 using Eq 3.7.
The expression compendium was then split into matrices g, f , and h, as follows.
The HGU95A microarray contained 4 different probe sets corresponding to STAT1,
which were highly correlated (r2 > 0.9 for all pairs). I calculated the mean of these
expression values within each sample to create a single representative expression
profile for STAT1 (matrix f , with J = 1). I also identified groups of probe sets
that corresponded to the same kinase or phosphatase gene and combined redundant
expression profiles. For each Entrez gene ID [132] corresponding to multiple probe
sets in a list of kinases and phosphatases on the HGU95A microarray, I applied
the clustering procedure shown in Box 4.1. Note that I still allow for a modifier to
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1. Identify all corresponding probe sets (expression profiles)
2. Identify the pair of expression profiles with the largest positive correlation, r2
3. If r2 > 0.5, average the corresponding pair of expression values within each
sample, and replace both profiles with the average expression profile
4. Repeat steps 2 and 3 until the criteria in step 3 is not met, or until a single
expression profile remains.
Box 4.1: Procedure for clustering probe sets annotated for the same kinase or phosphatase gene.
be represented by multiple expression profiles in the model input data if the probe
sets are not strongly correlated across the expression compendium. This process
resulted in K = 510 expression profiles for kinases and phosphatases (matrix h),
corresponding to 323 unique Entrez gene IDs. The remaining N = 8,973 probe
sets that passed the initial filtering, but did not correspond to STAT1, kinase, or
phosphatase genes, were treated as target genes (matrix g). No clustering was
applied to target gene probe sets, regardless of correlation. Thus, the probe sets
correspond to only 7,026 unique Entrez gene IDs. Combined expression profiles for
STAT1 and relevant modifiers were z-score normalized by the same method as for
individual probe sets (Eq 3.7).
STAT1-Target Gene Priors from ChIP-seq
To derive the TF-Gene prior matrix b, I obtained ChIP-Seq data for STAT1 from
GEO3 [9], previously published by Rozowsky et al. [165]. This data set includes
mapped reads for STAT1 ChIP-seq experiments and input DNA controls from IFN-
γ-treated HeLa S3 cells. I first filtered the data by removing all ambiguous or un-
mapped reads, then applied the Global Identifier of Target Regions (GLITR)
3Accessed at: http://www.ncbi.nlm.nih.gov/geo/ on 9/15/08 accession #GSE12782)
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algorithm [195] for peak-calling. Briefly, I used the filtered input DNA controls
from ref. [165] as “Pseudo” reads, and all input human DNA reads from ref. [195]
as “Background”. I removed duplicate start coordinates, then randomly removed a
small percentage (< 0.1%) from the remaining ChIP-seq start coordinates, such that
both the ChIP-seq and Pseudo input sets had the same number of unique start coor-
dinates. All other GLITR parameters were left at their default settings. The details
of mapping GLITR peak scores to prior probabilities are provided in Appendix B.
Each peak with probability > 0 after mapping was assigned to proximal target genes
based on a presumed promoter region of 1kb upstream from each annotated gene
region.
STAT1-Target Gene Priors from PWMs
STAT1 binds to two distinct motifs, depending on its dimerization partner and the
upstream signal triggering its activity [154]. The IFN-Stimulated Response Element
(ISRE) is typically bound by STAT1 in response to Type I IFNs (i.e. IFN-α/β),
while the IFN-γ-Activated Site (GAS) is typically bound by STAT1 in response to
the Type II IFN (IFN-γ). I used a PWM from TRANSFAC v10.2 [209] to represent
the ISRE motif (accession #M00258), and derived a PWM for GAS sites using 19
exemplary sequences compiled by Robertson et al. [162] (Figure 4.1).
I then scanned the same presumed promoter regions used for the ChIP-seq analy-
sis (1kb upstream from annotated gene regions) with both PWMs. As in Chapter 3,
each PWMmatch score was converted to a p-value following the strategy in ref. [124].
For each promoter i, I used the most significant p-value for either PWM, denoted
here as Pij. I then used an adjusted version of Eq 3.8 that accounts for the use of
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Figure 4.1: PWMs used to derive STAT1-Gene interaction priors mij . The upper PWM corre-
sponds to the IFN-Stimulated Response Element (ISRE) and the lower PWM corresponds to the
IFN-γ-Activated Site (GAS). Both PWMs are represented using WebLogo [37]
multiple PWMs to convert p-values to prior probabilities:
mij = (1− Pij)2[2`−(WI+WG−2)] (4.1)
Here, ` = 1000 is the length of the promoter sequence, WI = 15 is the width of the
ISRE PWM, and WG = 11 is the width of the GAS PWM. The exponent computed
in Eq 4.1 is the number of tests done against both PWMs for a single promoter
(both strands of sequence are scanned).
Modifier-STAT1 Priors from STRING
In this application, I considered only modifiers related to phosphorylation (kinases
and phosphatases), because two phosphorylation sites (Tyr-701 and Ser-727) are
known to be the primary regulators of STAT1 activity [39]. I derived a single TF-
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Modifier prior matrix a using selected channels of interest from the STRING database
v8.24 [99]. I then mapped STAT1 and all modifiers in the expression matrix h to
their corresponding STRING identifier via Entrez gene ID [132], and extracted all
protein links between STAT1 and the input modifiers. I used only the channel
scores titled “experimental” (denoted here as Se) and “database” (denoted here as
Sd), in order to focus on physical interactions, rather than the more generally defined
functional associations. I recomputed the combined score S for each link using the
Bayesian integration equation from ref. [202]:
S = 1− ((1− Se) (1− Sd)) (4.2)
Thus, each prior probability ajk corresponds to the recomputed score S for the link
between j = STAT1 and modifier k. All missing links were presumed to have ajk = 0
(therefore transformed to 0.05 by the restricted prior range described in Section 3.3).
Application of MoNsTEr to Human Data
Model-fitting procedures similar to those in Chapter 3 were applied to input matrices
{g, f ,h,b,m, a}. The network modeled here is approximately 30-fold larger than
the yeast network in Chapter 3, and therefore each run of the model-fitting algorithm
requires substantially more computing time. Rather than seed the algorithm with a
highly stochastic network, as I did for the yeast application, I opted to use a smaller
number of runs seeded with initial models closer to the network predicted by the
priors. I began by seeding the model-fitting method with a fixed network containing
only those edges with high prior probabilities. I ran the method 3 times with a fixed
start, in order to capture the small variation arising in the estimation phase. I
4Accessed at: http://string-db.org on 10/23/09
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• Non-Stochastic (NS): All network edges initalized by: Cij = 1 iff
√
bijmij ≥
0.75 and Djk = 1 iff ajk ≥ 0.75, all other parameters fit by OLS (3 runs)
• Perturbed Network (PN): All network edges initalized as in NS, then 1% of
edges switched at random, all other parameters fit by OLS (10 runs)
• Perturbed Parameters (PP): All network edges initalized as in NS, all other
parameters fit by OLS, then added random noise sampled from N(0, 0.05) (10
runs)
Box 4.2: Initialization procedures for multiple runs of MoNsTEr on human B cell data
then added a moderate amount of perturbation to the starting model, in order to
explore a larger portion of the solution space. I perturbed the network structure by
adding/removing edges at random. Alternatively, I perturbed the starting values of
numerical parameters by adding noise sampled from a normal distribution. Thus, I
ran the model-estimation heuristic multiple times, summarized in Box 4.2. Further
perturbations to the initialization phase did not identify any additional solution
modes (data not shown).
For all models, I used the thresholds P (Cij = 1) ≥ 0.9 to predict high-confidence
STAT1 target genes, and P (Djk = 1) ≥ 0.9, |γjk| ≥ 0.05 to predict high-confidence
STAT1 modifying enzymes.
Human B Cell Expression Permutation
As a control for the MoNsTEr network model, the expression values within each
profile (row) in g, f , and h were each randomly permuted with respect to conditions
t, in order to disrupt any biological regulatory signal in the data. I then repeated
the model-fitting method 10 times, using the same prior probabilities in m, b, and
a, and averaged together the model results. I repeated this entire permutation
and model-fitting procedure 10 times, and compared the distributions of model
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parameters across all permuted models to those in the primary STAT1 model.
Annotation Enrichment Analysis
To summarize the biological relevance of each network model, enrichment analy-
sis for predicted STAT1 target genes and modifiers was performed on each possi-
ble annotation using the BioConductor packages GOstats, GO.db, KEGG.db, and
org.Hs.eg.db [66]. I excluded all GO terms one or two levels below the ontology
root, as these tend to be the broadest and least informative. The significance of
annotation enrichment for putative target genes was performed using the hypergeo-
metric test with the full set of N candidate target genes from input matrix g as the
background set. As a comparison to individual data sources used for the MoNsTEr
application, I selected the same number of probe sets from lists of target genes
ranked by each of the input data sets alone, and repeated the enrichment analysis
for each of these lists. All reported p-values are corrected for multiple testing by
the Bonferroni method, i.e., multiplied by the number of tests performed for that
particular annotation class [54]. P-values that were greater than 1 after Bonferroni
correction are reported as ‘–’.
Due to the small sample size, and the general sparsity of pathway annotations,
it was not possible to reliably assess the significance of annotation enrichments for
STAT1 modifiers predicted by MoNsTEr against those predicted by STRING. Instead,
I selected the annotations with the strongest overall enrichment based on an odds
ratio. For each annotation “X” associated with at least one MoNsTEr-predicted
modifier, I computed the odds ratio of enrichment against the STRING-only list of
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modifiers, as follows:
Odds Ratio (X) =
% of MoNsTEr-predicted modifiers w/ annotation X
% of STRING-only modifiers w/ annotation X
(4.3)
For GO Biological Process (GOBP) annotations, I selected annotations associated with
at least 5 of the 21 MoNsTEr-predicted modifiers, and odds ratio > 2. For KEGG
Pathway annotations, which are sparser than GOBP annotations, I selected terms
with at least 3 of 21 MoNsTEr-predicted modifiers, and once again an odds ratio > 2.
4.3 MoNsTEr Predicts Three Distinct Network
Models
I applied MoNsTEr to input data for 7,026 unique target genes, 1 TF (STAT1), and
323 unique modifier genes encompassing most known kinases and phosphatases (see
Section 4.2). Consistent with a pleiotropic role for STAT1, and the fact that the
expression data covers a wide range of network perturbations, MoNsTEr predicted
three distinct network models given the available data (Table 4.1). I ran MoNsTEr
using several different initialization configurations to explore the overall model solu-
tion space and compute robust parameter estimates with reasonable efficiency (see
Section 4.2 for details). Model parameters from individual runs were hierarchically
clustered (see Section 3.2) and the resuling dendrogram is shown in Figure 4.2.
Note that there are much longer branches at the top of the hierarchy, indicating
well-separated clusters. Runs are labeled by the type of seeding method described
in Box 4.2, and the three major clusters are numbered I–III and outlined in green,
purple, and blue, respectively. I averaged model estimates together within each of
these clusters to produce three distinct network models.
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Figure 4.2: Hierarchical clustering of STAT1 network models estimated by 23 runs of MoNsTEr.
Distinct solution modes are outlined in green (I), purple (II), and blue (III).
As an overall comparison of the three network models, I first looked at basic
model properties, summarized in Table 4.2. The term β1 is the influence parameter
for STAT1, and describes the influence of STAT1, in general (independent of modi-
fiers), and whether it is an activator (β1 > 0) or repressor (β1 < 0). The term w1 is
the prior weight parameter for STAT1, and describes whether the inferred network
is more dependent on the ChIP-based prior matrix b, or PWM-based prior matrix
m. The number of targets is given in terms of probe sets, and is based on the
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Model β1 (s.d.) w1 (s.d.) target probe sets target genes
I 0.24 (0.003) 0.51 (0.003) 1,803 1,559
II −0.29 (0.07) 0.62 (0.008) 2,031 1,735
III −0.004 (0.0007) 0.26 (0.0006) 3,190 2,679
(Input) – – 8,973 6,975
Table 4.2: Properties of STAT1 network models averaged after hierarchical clustering. The number
of predicted targets is based on a threshold of P (Cij = 1) ≥ 0.9, and is shown as both the number
of individual probe sets (4th column), and the number of unique genes after mapping all probe
sets (5th column). For comparison, the total number of probe sets (N) and unique genes mapping
to these probe sets are shown in the bottom row.
threshold P (Cij = 1) ≥ 0.9. There is little overlap in the target genes predicted by
each model. Network models I and III share only 5 predicted targets, and networks
II and III share 95 predicted targets (by probe set). Network models I and II do
not share any predicted targets. This supports the notion that all three clusters of
model estimates are well-separated in the possible solution space.
The network model derived from cluster I produces the most reliable model for
several reasons. Most notably, the predicted targets in this model are significantly
enriched for known direct targets of STAT1, previously compiled by Roberston et al.
[162]. 23 of these known targets mapped to 39 probe sets in matrix g and of these,
25 (64%) were predicted by MoNsTEr (hypergeometric test p-value = 2.6x10−9). The
23 known direct target genes are listed in Table 4.3 with the corresponding HGU95A
probe set IDs present in the human B cell expression compendium.
Network I is also the only model with β1 > 0, which is in agreement with the
established role of STAT1 as an activator of transcription [39, 177]. This model has
w1 closest to 0.5, which indicates balanced use of the ChIP and PWM-based TF-
Gene priors. By comparison, model II is biased somewhat towards the ChIP-based
priors, which are limited to a singular cellular condition. Model III is heavily biased
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Gene Symbol Probe Set
ISG15
1107 s at
√
38432 at
IFI6
1358 s at
√
33832 at
34105 f at
37864 s at
√
GBP1 35735 at
√
FCGR1A/B/C 37220 at
√
CXCL10 431 at
√
IL6ST
35842 at
√
37621 at
√
IRF1 669 s at
√
INDO 36804 at
√
IFIT2
908 at
√
909 g at
√
IFIT1
32814 at
√
915 at
√
IFITM1 675 at
√
IFITM3 41745 at
√
Gene Symbol Probe Set
OAS1
38388 at
√
38389 at
√
FOS
1915 s at
√
1916 s at
√
2094 s at
SERPINA3 33825 at
ISG20 33304 at
CIITA
35616 at
41511 at
√
MVP 38064 at
√
NOS2A
1418 at
1419 g at
1948 f at
CCL2
34375 at
√
874 at
875 g at
√
ICAM1 32640 at
CD40
35149 at
35150 at
MX1 37014 at
√
Table 4.3: Gene symbols for verified direct STAT1 targets compiled by Robertson et al. [162],
with matching probe sets in the human B cell expression compendium.
√
indicates STAT1 target
is correctly predicted by MoNsTEr primary model.
towards the PWM-based priors, which are likely to have lower specificity in general
compared to the ChIP-based priors. Model III also predicts that STAT1 has very
weak influence on the predicted target genes (β1 ≈ 0).
To further compare these network models, I plotted histograms of the TF-Gene
priors, expression correlations to STAT1, and expression entropy [173] for the target
genes predicted by each network (Figure 4.3). These distributions further support
the selection of the model I as the most interesting and reliable solution mode.
Despite the fact that model II (purple bars) is more heavily weighted towards the
ChIP-seq prior matrix b, and is generally more enriched for target genes with higher
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Figure 4.3: Distributions of STAT1 network model properties. Distributions are shown for: (A)
ChIP-seq-based priors, (B) PWM-based priors, (C) STAT1-Target Gene expression correlation,
(D) Entropy of target genes. White bars represent background distribution for all target genes
used as input. Green, purple, and blue bars represent STAT1 target genes predicted by network
solution modes I–III, respectively.
bij priors, model I (green bars) is actually the most enriched for the group of target
genes with the highest bij scores (Figure 4.3A). This is also true for the PWM-based
priorsmij (Figure 4.3B). In other words, model I is the most enriched for target genes
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with the strongest prior scores based on both ChIP-seq and PWM. Model I is also
enriched for genes with the strongest correlation to STAT1 expression (Figure 4.3C).
Entropy [173] measures the overall broadness or lack of condition-specificity for
each target gene. Lower entropy indicates that a gene is specifically expressed in
a smaller set of expression samples in the compendium. Gene expression profiles
with low entropy are the most likely to represent active regulatory patterns rather
than random noise. Model III (blue bars), which also contains the largest number
of predicted targets, and the weakest STAT1 regulatory influence (Table 4.2), is
heavily biased towards target genes which appear to be the most random in their
expression patterns (Figure 4.3D). Model I is highly enriched for genes with lower
entropy, and therefore represents the strongest regulatory signal in the input data.
Based on the model comparisons described above, I chose model I as the “pri-
mary” model, i.e., the model most likely to capture the direct regulatory effects
of STAT1. This model is discussed in detail in the next section. In Section 4.5, I
discuss the possible biological implications of alternate network models II and III.
4.4 Analysis of the Primary STAT1-Mediated Net-
work Model
The primary STAT1 network model predicts that STAT1 regulates the transcription
of 1,559 unique target genes, represented by 1,803 probe sets in the input data. As
shown in Figure 4.4A, the predicted target genes generally have a greater expres-
sion correlation with STAT1 than the remaining input genes. The same is true when
comparing the priors bij and mij for the predicted target genes against all remaining
input genes (Figure 4.4B,C). However, none of these properties, by themselves, ac-
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Figure 4.4: Histograms of network edge properties for: STAT1 target genes predicted by the
primary network model (green), and all other input target genes (red). Distributions are shown
for (A) absolute correlations between STAT1 and target gene expression profiles across all input
samples, (B) ChIP-seq-based prior probabilities for STAT1 binding in the genes proximal promoter,
(C) PWM-based prior probabilities for STAT1 binding in the genes proximal promoter.
curately discriminate the same set of target genes predicted by MoNsTEr. Therefore,
the model-based prediction of network edges integrates the information embedded
in the priors and the expression data. Interestingly, the model correctly predicts
STAT1 as an activator, rather than repressor, of these target genes [39, 177].
As noted in Section 4.3, the primary network model is significantly enriched for
known direct targets of STAT1. Overall, the list of putative target genes is also
enriched for GO [4] and KEGG pathway [106] annotations relevant to both STAT1
and B cell functions (Table 4.4). With one exception, these annotations are not
significantly enriched among the top target genes predicted by any of the individual
data sources (Table 4.4, right-hand columns). A few additional, but biologically
unrelated annotations are specifically enriched among the top target genes predicted
by ChIP-seq, but otherwise there is little functional enrichment detectable in the
target genes predicted by individual data sources.
This network model also predicts 20 kinases and 1 phosphatase (represented by
23 probe sets, Figure 4.5) that influence STAT1 activity, including all 4 members
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GO Biological Process MoNsTEr Expr ChIP PWM
signal transduction 6E-08 – – –
regulation of I-kappaB kinase/NF-kappaB cascade 7E-06 – – –
regulation of signal transduction 5E-05 – – –
I-kappaB kinase/NF-kappaB cascade 2E-04 – – –
inflammatory response 4E-04 – – 0.049
positive regulation of I-kappaB kinase/NF-kappaB
cascade
4E-04 – – –
intracellular signaling cascade 7E-04 – – –
response to wounding 8E-04 – – 0.346
cell death 0.002 – – –
response to virus 0.003 – – –
protein kinase cascade 0.004 – – –
programmed cell death 0.005 – – –
apoptosis 0.007 – – –
negative regulation of biological process 0.01 – – –
biopolymer metabolic process – – 3E-07 –
nucleobase, nucleoside, nucleotide and nucleic acid
metabolic process
– – 2E-06 –
RNA metabolic process – – 0.006 –
regulation of cellular metabolic process – – 0.007 –
regulation of nucleobase, nucleoside, nucleotide and
nucleic acid metabolic process
– – 0.016 –
response to DNA damage stimulus – – 0.037 –
KEGG Pathway
Leukocyte transendothelial migration 3E-07 – – –
Focal adhesion 1E-05 – – –
Cell adhesion molecules (CAMs) 0.009 – – –
T cell receptor signaling pathway 0.01 0.835 – –
Cytokine-cytokine receptor interaction 0.012 – – –
ECM-receptor interaction 0.02 – – –
Table 4.4: Significantly enriched annotations (1st column) for gene targets in primary STAT1
network, using all gene targets in the input data as the background, with Bonferroni-corrected
p-values (2nd column). As a control, corrected p-values are also shown for the most correlated
genes (3rd column), and genes with the highest ChIP-seq and PWM-based priors (4th and 5th
columns). ‘–’ indicates a p-value > 1 after Bonferroni correction.
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Figure 4.5: STAT1 modifiers predicted by MoNsTEr primary network model. All predicted modifiers
have P (Djk = 1) > 0.9 and |γjk| > 0.05, and are ordered by decreasing |γjk|. DUSP3 and LCK
are modeled by multiple, uncorrelated probe sets, and therefore have multiple γjk parameters.
of the Janus Kinase family, which are well-characterized activators of the STAT
family [177]. Based on the γjk values, the most influential modifier in this STAT1
network model is JAK1, which has experimentally characterized roles in both Type
I and II interferon signal transduction through STAT1 [16]. Additional literature
supporting each predicted modifier is summarized in Table 4.5. Overall, 18 (86%)
of the predicted modifiers have existing evidence for specific regulation of STAT1
transcriptional activity.
All predicted modifiers have high STAT1 interaction priors ajk derived from
STRING [99], but not all modifiers with high priors were predicted by MoNsTEr (see
Discussion). Therefore the method specifically predicts modifiers likely to affect
STAT1 transcriptional activity in B cells and related cancers, given some prior
knowledge of general protein-protein interaction with STAT1. To further assess the
functional implications of the modifier list predicted by MoNsTEr as compared to
83
Modifier γ Value Summary of Supporting Literature
JAK1 0.29 Activator of STAT1 in both IFN-γ and IFN-α/β signaling [16, 154].
LCK 0.16, -0.05* STAT1 activation during HSV infection of T-Cells is LCK-
dependent [130].
RIPK1 -0.15 Competes with STAT1 for binding at TNF-α receptor [206], no
known effect on STAT1 TF activity.
SYK -0.15 STAT1 activation in response to IFN-α is SYK-dependent [188].
BMX 0.12 BMX activates STAT1 to promote target genes, including apoptotic
genes [23, 166, 208].
RPS6KA5 -0.10 Promotes STAT1 S727 phosphorylation in response to UVA in vivo
and phosphorylates this residue directly in vitro [221].
CSNK2B -0.09 No literature evidence
JAK3 -0.09 Mediates JAK/STAT signaling in response to IL-2-family cy-
tokines [75], activates STAT1 in macrophages [169].
TYK2 0.08 Activator of STAT1 in IFN-α/β signaling [16, 154].
MAPK14 0.08 Required for STAT1 S727 phosphorylation in IFN signaling [69].
Phosphorylates STAT1 S727 directly in response to UV stress [116].
AKT1 0.08 Mediates STAT1 S727 phosphorylation in IFN-γ signaling [149].
EIF2AK2 -0.08 Inhibits STAT1 transcriptional activity [212].
CAMK2G 0.07 Phosphorylates STAT1 S727, promotes TF activity [144, 205, 214].
PRKCD -0.07 Phosphorylates STAT1 S727, promotes TF activity [41, 43, 196, 222].
KIT 0.07 Phosphorylates STAT1 in vitro, activates and physically interacts
with STAT1 in vivo [32, 42].
DUSP3 -0.06, 0.12* Viral homolog VH1 inhibits STAT1 activity [145], interaction be-
tween endogenous DUSP3 and STAT1 has not been studied.
ERBB2 0.06 Interacts with STAT1 in vitro [102]. Overexpression in bladder can-
cer blocks IFN-γ-induced STAT1 activation [187].
FYN 0.06 Required for STAT1 phosphorylation in Angiotensin II-treated vas-
cular smooth muscle cells [200]. Required for STAT1 phosphoryla-
tion and DNA binding in EGF-treated JB6 cells [83].
PDGFRA 0.06 Activates STAT1 in response to platelet-derived growth factor [198].
FGFR3 -0.05 Can either activate [167] or inhibit [118] STAT1 TF activity, de-
pending on context. Known to be mutated with differential effect on
STAT1 activity in some multiple myeloma cell lines [164].
JAK2 0.05 Activator of STAT1 in IFN-γ signaling [16, 154].
Table 4.5: STAT1-Modifiers predicted by primary network model, listed by gene symbol, with γjk
value and summary of known role in STAT1 regulation. γjk values marked ∗ indicate a probe set
annotated for the same modifier, which corresponds to an incomplete transcript.
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GOBP Term MoNsTEr Count Odds Ratio
intracellular signaling cascade 15 5.69
protein kinase cascade 11 3.45
hemopoiesis 5 4.82
apoptosis 5 4.82
cell death 5 4.82
programmed cell death 5 4.82
hemopoietic or lymphoid organ development 5 4.82
protein amino acid phosphorylation 19 2.84
phosphorylation 19 2.84
organ development 10 2.14
system development 10 2.14
KEGG PATHWAY Term
T cell receptor signaling pathway 3 ∞
Tight junction 3 ∞
Adipocytokine signaling pathway 5 4.82
Jak-STAT signaling pathway 5 2.29
Table 4.6: Pathway annotations with strong odds ratios when comparing MoNsTEr-predicted mod-
ifiers to other modifiers predicted by STRING.
other interacting partners predicted by STRING, I compared the list of 21 MoNsTEr-
predicted modifiers to the remaining 17 modifiers (kinases and phosphatases only)
predicted only by STRING. These lists are too short for a robust statistical analysis,
but I observed obvious trends in the functional enrichment of the MoNsTEr-predicted
list as compared to the STRING-only list, based on the odds ratios (Eq 4.3). It is
striking that many of the annotations in Table 4.6 recapitulate known pathways
for STAT1, such as apoptosis, and related terms also enriched among the predicted
target genes (Table 4.4). The list also includes annotations relevant to B cells and
related cancers, such as hemopoiesis and hemopoietic or lymphoid organ develop-
ment.
As an additional control, I repeatedly permuted the expression values within
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each gene profile and recomputed the MoNsTEr network model (see Section 4.2). In
all cases, the permuted model predicted fewer target genes and upstream modifiers
for STAT1, with weaker β and γ influence parameters (Figure 4.6). This control
empirically demonstrates that the predicted network is the result of coherent signal
in both the expression and network prior data.
Additionally, I analyzed the known functional associations between STAT1 target
genes and modifiers predicted by this network model. The predicted modifiers of
STAT1 should be functionally linked to the predicted targets of STAT1 if the network
model truly captures biological functions mediated through STAT1. To test this,
I first extracted from the STRING database [99] functional association scores for all
pairs (i, k) in the human B cell input data. I recomputed the association scores by
excluding the “expression correlation” channel to avoid any commonality with the
input data that might bias the results. Note that these association scores were not
used to compute the STAT1-Modifier prior matrix a, and therefore are independent
of the input data used by MoNsTEr.
I separated the association scores into those within the primary network model,
i.e., for which both i was a predicted target of STAT1 and k was a predicted mod-
ifier of STAT1, and those outside the network (all remaining associations). I first
analyzed the density of associations in each category, based on the number of as-
sociations contained in STRING vs. the number of possible pairs (i, k). I found that
the density of defined associations within the network was approximately 4.5-fold
greater within the network (0.0219 vs. 0.0049), and this difference is highly signif-
icant according to Fisher’s exact test (p-value < 2.2E-16). I also compared the
distribution of the defined STRING scores, independent of density, and found that in
general the association scores defined for (i, k) pairs within this network were higher
than those outside the network (Figure 4.7, Mann-Whitney Test p-value < 2.2E-16).
86
0.05 0.25 0.45 0.65 0.85
P(C=1)
%
 o
f 
T
a
rg
e
t 
G
e
n
e
s
0
2
0
4
0
6
0
A
−0.01 0.07 0.15 0.23
STAT1 Beta
%
 o
f 
M
o
d
e
ls
0
2
0
4
0
6
0
8
0
1
0
0
C
0.05 0.25 0.45 0.65 0.85
P(D=1)
%
 o
f 
M
o
d
if
ie
rs
0
2
0
4
0
6
0
8
0
B
0.025 0.125 0.225
Gamma Magnitude
%
 o
f 
S
T
A
T
1
−
M
o
d
if
ie
r 
E
d
g
e
s
0
2
0
4
0
6
0
8
0
D
Figure 4.6: Primary STAT1 network model vs. permuted expression controls. Distributions of
model parameters for primary STAT1 network (green), and for the networks obtained from ran-
domly permuted expression data (blue) for: (A) STAT1-Gene posterior probabilities, (B) STAT1-
Modifier posterior probabilities, (C) STAT1 βj parameters, and (D) STAT1-Modifier γjk magni-
tudes.
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Figure 4.7: STRING functional associations between predicted STAT1 modifiers and putative target
genes within primary network model, compared to functional associations outside the primary
network.
Therefore, I conclude that this network predicts STAT1 target genes and modifiers
which are functionally coherent, i.e., involved in common biological processes.
4.5 Discussion
Biological Insights from the Primary Model
The primary MoNsTEr model predicted a large module of target genes regulated by
STAT1 in human B cells. This module is significantly enriched for known direct
targets of STAT1. Moreover, the genes in the module are enriched for GO biological
processes relevant to STAT1, such as apoptosis [92] and I-kappaB kinase/NF-kappaB
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cascade [206]. Other enriched GO terms suggest general STAT1 and B cell functions,
e.g., response to virus and inflammatory response (Table 4.4). Importantly, nearly
all of these annotations are not enriched among the top target genes as predicted
by ChIP-seq, PWM, or expression correlation analysis alone. Overall the functional
enrichment analysis of predicted target genes support the relevance of this network
model to the TF and cell type analyzed.
The primary STAT1 network model inferred by MoNsTEr also provides a com-
pelling list of potential STAT1 modifiers, including known, suspected, and novel
regulators of STAT1 transcriptional activity. This network model correctly iden-
tifies JAK1 (γjk = 0.29), TYK2 (γjk = 0.08), and JAK2 (γjk = 0.05) as positive
regulators of STAT1 activity. Notably, JAK1 has the strongest effect on STAT1
(γjk = 0.29) in this model and JAK1 is known to be a highly influential regulator of
both IFN-α/β and IFN-γ-dependent STAT1 activity [16]. Many of the other γjk pa-
rameter values for predicted STAT1 modifiers are supported by literature evidence
(Table 4.5). Many of the STAT1 modifiers predicted by MoNsTEr are annotated for
pathways related to the immune system, while STAT1 interaction partners predicted
only by STRING are not (Table 4.6). However, there are relatively few modifiers pre-
dicted by either method, as is expected, and many of these modifiers are poorly
annotated, limiting the power of any statistical test for this observation. Overall,
86% of the predicted modifiers are supported by existing literature (Table 4.5), with
the exception of several novel predictions discussed below. Furthermore, a role in B
cell function or STAT1 regulation specific to this cell type is a novel prediction in
most cases.
MoNsTEr predicts a novel association between the dual-specificity phosphatase
DUSP3/VHR and STAT1 transcriptional activity. This phosphatase has been shown
to dephosphorylate STAT5 in interferon signaling [88] and inactivate Erk2 and Jnk
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downstream of the T cell antigen receptor [2]. VH1, the vaccinia virus homolog
of DUSP3, is known to block STAT1 activation during infection [145]. However,
this analysis is the first to suggest a link between endogenous DUSP3 and STAT1
transcriptional control.
MoNsTEr also predicts Receptor-Interacting Protein Kinase 1 (RIPK1) as a direct
modifier of STAT1 transcriptional activity. RIPK1 is a kinase known to interact with
TNF receptor 1 (TNFR1) resulting in a switch between the pro-apoptotic and anti-
apoptotic responses to TNF-α. Experiments in 293T cells have shown that STAT1
can competitively bind TNFR1, displacing the interaction with RIPK1, and disrupt-
ing downstream signaling through the NF-κB pathway independently of STAT1 nu-
clear import or DNA binding [206]. Cancer progression models in mice have shown
that TNF-α can suppress tumor growth in a STAT1-dependent manner [213]. The
model presented here is the first to suggest that RIPK1 may antagonize signaling
through STAT1 in a way that affects STAT1 target gene transcription. In com-
bination with the predicted STAT1 target genes related to apoptosis and NF-κB
signaling (Table 4.4), the network suggests a critical role for STAT1 in balancing
the pro-apoptotic and pro-survival responses to TNF-α in tumor progression.
Influence of Input Data Sources on Model Parameters
The primary STAT1 network model inferred by MoNsTEr provides a compelling
list of potential STAT1 modifiers, including known, suspected, and novel regulators
of STAT1 transcriptional activity. I used two thresholds for the prediction of high-
confidence STAT1 modifiers, specifically: TF-Modifier edge posterior P (Djk = 1) ≥
0.9 and the influence parameter for this edge has magnitude |γjk| ≥ 0.05. This crite-
ria selects for TF-Modifier interactions with both an overall strong probability and
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a substantial effect on the expression of downstream target genes. This is important
because the overall posterior probabilities Djk are influenced by the corresponding
prior probabilities, as well as by the expression data. It is possible, in the model-
fitting procedure, for a TF-Modifier interaction with a strong prior probability to
be included in the model, even while its impact in Eq 3.1 is minimized by setting
γjk ≈ 0, especially when only one type of TF-Modifier prior matrix is available. I
chose the particular threshold |γjk| ≥ 0.05 based on the earlier S. cerevisiae analysis
(Section 3.5) in which all known modifiers met this threshold, and also because it
was outside the range of γjk values estimated using the permuted B cell expression
data as a control.
To further explore this issue, I generated scatter plots comparing the estimated
modifier interaction parameters (D and γ) to the individual input data sources.
First, I noticed that the edge posteriorsDjk are significantly biased by the edge priors
ajk (Figure 4.8A). This is partly because of the limited sensitivity demonstrated in
the simulation experiments, and also because we only have a single source of prior
information for TF-Modifier edges, as noted above. Overall, the selection of STAT1
modifiers in the network model appears to be restricted to only those with above
average prior probabilities based on the STRING database, even though no such
threshold is explicitly stated in our model. However, a strong prior probability does
not guarantee inclusion in the final network model, and our prediction criteria also
include a threshold on the γjk parameter. I confirmed that |γjk| is not biased by the
prior probabilities ajk or by expression correlations between STAT1 and individual
modifiers k in our primary model (Figure 4.8C,D).
Furthermore, the probabilities derived from STRING are only meant to predict
general protein-protein interactions, while our model specifically predicts interac-
tions that influence TF activity in the cell type analyzed. As previously discussed
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in Section 3.6, MoNsTEr can be thought of as a way to filter a list of possible inter-
actions represented as prior knowledge to a more specific set of putative functional
modifiers that fit the observed expression values. This idea is supported here by
the observation that many of the STAT1 modifiers predicted by MoNsTEr are anno-
tated for pathways related to the immune system, while STAT1 interaction partners
predicted only by STRING are not (Table 4.6).
Alternate STAT1-Mediated Network Models
As noted in Chapter 3, it is possible for multiple models fit to the same input
data to discover distinct and equally correct biological aspects of a network. For
example, if a TF acts as an activator at some promoters, but as a repressor at
others, there is no way for a single version of the MoNsTEr model to capture this.
However, the model-fitting algorithm can be run multiple times to identify two
distinct, but equally valid, models—one encompassing the activated targets of the
TF, and another encompassing the repressed targets.
In this chapter, the model-fitting algorithm produced three distinct network
models. I chose to follow up on one model that was well supported by the existing
knowledge of STAT1 targets and pathways, but it is likely that the remaining two
models capture some relevant aspects of STAT1 biology, discussed below. However,
it is unclear, without further experimental validation, whether these alternate mod-
els represent direct STAT1 activities, or broader downstream effects correlated to
STAT1. Therefore, I did not investigate the modifiers predicted by these network
models, because the TF-Modifier connections are ultimately inferred from their ef-
fects on target gene expression (Eq 3.1). In other words, questions remain about the
validity of the putative target genes in these models, and the modifier predictions
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Figure 4.8: Scatter plots investigating the dependence of STAT1-Modifier edge parameters Djk
and γjk on STRING-based priors ajk and STAT1-Modifier expression correlation. Plots shown for
(A) Djk vs. ajk, (B) Djk vs. expression correlation, (C) γjk vs. ajk, and (D) γjk vs. expression
correlation. Only the dependence in (A) is significant.
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can only be as reliable as the target gene predictions.
The average network model derived from cluster II in Figure 4.2 linked STAT1
to the negative regulation of 2,031 probe sets corresponding to 1,735 unique genes.
This set of genes is significantly enriched for annotations related to metabolic and
biosynthentic processes, as shown in Table 4.7, and once again these enrichments are
not found in top genes based on each individual input. However, this set of genes
contains none of the direct STAT1 targets compiled by Robertson et al. [162]. This
model also suggests a repressive role for STAT1 (β1 = −0.29), although STAT1 is
primarily characterized as an activator in the literature [39, 154]. Therefore I argue
that this network model is probably representative of downstream effects. However,
it does suggest that in general STAT1 activity is negatively correlated with cell
growth and proliferation in the analyzed expression data. Negative regulation of
these functions is a known downstream effect of STAT1 activity in many cell and
tumor types [160]. As with all of the network models, I cannot completely rule out
indirect or parallel effects, both in terms of the target genes and STAT1 modifiers.
I hypothesize that the network model derived from cluster III is most likely
artifactual or representative of broad cellular trends, rather than STAT1-specific
regulation. The value of the β1 parameter in this model suggests that STAT1 has
little direct influence on the predicted target genes, although this could simply
mean that STAT1 is completely dependent on upstream modifiers for the regulation
of target genes in this network model. The value of β1 is also within the range of
values observed when the input expression data is randomly permuted, making it
difficult to assess the significance of this model. Furthermore, the list of predicted
target genes is heavily biased towards high-entropy genes which are unlikely to
carry significant biological regulatory signal in the expression set (Figure 4.2D).
This target gene list is also enriched primarily for functional annotations related
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to the nervous system rather than the immune system, although these functional
annotations are still highly significant and would not be predicted using the PWM
scores alone (Table 4.8).
I offer several alternate hypotheses for this model. One possibility is that the
network reflects indirect regulatory connections between the modifiers and target
genes, but mediated by TFs other than STAT1. This may occur in the procedure
because other mediating TFs were left out due to lack of sufficient data. Another
possibility is that this model does represent a STAT1-mediated network, albeit one
that is not primarily active in B cells. This model is biased towards the PWM-based
priors, and therefore is more likely to identify STAT1 binding sites across all cell
types and signaling pathways. A role for STAT1 in regulating gene expression in
neurons has been experimentally demonstrated [27, 28]. In this case, the network
model parameters may be indicative that STAT1 is being decoupled from the reg-
ulation of these target genes by the upstream modifiers in the samples covered by
this particular expression compendium. Even if this is the case, it is likely that
additional false positive target genes were picked up due to the lack of a stringent
expression model. Ultimately, I cannot differentiate among these possibilities using
existing data.
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Table 4.7: Significantly enriched annotations (1st column) for gene targets in STAT1 network
model II, using all gene targets in the input data as the background, with Bonferroni-corrected
p-values (2nd column). As a control, corrected p-values are also shown for the most correlated
genes (3rd column), and genes with the highest ChIP-seq and PWM-based priors (4th and 5th
columns). ‘–’ indicates a p-value > 1 after Bonferroni correction.
GO Biological Process MoNsTEr Expr ChIP PWM
nucleobase, nucleoside, nucleotide and nucleic acid
metabolic process
5E−38 – 7E−08 –
biopolymer metabolic process 2E−27 – 4E−09 –
DNA metabolic process 4E−24 – 0.045 –
ribonucleoprotein complex biogenesis and assembly 4E−22 – – –
mRNA metabolic process 2E−21 – – –
mRNA processing 9E−21 – – –
RNA splicing 1E−18 – – –
DNA replication 3E−18 – – –
response to DNA damage stimulus 9E−17 – 0.003 –
DNA repair 4E−16 – 0.15 –
ribosome biogenesis and assembly 4E−16 – – –
cell cycle phase 1E−15 – – –
RNA metabolic process 1E−14 – 0.001 –
M phase 5E−14 – – –
oxidative phosphorylation 5E−14 – – –
mitotic cell cycle 2E−12 – – –
rRNA processing 3E−11 – – –
rRNA metabolic process 3E−11 – – –
electron transport 3E−11 – – –
M phase of mitotic cell cycle 1E−10 – – –
ATP synthesis coupled electron transport 4E−10 – – –
organelle ATP synthesis coupled electron transport 4E−10 – – –
macromolecular complex assembly 6E−10 – – –
mitosis 7E−10 – – –
DNA-dependent DNA replication 9E−10 – – –
cellular component assembly 1E−08 – – –
tRNA metabolic process 1E−08 – – –
mitochondrial electron transport, NADH to
ubiquinone
2E−08 – – –
cellular biosynthetic process 5E−08 – – –
nuclear mRNA splicing, via spliceosome 7E−08 – – –
RNA splicing, via transesterification reactions 7E−08 – – –
Continued on next page
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Table 4.7: Enriched annotations for gene targets in STAT1 network model II (continued).
GO Biological Process MoNsTEr Expr ChIP PWM
RNA splicing, via transesterification reactions with
bulged adenosine as nucleophile
7E−08 – – –
macromolecule catabolic process 2E−07 – – –
protein-RNA complex assembly 2E−07 – – –
organelle organization and biogenesis 8E−07 – – –
biopolymer catabolic process 3E−06 – – –
cellular macromolecule catabolic process 4E−06 – – –
purine nucleotide biosynthetic process 6E−06 – – –
ribonucleotide biosynthetic process 1E−05 – – –
protein metabolic process 5E−05 – 0.051 –
ribonucleotide metabolic process 6E−05 – – –
intracellular transport 6E−05 – – –
purine nucleotide metabolic process 8E−05 – – –
purine ribonucleotide biosynthetic process 1E−04 – – –
intracellular protein transport across a membrane 2E−04 – – –
protein folding 3E−04 – – –
purine ribonucleotide metabolic process 3E−04 – – –
cell cycle checkpoint 3E−04 – – –
macromolecule biosynthetic process 4E−04 – – –
spindle organization and biogenesis 5E−04 – – –
cellular catabolic process 5E−04 – – –
cellular protein metabolic process 9E−04 – 0.658 –
ubiquitin-dependent protein catabolic process 9E−04 – – –
tRNA aminoacylation for protein translation 0.001 – – –
amino acid activation 0.001 – – –
tRNA aminoacylation 0.001 – – –
tRNA processing 0.001 – – –
modification-dependent macromolecule catabolic
process
0.001 – – –
microtubule-based process 0.001 – – –
modification-dependent protein catabolic process 0.001 – – –
proteolysis involved in cellular protein catabolic pro-
cess
0.001 – – –
cellular protein catabolic process 0.002 – – –
cellular macromolecule metabolic process 0.002 – – –
nucleobase, nucleoside and nucleotide metabolic
process
0.003 – – –
Continued on next page
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Table 4.7: Enriched annotations for gene targets in STAT1 network model II (continued).
GO Biological Process MoNsTEr Expr ChIP PWM
RNA transport 0.004 – – –
nucleic acid transport 0.004 – – –
nucleobase, nucleoside, nucleotide and nucleic acid
transport
0.004 – – –
DNA recombination 0.006 – – –
double-strand break repair 0.006 – – –
RNA localization 0.007 – – –
protein catabolic process 0.007 – – –
interphase of mitotic cell cycle 0.01 – – –
transcription initiation 0.011 – – –
nucleoside monophosphate biosynthetic process 0.012 – – –
nucleoside monophosphate metabolic process 0.012 – – –
interphase 0.012 – – –
amino acid metabolic process 0.017 – – –
nucleotide biosynthetic process 0.017 – – –
sterol biosynthetic process 0.022 – – –
mRNA transport 0.023 – – –
translational initiation 0.025 – – –
recombinational repair 0.026 – – –
double-strand break repair via homologous recom-
bination
0.026 – – –
nucleoside phosphate metabolic process 0.032 – – –
nucleotide metabolic process 0.032 – – –
DNA replication initiation 0.038 – – –
ribonucleoside monophosphate biosynthetic process 0.039 – – –
ribonucleoside monophosphate metabolic process 0.039 – – –
coenzyme metabolic process 0.044 – – –
regulation of cellular metabolic process – – 0.002 –
regulation of nucleobase, nucleoside, nucleotide and
nucleic acid metabolic process
– – 0.002 –
ubiquitin cycle – – 0.024 –
regulation of RNA metabolic process – – 0.025 –
regulation of transcription – – 0.03 –
DNA damage response, signal transduction result-
ing in induction of apoptosis
– – 0.038 –
regulation of transcription, DNA-dependent – – 0.044 –
Continued on next page
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Table 4.7: Enriched annotations for gene targets in STAT1 network model II (continued).
GO Biological Process MoNsTEr Expr ChIP PWM
negative regulation of nucleobase, nucleoside, nu-
cleotide and nucleic acid metabolic process
– – 0.049 –
inflammatory response – – – 0.045
KEGG Pathway
Oxidative phosphorylation 2E−19 – – –
Proteasome 7E−11 – – –
Cell cycle 2E−09 – – –
Pyrimidine metabolism 3E−09 – – –
Aminoacyl-tRNA biosynthesis 1E−05 – 0.452 –
Purine metabolism 3E−05 – – –
RNA polymerase 3E−04 – – –
DNA polymerase 4E−04 – – –
Basal transcription factors 0.003 – – –
One carbon pool by folate 0.017 – – –
Ubiquitin mediated proteolysis 0.02 – – –
Biosynthesis of steroids 0.023 – – –
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Table 4.8: Significantly enriched annotations (1st column) for gene targets in STAT1 network
model III, using all gene targets in the input data as the background, with Bonferroni-corrected
p-values (2nd column). As a control, corrected p-values are also shown for the most correlated
genes (3rd column), and genes with the highest ChIP-seq and PWM-based priors (4th and 5th
columns). ‘–’ indicates a p-value > 1 after Bonferroni correction.
GO Biological Process MoNsTEr Expr ChIP PWM
neurological system process 9E−26 – – –
G-protein coupled receptor protein signaling path-
way
2E−19 – – –
synaptic transmission 2E−17 – – –
cell-cell signaling 5E−17 – – –
system development 9E−16 – – –
transmission of nerve impulse 4E−15 – – –
cell surface receptor linked signal transduction 5E−12 0.005 – –
nervous system development 4E−11 – – –
ion transport 3E−10 – – –
sensory perception 3E−09 – – –
organ development 1E−07 – – –
metal ion transport 1E−07 – – –
neuron development 8E−07 – – –
tissue development 3E−06 – – –
neurogenesis 4E−06 – – –
axonogenesis 7E−06 – – –
sensory perception of light stimulus 8E−06 – – –
visual perception 8E−06 – – –
generation of neurons 9E−06 – – –
G-protein signaling, coupled to cyclic nucleotide sec-
ond messenger
1E−05 – – –
neurite development 2E−05 – – –
neuron morphogenesis during differentiation 2E−05 – – –
neurite morphogenesis 2E−05 – – –
cellular morphogenesis during differentiation 4E−05 – – –
cyclic-nucleotide-mediated signaling 6E−05 – – –
potassium ion transport 7E−05 – – –
neuron differentiation 1E−04 – – –
cation transport 2E−04 – – –
feeding behavior 2E−04 – – –
Continued on next page
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Table 4.8: Enriched annotations for gene targets in STAT1 network model III (continued).
GO Biological Process MoNsTEr Expr ChIP PWM
muscle system process 5E−04 – – –
muscle contraction 5E−04 – – –
monovalent inorganic cation transport 5E−04 – – –
signal transduction 7E−04 – – –
G-protein signaling, coupled to cAMP nucleotide
second messenger
0.003 – – –
second-messenger-mediated signaling 0.003 – – –
cAMP-mediated signaling 0.013 – – –
neuropeptide signaling pathway 0.014 – – –
sodium ion transport 0.016 – – –
skeletal development 0.021 0.860 – –
ectoderm development 0.026 – – –
central nervous system development 0.028 – – –
brain development 0.041 – – –
biopolymer metabolic process – – 6E−18 –
nucleobase, nucleoside, nucleotide and nucleic acid
metabolic process
– – 7E−15 –
RNA metabolic process – – 1E−08 –
response to DNA damage stimulus – – 9E−06 –
ubiquitin cycle – – 2E−04 –
regulation of cellular metabolic process – – 3E−04 –
DNA metabolic process – – 4E−04 –
protein metabolic process – – 4E−04 –
RNA biosynthetic process – – 0.002 –
DNA repair – – 0.002 –
transcription, DNA-dependent – – 0.002 –
regulation of nucleobase, nucleoside, nucleotide and
nucleic acid metabolic process
– – 0.003 –
cellular protein metabolic process – – 0.005 –
regulation of RNA metabolic process – – 0.006 –
regulation of transcription – – 0.008 –
regulation of transcription, DNA-dependent – – 0.009 –
cellular macromolecule metabolic process – – 0.009 –
biopolymer modification – – 0.019 –
RNA splicing – – 0.029 –
Continued on next page
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Table 4.8: Enriched annotations for gene targets in STAT1 network model III (continued).
GO Biological Process MoNsTEr Expr ChIP PWM
mRNA processing – – 0.038 –
mRNA metabolic process – – 0.044 –
response to wounding – – – 0.048
KEGG Pathway
Neuroactive ligand-receptor interaction 2E−26 0.77 – –
Calcium signaling pathway 0.001 – – –
Cell Communication 0.013 – – –
C21-Steroid hormone metabolism 0.042 – – –
p53 signaling pathway – – 0.045 –
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Chapter 5
Reliable Identification of PTMs
Using Mass Spectrometry
This chapter adapted from Everett LJ, Bierl C, and Master SR “Unbiased statistical analysis for
multi-stage proteomic search strategies” Journal of Proteome Research 2010 9(2):700–707 with
permission from the American Chemical Society
5.1 Introduction
A major paradigm in proteomics is that of bottom-up sequencing by tandem mass
spectrometry (tandem MS). In bottom-up proteomics, proteins are digested into
shorter peptides with a sequence-specific protease, separated by high-performance
liquid chromatography, and ionized into the mass spectrometer by an electrospray
interface. Inside the mass spectrometer, the mass-to-charge ratio (m/z) is measured
for each ionized peptide, and the intensity of each peak in the spectrum represents
the relative abundance. In tandem MS, the dominant peptide species in this initial,
or precursor, scan (MS1) are each isolated in an ion trap and fragmented, typically by
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collision with an inert gas. Fragmentation methods are designed such that peptides
tend to fragment at an amide bond along the peptide backbone, and one of the
resulting fragments retains a charge. After fragmentation, the resulting product ions
are scanned again (MS2), measuring them/z values for the peptide fragments. Thus,
the precursor mass and MS2 spectrum can be observed for thousands of peptides
in a single experiment. Each PTM alters the mass of the modified peptide, and
therefore alters the intact m/z value and a subset of peaks in the MS2 spectrum
generated by the PTM-containing peptide [101]. For a detailed review of typical
LC-MS/MS workflows, see ref. [181].
The primary analytical task in computational proteomics is to identify the bi-
ological peptide that generated each MS2 spectrum. In theory, it is possible to
identify a series of peaks in the MS2 spectrum such that the difference in masses
correspond to each residue in the peptide (with any PTM). However, this task is
often complicated by the fact that a typical MS2 spectrum contains at least two
such ion series, corresponding to charge retention on either the amino- or carboxy-
terminus, and neither series is complete in most cases. Noise peaks, fragmentation of
other bonds, higher charge states, and imperfect mass accuracy further complicate
the task of sequencing an MS2 spectrum de novo [181].
A popular solution to sequencing by tandem MS is to instead compare experi-
mental spectra to a database1 of known protein sequences, typically translated from
open reading frames in the genome. Each matched pair in a database search—
consisting of a MS2 spectrum and its corresponding peptide—is designated a spec-
trum match. Thus, the complete solution space for any database search problem
is the set of all peptide sequences in the database, with all possible PTM states.
1The known sequences used for proteomic database searching are actually stored in a simple
text format, but this file is often referred to as the sequence “database”.
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Given the large number of possible PTMs, and the combinatoric complexity of mul-
tiple PTMs, it is impractical to search this solution space exhaustively, especially
when the problem must be solved for thousands of spectra generated in a single
experiment.
A common analysis strategy in proteomic database search algorithms, such as
X!Tandem [34] and Mascot [153], is to further limit the search space in several ways.
For each individual spectrum, the search space is also limited to peptides within a
predefined window around the measured parent ion mass. Furthermore, the peptides
derived from the sequence database can be limited to the cleavage patterns expected
from the digest enzyme used in sample preparation. At best, only a few potential
PTM types can be considered in a standard proteomics data analysis, even though a
much wider variety could be potentially be inferred from the available data [147, 150].
In other words, database search algorithms search only the a priori most likely
portions of the solution space at the cost of unexpected, but nonetheless biologically
interesting, spectrum matches.
Multi-Stage Search Strategies
Any search strategy can be considered to have multiple “stages” if one or more ad-
ditional peptide identification steps are taken based on information from spectrum
matches identified by searching the same data set. A typical example of this is
the model refinement option in X!Tandem [33], which first identifies a list of high-
confidence proteins based on fully enzymatic, unmodified peptides (initial stage)
and then searches this list of proteins for a larger range of possible peptides, in-
cluding peptides with one or more PTMs (refinement stage). The initial stage is
also typically limited based on knowledge of the enzyme used for protein digestion,
105
most commonly trypsin. The refinement stage is therefore typically used to iden-
tify nonenzymatic peptides resulting from in vivo cleavage, atypical digestion, or
unexpected fragmentation during the ionization process, in addition to PTM iden-
tification. A related problem to PTM identification is that of identifying single
amino acid substitutions—point mutations—which alter the mass of a residue in
the peptide sequence and therefore are mathematically equivalent to PTMs within
the context of the spectrum matching problem.
Other examples of multi-stage search include error tolerant search option in
Mascot [35], and the iterative search options in VEMS [135] and Spectrum Mill.
The multi-stage concept does not include strategies in which multiple searches are
performed independently and then combined, e.g., Scaffold [174]. This concept
also does not necessarily include strategies in which a single search stage is followed
by one or more filtering or statistical analysis steps, e.g., PeptideProphet [108].
In other words, for the method to be considered a multi-stage search strategy as
discussed in this work, each stage of the search must result in new matches, and
stages must be performed in an iterative manner.
The primary motivation for a multi-stage search strategy is that wide searches—
e.g., searches including peptides with nonenzymatic cleavages or multiple PTMs—
are often too slow and prone to false positives to be efficiently performed using a
single-stage strategy. This is especially true for mammalian proteomes, in which
even the limited search space of fully enzymatic and unmodified peptides is already
substantially large.
A secondary motivation for performing a multi-stage search is that the goals of
narrow searches are often different than the goals of wide searches. In a narrow
search, the primary goals are typically protein identification and quantification. A
wide search may include additional goals such as protein characterization through
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analyzing the biologically relevant PTMs of the protein. The basis of X!Tandem
model refinement is that narrow searches are sensitive enough for the goal of pro-
tein identification, and thus should be used initially for this task [33]. Subsequent
goals, including increasing the confidence of the initial protein identifications and
characterizing the PTM states of these proteins, can then be achieved through wider
searches that are specific to the initially identified proteins.
False Discovery Rate in Computational Proteomics
A single LC-MS/MS experiment can generate tens of thousands of MS2 spectra.
Thus, database searching requires the evaluation a large number of hypotheses, and
is prone to false positives if not corrected for multiple-testing. Furthermore, it is
well-established that the expected null distribution of peptide match scores varies
depending on the instrument parameters [30, 108, 114]. This presents a serious
challenge when filtering to a high-confidence set of peptide matches.
Proteomic database search results are typically controlled by False Discovery
Rate (FDR)—the expected proportion of false positive spectrum matches among all
accepted matches. However, the lack of a reliable null distribution makes it difficult
to use p-value-based approaches for FDR estimation [54]. One common solution to
this problem is the empirical estimation of the FDR by searching the same set of
experimental spectra against an equivalent database of “decoy” peptides, e.g., the
reverse of all sequences in the target database [46, 104, 105].
While impossible to compute analytically, the accuracy of decoy-based methods
have been demonstrated empirically using control samples of known protein ana-
lytes [109, 114]. Spectra generated from control samples can be searched against
a database containing the sequences of the true protein components, as well as a
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large number of additional sequences, such as the complete proteome of a distantly
related species. In this case, two forms of the FDR can be estimated. The con-
trol FDR is computed from the known identities of proteins in the control sample,
and relies on the assumption that spurious spectrum matches to these proteins are
negligibly rare if the sequence database contains a sufficient number of additional
sequences. The decoy FDR is computed using a reverse database, i.e., the same
strategy used for experimental samples of unknown composition. The control and
decoy FDR estimates can be compared at varying spectrum match score thresholds
to demonstrate the overall accuracy of the decoy FDR estimate.
FDR Estimation in Multi-Stage Search Strategies
Despite the fact that multi-stage search strategies have been proposed in the lit-
erature and implemented in several common search algorithms [33, 35, 147], little
consideration has been given to their compatibility with popular statistical methods
such as decoy-based estimates of the FDR [46, 104, 105] and validation using con-
trol samples [109, 114]. In this chapter, I identify key assumptions made by these
methods that can become problematic in validating and using a multi-stage search
strategy. I demonstrate these problems using a set of spectra generated from con-
trol samples and analyzed with the most widely used multi-stage search tool: the
model refinement option in X!Tandem [33]. I present solutions to these problems,
and implement one critical solution—the maintenance of forward and reverse protein
pairs in the model refinement stage—as a patch for the publicly available X!Tandem
source code [34]. I argue that, in general, multi-stage search strategies can be used
both to speed up protein identification tasks and to expand the scope of proteomics
analyses. However, special care must be taken to ensure that downstream statistical
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methods are not compromised in the process. The methods presented here provide
a template for validating other combinations of multi-stage search strategies and
statistical methods.
5.2 Materials and Methods
Preparation of Control Solution
A control solution of known proteins was prepared using the Universal Proteomics
Standard (Sigma-Aldrich, UPS-1), an equimolar mixture of 48 known proteins. Pro-
teins were resuspended in 50 µL of extraction reagent prior to reduction and alky-
lation with iodoacetamide (IAA) per the manufacturers instructions (PROT-RA
ProteoPrep kit, Sigma-Aldrich). Proteins were digested using a Trypsin Spin Col-
umn (TT0010, Sigma-Aldrich), and peptides were eluted with 2 rounds of 150 µL
of enzyme reaction buffer. The final volume was diluted to 500 µL and aliquoted
into 10 µL quantities, which were further diluted (10×) for an estimated final con-
centration of 1 fmol/µL.
LC-MS/MS Protocol
A single aliquot of control solution was analyzed in 6 technical replicates. For each
replicate, 1 µL (estimated 1 fmol of protein) of sample was loaded onto a reverse
phase LC column for 10 min, then separated using a 30-min gradient of 12-34%
acetonitrile at 300 nL/min. nESI-MS/MS was performed using an Advion TriVersa
Nanomate connected to a Thermo LTQ-Orbitrap. Spectra were obtained in data-
dependent mode, with MS1 spectra obtained with high mass accuracy and resolution
(R = 60,000) in the Orbitrap and MS2 spectra for the top 5 peaks obtained in the
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Search Times (sec)
Replicate MS2 spectra Single Multi Re-Rev
1 4,519 698 27 29
2 4,344 845 30 32
3 4,414 845 30 33
4 4,039 600 24 26
5 4,245 678 27 28
6 4,432 842 31 33
Total 25,993 4,508 169 181
Table 5.1: Replicate Data for Proteomics Analysis. Each replicate was generated from a control
sample of 48 known proteins. The number of MS2 spectra extracted from each RAW file is shown
in the second column. Run times for semi-tryptic searches are shown in columns 3 (single-stage
search), 4 (multi-stage search), and 5 (multi-stage search with corrected X!Tandem code). Searches
were run on a laptop with a 2.4 GHz Intel Core 2 Duo using a single thread.
linear ion trap. The 6 replicate runs resulted in a total of 25,993 MS2 spectra
(Table 5.1).
Preparation of Search Databases
The complete sequences for all proteins in the control mix (true positives) were
supplemented with 4,939 E. coli proteins that serve as known false positives. In
addition, the sequences for porcine trypsin and common contaminant proteins such
as keratins were added to the database used for all searches.
A separate version of this database was also generated by manually introducing
point mutations in silico into the sequences of control proteins. The locations of
point mutations were chosen to avoid changing any potential tryptic cleavage sites.
Locations were also chosen to occur in peptides that were identifiable in an initial
search of spectra using the database of correct sequences. At least one fully tryptic,
unmodified peptide per protein was left unchanged in this database to guarantee
that each protein could be identified in the initial search stage of X!Tandem.
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Spectrum File Conversion and Database Searches
Files in RAW format were converted to DTA format using DeconMSn v1.6 [136], and then
DTA files from each RAW file were converted to single mzXML files using the dta2mzxml
tool packaged in the Trans-Proteomic Pipeline (TPP) v3.5.1 [107]. mzXML files
corresponding to each technical replicate were searched individually against the
databases described above using X!Tandem v2008.02.01.1 [34]. All searches were
performed using a 50 ppm error tolerance on the parent ion mass and a 0.4 Da
error tolerance on the fragment masses. Scoring of spectra was performed using
the K -score module [131], unless otherwise noted. A fixed mass shift of 57.022 Da
was applied to Cysteine residues to account for alkylation, and a potential mass
shift of 15.994915 Da was allowed for Methionine oxidation. In most searches,
reversed sequences were generated on-the-fly by X!Tandem and searched simultane-
ously with the forward sequences. Alternatively, a reversed sequence database was
pre-generated and searched separately from the forward sequences, where noted. In
multi-stage searches, the refinement threshold was set to an Expect value of 0.1. I
developed a modified version of the X!Tandem source code to include the “Re-Rev”
option, which can only be used with model refinement and on-the-fly generation of
reversed sequences. This option changes how X!Tandem constructs the refinement
list—the shortened list of proteins to consider in the refinement stage—by first fil-
tering all reversed sequences from the list, then including the reversed sequence of
each protein on the list.
Fully tryptic peptides are defined as those with a cleavage site matching the
pattern [RK] | {P}, i.e., cleavage C-terminal to an Arginine or Lysine not followed
by a Proline, at both termini (except at the protein termini), and no more than
two sites matching this pattern within the peptide sequence (missed cleavages).
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“Semi-tryptic” peptides are defined as having one terminus that does not match the
cleavage pattern. Peptides containing 3–5 missed cleavage sites are also considered;
for convenience of nomenclature, I group these together into the “semi-tryptic” pep-
tide definition. For semi-tryptic multi-stage searches, the initial search stage was
used to identify fully tryptic peptides, and the refinement stage was used to identify
semi-tryptic peptides. For the comparable single-stage searches, the initial search
was used to identify both fully tryptic and semi-tryptic peptides for all proteins in
the database; no refinement stage was performed. For the point mutation searches,
an initial stage was used to identify fully tryptic peptides in the mutated database
described above, and the refinement stage was used to consider all possible point mu-
tations. Semi-tryptic peptides were not considered in the point mutation searches,
or vice versa.
FDR Analysis
The search results for each technical replicate were pooled together into a single
spectrum match set for each search strategy performed. For each unique spectrum
match score, the FDR for the subset of all matches with scores less than or equal
to this threshold was estimated using two different strategies: (i) using the known
identity of control proteins as true positives, called control FDR [109, 114], and (ii)
using the number of reverse matches divided by the number of forward matches,
called decoy FDR [46, 104, 105]. These FDR calculations are shown in Eq 5.1 and
Eq 5.2, respectively, for an arbitrary scoring method that produces scores x. In
different analyses, I applied these FDR calculations to thresholds on the default
“hyperscore” [34], the K -score [131], and the Expect score [57] (in which case, the
threshold was x ≤ X). Unless otherwise noted, FDR calculations are based on
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Expect score thresholds. Additional FDR values were also calculated for: (i) only
those spectrum matches identified in the initial search, and (ii) only those spectrum
matches identified in the refinement stage.
Control FDR(X) =
# of Incorrect Matches s.t. x ≥ X
# of Total Matches s.t. x ≥ X (5.1)
Decoy FDR(X) =
# of Reverse Matches s.t. x ≥ X
# of Forward Matches s.t. x ≥ X (5.2)
When computing control FDR for a multi-stage semi-tryptic search, matches
from the refinement stage were only considered correct if they could also be obtained
from the comparable single-stage search. When computing control FDR for a point
mutation search, matches from refinement were only considered correct if the point
mutation matched the true control sequence of the protein in the unaltered database.
Spectrum matches to contaminant proteins, including the trypsin enzyme used for
digestion, were excluded from all FDR calculations.
The control FDR and decoy FDR estimates were paired for each score threshold
and plotted to visually assess the accuracy of the decoy FDR. In these plots, a line
that roughly follows the diagonal (decoy FDR ≈ control FDR) indicates a reliable
estimate of the FDR using decoy matches. A line that skews into the top-left
quadrant of the plot (decoy FDR  control FDR) indicates an underestimation of
the FDR using decoy matches. A line that skews into the bottom-right quadrant of
the plot (decoy FDR control FDR) indicates an overestimation of the FDR using
decoy matches. Plots were smoothed by replacing the FDR value at each threshold
X with the lowest FDR value from the same estimation method at a threshold
greater than or equal to X. This is equivalent to computing a q-value [30, 104, 105].
At stricter thresholds X corresponding to low FDR values (1–5%), the decoy
FDR estimate is computed from a small number of decoy matches, and therefore
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is expected to have a larger variance due to sampling effects. Therefore, I also
applied a previously published error model [95] to the decoy FDR estimates, with
the alteration that I only computed F (a|n) for values of a ranging from 0 to the
number of observed forward matches. This allows for a comparison between the
control FDR and the 95% confidence interval of the decoy FDR estimate, to account
for sampling effects at low FDR.
5.3 Results
Control Sample Validation Bias in Multi-Stage Search Strate-
gies
The reliability and accuracy of statistical methods in proteomics can be demon-
strated empirically using spectra generated from control solutions of known protein
content [109, 114]. Although simplified control mixtures may not fully capture the
complexity seen in some experimental samples, they nonetheless have functioned as
a valuable standard for validating spectrum matches. The basic assumption of this
approach is that spectrum matches to control proteins (hereafter designated control
matches) are correct based on a priori knowledge of the analyzed sample. As long as
the search database contains a substantial number of additional, unrelated proteins,
the probability of a false positive match to a control protein is negligible. Thus, a
highly accurate estimate of the FDR can be computed from the control sequence
matches (the control FDR) and compared to more generally applicable estimates of
the FDR, such as the decoy FDR computed from reverse sequences.
The simple strategy just described is sufficient for validating statistical meth-
ods for single-stage searches, but it is insufficient for multi-stage searches. The key
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problem is that secondary search stages, such as X!Tandem model refinement, are
often used for characterizing the state of a protein, such as the presence of PTMs.
While a simple strategy can take advantage of a priori knowledge of the sample
content, there is often no comparable a priori knowledge regarding sample charac-
terization. That is, while a subset of well-known modifications on control proteins
may be known, there is insufficient knowledge on the complete set of potential
modifications across all control proteins to unambiguously label every modified or
nonenzymatic spectrum match as true or false. Thus, a search stage that specifically
aims to identify these types of peptides has no equivalent rule on which to base the
computation of the control FDR.
Another way to conceptualize this problem is as follows: during the initial search
stage (or, equivalently, for a single-stage search), the set of control proteins is only
a small portion of the overall search space. Thus, false positive matches to the
control proteins occur rarely by chance and the correctness of control matches can
be assumed. However, in the model refinement stage of a multi-stage search, the
list of proteins to search becomes enriched for control sample proteins, and false
positive matches occur with high probability.
To demonstrate this problem, I searched spectra from a set of six control sample
replicates with X!Tandem using a database of 48 known control solution proteins
and 4,939 E. coli proteins, using the multi-stage model refinement option to identify
semi-tryptic peptides in the refinement stage only. These searches identified a total
of 2,047 semi-tryptic matches from the control proteins (Figure 5.1). However, when
these spectra were searched against the same database using a single-stage search for
both fully tryptic and semi-tryptic peptides, only 261 semi-tryptic control matches
were identified, the majority of which overlapped matches from the multi-stage
search (Figure 5.1B). The majority of refinement-stage control matches could not
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Figure 5.1: Overlap of matches between single-stage search and multi-stage search for (A) fully
tryptic matches (Initial stage of multi-stage search) and (B) semi-tryptic matches (Refinement
stage of multi-stage search). Areas are not drawn to scale. Additionally, a negligible number (9) of
control matches were identified in both search strategies but matched different control proteins or
peptides (not shown). Reprinted from Everett LJ, Bierl C, and Master SR “Unbiased statistical
analysis for multi-stage proteomic search strategies” Journal of Proteome Research 2010 9(2):700–
707 with permission from the American Chemical Society.
be corroborated by a single-stage search and are likely to be false positives based
on the violation of the key assumption discussed above. Conversely, the matches
from the initial search stage, in which the necessary assumption is valid, are mostly
confirmed by a single-stage search (Figure 5.1A).
To test the assumption that semi-tryptic control matches from the refinement
stage are invalid if not confirmed by a single-stage search, I analyzed the distributions
of delta mass (Figure 5.2A), K -score (Figure 5.2B), and Expect score (Figure 5.2C)
on the semi-tryptic control matches occurring in both search results (Figure 5.2,
solid lines) or only in the refined search (Figure 5.2, dashed lines). For comparison,
I also plot these distributions for known false positive matches to E. coli proteins
(Figure 5.2, dotted line). Delta mass is the difference between the observed parent
ion mass, measured at high mass accuracy for this data set, and the theoretical
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Figure 5.2: Distributions of spectrum match properties for semi-tryptic control matches identified
in both searches (solid green lines) vs those identified in multi-stage search only (dashed blue
lines). The distributions for all known false positive matches are also shown for comparison (dotted
red lines). Distributions shown for (A) Delta Mass, (B) K -score, (C) Expect (log transformed).
Reprinted from Everett LJ, Bierl C, and Master SR “Unbiased statistical analysis for multi-stage
proteomic search strategies” Journal of Proteome Research 2010 9(2):700–707 with permission
from the American Chemical Society.
mass of the peptide from the database. For correct matches, a narrow delta mass
distribution centered near 0 is expected, while a wider delta mass distribution is
indicative of incorrect matches. K -Score [131] is a measure of similarity between
the observed MS2 spectrum and the theoretical spectrum. Lower K -Scores indicate
poorer matches and in general are more likely to be false positives. Expect score [57]
is the number of matches expected to occur by chance for a particular spectrum and
is estimated using the K -score distribution from all theoretical spectra within the
parent mass window of the observed spectrum. Lower Expect scores indicate more
significant matches, and thus, the log transformation also follows this trend. All of
these distributions are highly similar between the known false positive matches and
the semi-tryptic control matches identified only in the multi-stage search. Therefore,
simply using the list of known control proteins to mark matches as correct or incor-
rect is insufficient to accurately compute the control FDR when using multi-stage
search strategies.
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To more reliably identify true positive semi-tryptic matches, I next compared
each match from the refinement stage to the match for the same spectrum in a
comparable single-stage search (Figure 5.3A). If a spectrum matches the same con-
trol protein sequence in both the single-stage and multi-stage searches, then the
spectrum match from the refinement search is marked as correct. Otherwise, it
is considered a false positive when computing the control FDR. The decoy FDR,
computed for the refinement search results based on the reverse matches, is then
compared to the control FDR to determine its approximate accuracy.
Decoy-Based FDR Bias in the Refinement Stage
The decoy-based estimates of FDR [46, 104] rely on the basic assumption that false
positive matches occur against the forward and reverse sequences with equal proba-
bility [30]. While this has been repeatedly demonstrated empirically for single-stage
searches, the list of refinement proteins prepared by X!Tandem does not guarantee
an equal number of forward and reverse proteins, nor should such a proportion be
expected in practice.
There are typically very few reverse proteins in the refinement list and the prob-
ability of a false positive spectrum match to a reverse sequence in general becomes
much lower than the probability of a false positive spectrum match to a forward pro-
tein. The result is an unacceptable underestimation of the FDR specifically within
the set of matches obtained from the refinement stage (Figure 5.4B, dotted lines).
This bias is masked in cases where most matches are obtained from the initial search
(Figure 5.4A, dotted lines), but can still be problematic when the refinement stage is
used for protein characterization (e.g., PTM identification) and subsequent analyses
focus on is the spectrum matches returned by the refinement stage. I also analyzed
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Figure 5.3: Analysis workflows to analyze FDR estimates on multi-stage search using the refinement
stage to identify (A) semi-tryptic peptides and (B) point mutations. Semi-tryptic control matches
are marked correct only if they can also be identified in a single-stage search. Control matches with
point mutations are only correct if they match the original control sequence. ∗Marks the key step
introduced into the X!Tandem source code. Reprinted from Everett LJ, Bierl C, and Master SR
“Unbiased statistical analysis for multi-stage proteomic search strategies” Journal of Proteome
Research 2010 9(2):700–707 with permission from the American Chemical Society.
these results for the refinement hits in the FDR range of 0.1% to 10% FDR, as these
encompass FDRs used in most applications. The decoy FDR is compared to the
control FDR for a number of typical thresholds in Table 5.2. All cases where the
control FDR falls outside the 95% confidence interval for the estimated error range
of the decoy FDR [95] are shown in bold.
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Figure 5.4: Plot of the Control FDR, computed from known set of true and false positives, and the
Decoy FDR, computed from reverse sequence matches. FDR values are plotted for subsets of the
full result set over a range of possible Expect thresholds. A line close to the diagonal (black line)
indicates a reliable Decoy FDR. The results using the semi-tryptic workflow without the Re-Rev
patch (dotted blue line) and with the Re-Rev patch (dashed green line) are shown for (A) all
spectrum matches and (B) only the semi-tryptic spectrum matches. Reprinted from Everett LJ,
Bierl C, and Master SR “Unbiased statistical analysis for multi-stage proteomic search strategies”
Journal of Proteome Research 2010 9(2):700–707 with permission from the American Chemical
Society.
Decoy FDR Control FDR Rev / Fwd Counts 95% CI
0.1% 0% 0 / 101 NA
1% 0% 1 / 122 0%–4.1%
2% 1.6% 2 / 126 0%–5.6%
3% 3% 4 / 134 0%–7.5%
4% 9.9% 6 / 152 0%–8.6%
5% 20% 9 / 185 0.5%–9.2%
10% 90% 177 / 2129 NA
Table 5.2: FDR table for Semi-Tryptic analysis refinement-stage spectrum matches obtained from
X!Tandem. Column 1 contains the limit placed on decoy FDR, Column 2 contains the control
FDR calculated for the same Expect threshold, Column 3 contains the actual count of reverse and
forward spectrum matches (needed for error model), and Column 4 contains the range of possible
FDR values in the 95% Confidence Interval (CI) for the number of reverse matches observed [95].
CI was not computed for cases with 0 or greater than 25 decoys. Control FDR values that fall
outside the 95% CI are shown in bold.
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Artificial Point Mutations for Control Sample Validation
Identifying PTMs on specific residues in a complex mixture of (initially) unknown
proteins is a common use for multi-stage search strategies [33, 35, 135]. As with
semi-tryptic searches, this presents a problem for validation using control solutions
because the set of dynamic PTMs on all control proteins is not known completely
and would be laborious to validate experimentally. With this problem in mind, I pro-
pose another validative framework (Figure 5.3B) in which artificial point mutations
are introduced in silico into the control sequence database, and these mutations are
subsequently identified using the refinement stage. Each match identified in the re-
finement stage, that is, any match containing a point mutation, can be automatically
considered correct or incorrect solely on its sequence matching the original database
(prior to in silico mutation), without any need to run a comparable single-stage
search. As noted earlier in this chapter, point mutations are conceptually similar to
PTMs: both result in predictable mass shifts in the overall parent ion and a subset
of the fragment ions.
To test the validity of this approach, I once again compared the property dis-
tributions of matches corresponding to intended point mutations, i.e., those added
in silico (Figure 5.5, solid lines), and unintended point mutations, i.e., all others
predicted by the search algorithm (Figure 5.5, dashed lines). Here, the distributions
for all other false positive matches (E. coli, no point mutations) are provided for
comparison (Figure 5.5, dotted lines). The distributions for unintended point muta-
tions are more like the distributions for other false positives and are well-separated
from the distributions of intended point mutations. Therefore, introducing known
point mutations in silico is a reliable method for separating correct and incorrect
matches from the refinement stage.
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Figure 5.5: Distributions of spectrum match properties for point mutations matching the original
control sequences (solid green lines) vs non-matching point mutation matches (dashed blue line)
to demonstrate the reliability of in silico point mutations for automated validation on control
samples. Also included is the distribution of other known false positive matches with no point
mutations (dotted red line). Distributions shown for (A) Delta Mass, (B) K -score, (C) Expect (log
transformed). Reprinted from Everett LJ, Bierl C, and Master SR “Unbiased statistical analysis
for multi-stage proteomic search strategies” Journal of Proteome Research 2010 9(2):700–707 with
permission from the American Chemical Society.
Plots of control vs. decoy FDR at varying Expect thresholds using this alternate
analysis strategy are shown in Figure 5.6 (blue dotted lines). Once again, a strong
bias is demonstrated in the estimation of decoy FDR for spectrum matches in the
refinement stage (panel B). Results for the refinement stage spectrum matches at
common FDR thresholds are tabulated in Table 5.3.
An Improved Strategy for Unbiased FDR Estimates
To correct the bias demonstrated in multi-stage refinement searches, I modified the
X!Tandem source code to adjust the refinement list prior to a refinement search
stage. Specifically, the initial refinement list contains all proteins for which at least
one peptide was identified with an Expect score less than 0.1; this is the list of
proteins to be considered in the refinement stage of the search. The adjustment
that I implemented filters all reversed proteins matched by chance from this list,
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Figure 5.6: Plot of the Control FDR and the Decoy FDR. The results using the point mutation
workflow without the Re-Rev patch (dotted blue line) and with the Re-Rev patch (dashed green
line) are shown for (A) all spectrum matches and (B) only the spectrum matches containing point
mutations. Reprinted from Everett LJ, Bierl C, and Master SR “Unbiased statistical analysis for
multi-stage proteomic search strategies” Journal of Proteome Research 2010 9(2):700–707 with
permission from the American Chemical Society.
Decoy FDR Control FDR Rev / Fwd Counts 95% CI
0.1% 9.9% 0 / 160 NA
1% 13.2% 1 / 167 0%–3%
2% 36.1% 4 / 227 0%–4.4%
3% 79.5% 18 / 706 1%–4.1%
4% 79.5% 18 / 706 1%–4.1%
5% 79.5% 18 / 706 1%–4.1%
10% 79.5% 18 / 706 1%–4.1%
Table 5.3: FDR table for point mutation analysis refinement-stage spectrum matches obtained
without the Re-Rev patch. Control FDR values shown in bold fall outside the 95% Confidence
Interval (CI) computed for the corresponding Decoy FDR value [95].
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Decoy FDR Control FDR Rev / Fwd Counts 95% CI
0.1% 0% 0 / 99 NA
1% 0% 1 / 112 0%–4.5%
2% 0% 2 / 117 0%–6%
3% 0.8% 3 / 122 0%–6.6%
4% 1.5% 5 / 131 0%–8.4%
5% 1.5% 5 / 131 0%–8.4%
10% 2.9% 12 / 135 2.2%–15.6%
Table 5.4: FDR table for semi-tryptic analysis refinement-stage spectrum matches obtained with
the Re-Rev patch. All Control FDR values fall within the 95% Confidence Interval (CI) [95].
and then adds the corresponding reversed (decoy) protein for each forward (target)
protein in the refinement list. The goal of this step is to maintain the approximately
equal probability of false positive matches to forward and reverse sequences. To
test this correction, I compared results from both semi-tryptic and point mutation
refinement searches performed with and without refinement list adjustment. The
results (Figures 5.4B and 5.6B, dashed lines) demonstrate that the marked FDR
bias was removed in both the semi-tryptic and point mutation searches. Results
for the refinement spectrum matches at common FDR thresholds are tabulated in
Table 5.4 for semi-tryptic searches and Table 5.5 for point mutation searches. In
semi-tryptic searches, this adjustment adds only several seconds to the run time of
each search while still representing an overall reduction of 96% in the total search
time as compared to the corresponding single-stage search (Table 5.1).
FDR Bias is Independent of Search Parameters
In order to confirm that the results found in this analysis can be generalized to
other FDR estimation methods, I performed similar analyses using slightly different
search or estimation parameters. First, using the same search results and rules
about defining false positives as in the analyses above, I recalculated the control
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Decoy FDR Control FDR Rev / Fwd Counts 95% CI
0.1% 3% 0 / 132 NA
1% 3% 1 / 132 0%–3.8%
2% 5.9% 2 / 136 0%–5.1%
3% 6.6% 4 / 137 0%–7.3%
4% 8.6% 5 / 140 0%–7.9%
5% 9.2% 7 / 141 0%–9.9%
10% 13.5% 14 / 148 2.7%–16.2%
Table 5.5: FDR table for Point Mutation analysis refinement-stage spectrum matches obtained
with the Re-Rev patch. Control FDR values shown in bold fall outside the 95% Confidence
Interval computed for the corresponding Decoy FDR value [95].
FDR and decoy FDR using thresholds on the raw K -score value of each spectrum
match (instead of the Expect score, used above). The results for the semi-tryptic
validation pipeline are shown in Figure 5.7 and the results for the point mutation
validation pipeline are shown in Figure 5.8. In both cases, there is still a clear
underestimation of the FDR using decoy hits (blue dotted line in Figures 5.7B and
5.8B), which is corrected when using the Re-Rev patch to the X!Tandem code (green
dashed line). Thus, I conclude that the observed bias is not an artifact of using the
Expect score as a threshold for estimating FDR values.
I repeated the searches performed in the primary analysis using the default
X!Tandem scoring module, or “hyperscore”, in place of the K -score module. Fig-
ures 5.9 and 5.10 show the score distributions for semi-tryptic and point mutation
analyses, respectively. In both cases, the distribution of control protein spectrum
matches from the refinement stage that I marked as false positives (based on the cri-
teria established above) is more like the distribution of other false positive matches
(E. coli decoys) than the other presumed true positive matches. This confirms that
the reliability of both validation methods is not specific to the K -score module.
Figures 5.11 and 5.12 show the FDR estimates for the two validation methods using
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Figure 5.7: FDR Analysis using K -score thresholds instead of Expect, with semi-tryptic peptides
identified in refinement stage. Reprinted from Everett LJ, Bierl C, and Master SR “Unbiased
statistical analysis for multi-stage proteomic search strategies” Journal of Proteome Research 2010
9(2):700–707 with permission from the American Chemical Society.
different thresholds on the Expect score. In both cases, there is still a clear under-
estimation of the FDR using decoy matches (blue dotted lines), which is corrected
when using the Re-Rev patch to the X!Tandem code (green dashed lines). Thus, I
conclude that the observed bias is not an artifact of using the K -score module.
Other reports on FDR analysis have suggested that it is generally more accurate
to estimate FDR by comparing spectrum matches identified in separate database
searches of the forward and reverse sequence databases [104]. I tested whether the
observed bias here was simply a result of searching the forward and reverse databases
simultaneously. For the semi-tryptic pipeline I performed three additional searches
of the experimental spectra:
1. spectra vs. forward database, multi-stage search
2. spectra vs. forward database, single-stage search
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Figure 5.8: FDR Analysis using K -score thresholds instead of Expect, with point mutations iden-
tified in the refinement stage. Reprinted from Everett LJ, Bierl C, and Master SR “Unbiased
statistical analysis for multi-stage proteomic search strategies” Journal of Proteome Research 2010
9(2):700–707 with permission from the American Chemical Society.
3. spectra vs. reverse database, multi-stage search
To compute the control FDR, spectrum matches to the control proteins in search #1
were only considered correct if they were also identified in search #2. To estimate
the FDR from decoy matches, at each threshold the decoy FDR was estimated as
the number of spectrum matches from search #3 passing the threshold divided by
the number of spectrum matches from search #1 passing the threshold.
For the point mutation pipeline, I performed two additional searches of the
experimental spectra:
4. spectra vs. forward database (with point mutations), multi-stage search
5. spectra vs. reverse database (with point mutations), multi-stage search
As in the previous analyses, I considered point mutation spectrum matches from
search #4 to be correct only if they matched the sequence in the true, unaltered
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Figure 5.9: Score distributions using the default scoring module instead of K -score (semi-tryptic
refinement stage). Reprinted from Everett LJ, Bierl C, and Master SR “Unbiased statistical anal-
ysis for multi-stage proteomic search strategies” Journal of Proteome Research 2010 9(2):700–707
with permission from the American Chemical Society.
sequence database. To estimate the FDR from decoy matches, at each threshold
the decoy FDR was estimated as the number of spectrum matches from search #5
passing the threshold divided by the number of spectrum matches from search #4
passing the threshold.
Figures 5.13 and 5.14 show the score distributions for the separated semi-tryptic
and point mutation search analyses, respectively. As with the previous analyses,
the semi-tryptic spectrum matches to control proteins identified in the refinement
stage that do not pass the additional criteria indeed follow score distributions more
like those of known false positive matches. Thus, both validation methods are
also applicable when searches are performed separately on the forward and reverse
sequence databases.
Figures 5.15 and 5.16 show the FDR estimates for both validation methods.
In both cases, there is still substantial underestimation of the FDR for refinement
matches when using reverse decoys (dotted blue lines, B panels). The X!Tandem Re-
Rev patch cannot be applied in the case of separate forward and reverse searches,
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Figure 5.10: Score distributions using the default scoring module instead of K -score (point muta-
tion refinement stage). Reprinted from Everett LJ, Bierl C, and Master SR “Unbiased statistical
analysis for multi-stage proteomic search strategies” Journal of Proteome Research 2010 9(2):700–
707 with permission from the American Chemical Society.
because the choice of reverse proteins used for refinement would need to be informed
by the forward proteins selected for refinement in the separate forward search. Thus,
there is no corrected FDR estimate shown in these figures. The bias in the decoy
FDR is not as severe when using model refinement to identify semi-tryptic peptides,
and may not be an issue within the desirable range of FDR cut-offs. However,
there is still severe bias observed when using the model refinement for point muta-
tions. Therefore, I conclude that separating the searches of the forward and reverse
databases is not a general solution to the problems discussed in this chapter.
5.4 Discussion
High-throughput protein identification remains a fundamental challenge for modern
proteomics. Additionally, the recent focus on identifying functional PTMs has added
complexity by increasing the search space of peptide matches that must be explored.
To address this problem, multi-stage search strategies have been developed to allow
a more thorough search for PTMs on a subset of high-confidence proteins. Thus,
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Figure 5.11: FDR analysis using the default scoring module instead of K -score, threshold on
Expect value (semi-tryptic refinement stage). Reprinted from Everett LJ, Bierl C, and Master SR
“Unbiased statistical analysis for multi-stage proteomic search strategies” Journal of Proteome
Research 2010 9(2):700–707 with permission from the American Chemical Society.
validation of search results includes both determining whether the protein was de-
tected in some form (protein identification) as well as assessing whether interesting
modifications have been reliably identified (protein characterization).
Validation of Multi-Stage Search Algorithms
In this chapter, I have identified two critical problems in the validation and use of
multi-stage search algorithms such as the one used in X!Tandem model refinement.
These problems are generally applicable to any multi-stage search strategy that
limits subsequent search stages to a small set of high confidence proteins, such as
the Error Tolerant Search option in Mascot [35]. One such problem is the inability
to assign each spectrum match as a true or false positive based solely on its identity
as a control sequence, a critical step for automated validation of a proteomic analysis
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Figure 5.12: FDR Analysis using the default scoring module instead of K -score, threshold on Ex-
pect value (point mutation refinement stage). Reprinted from Everett LJ, Bierl C, and Master SR
“Unbiased statistical analysis for multi-stage proteomic search strategies” Journal of Proteome
Research 2010 9(2):700–707 with permission from the American Chemical Society.
method. I have presented two different solutions to this problem. In one case, I used
a comparable single-stage search to automatically validate each control sequence
match identified in the refinement stage. Eighty-eight percent of the fully tryptic
matches from a multi-stage search were identified in a corresponding single-stage
search, while only 12% of the semi-tryptic matches (which correspond to refinement
stage hits) had a corresponding single-stage match (Figure 5.1). This result is
consistent with a marked increase in the false positive rate within control sequences
for refinement results. Some misclassifications may occur with this method, and
the 309 fully tryptic matches not identified in a single-stage search (Figure 5.1A)
were likely missed as a result of interrogating a larger search space. Despite this
limitation, the distribution of match characteristics from true- and false-positive
groups identified using single-stage validation (Figure 5.2) provides evidence of the
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Figure 5.13: Score distributions from a search containing only forward proteins, with semi-tryptic
peptides identified in the refinement stage. Reprinted from Everett LJ, Bierl C, and Master SR
“Unbiased statistical analysis for multi-stage proteomic search strategies” Journal of Proteome
Research 2010 9(2):700–707 with permission from the American Chemical Society.
overall validity of this approach.
As a second solution to the problem of identifying true-positive matches to con-
trol spectra, I introduced artificial point mutations in silico into the control se-
quences in the database used by the search algorithm, thereby allowing us to iden-
tify true matches as those corresponding to the intended point mutations. This
approach has the added benefit of more closely mimicking the search for peptides
containing PTMs.
It should be noted that experimental samples may differ from these two test cases
in certain important ways. For example, an experimental mixture may contain a
much larger proportion of modified, semi-tryptic, or mutated peptides, resulting in
a larger set of high-scoring spectrum matches in the refinement stage. Furthermore,
mixtures derived from whole-cell lysates (rather than, e.g., pull-down experiments
to characterize a protein complex) will be substantially more complex than the
control mixtures used here, both in terms of the number of proteins present and
the dynamic range. First-stage analysis of these complex mixtures will likely result
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Figure 5.14: Score distributions from a search containing only forward proteins, with point mu-
tations identified in the refinement stage. Reprinted from Everett LJ, Bierl C, and Master SR
“Unbiased statistical analysis for multi-stage proteomic search strategies” Journal of Proteome
Research 2010 9(2):700–707 with permission from the American Chemical Society.
in a larger refinement list containing more false positive proteins, and this may
dampen the extent of the second-stage bias in comparison with shorter refinement
lists having only several decoy proteins by chance. However, since the proposed
patch also guarantees a more reliable estimate in the case of complex mixtures and
has no substantial drawbacks, I suggest that it be used for these sample types as
well. The potential gains of performing a subsequent search stage may be assessed
beforehand by, for example, applying a quality metric to unmatched spectra after
the initial search [147].
Decoy FDR Estimation with Multi-Stage Search Methods
Another problem with statistical control of multi-stage searches is the marked bias in
decoy FDR. A comparison of the validated control FDR against the estimated decoy
FDR demonstrates that such estimates are highly skewed for the subset of matches
identified during the search stages performed on high-confidence proteins (Figures
5.5 and 5.6). I have corrected this problem by guaranteeing equal numbers of corre-
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Figure 5.15: FDR Analysis using separate searches of the forward and reverse database, with
semi-tryptic peptides identified in the refinement stage. Reprinted from Everett LJ, Bierl C, and
Master SR “Unbiased statistical analysis for multi-stage proteomic search strategies” Journal of
Proteome Research 2010 9(2):700–707 with permission from the American Chemical Society.
sponding forward and reverse protein pairs through all search stages, implemented
as a minor patch to the X!Tandem source code. This correction amounts to main-
taining the null model used for statistical validation: specifically, that false positive
matches to target and decoy proteins occur with approximately equal probability
and score distributions.
Because second-stage bias becomes most apparent at higher FDR thresholds, it
is reasonable to ask whether the phenomenon is relevant at realistic FDRs used in
common practice (e.g., 1%). There are several reasons why it is difficult to directly
demonstrate this statistical bias at more stringent FDR thresholds. Because of the
relative simplicity of a 48-protein control mixture, the validation examples analyzed
here identify relatively few spectrum matches in the refinement stage, and even
fewer at stringent FDR thresholds. Decoy-based FDR estimates have larger errors
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Figure 5.16: FDR Analysis using separate searches of the forward and reverse database, with point
mutations identified in the refinement stage. Reprinted from Everett LJ, Bierl C, and Master SR
“Unbiased statistical analysis for multi-stage proteomic search strategies” Journal of Proteome
Research 2010 9(2):700–707 with permission from the American Chemical Society.
when using a small number of reverse spectrum matches [95], and this error may
mask the true statistical bias. Despite these difficulties, I have identified second-
stage bias that cannot be explained by a previously proposed error model [95] at 5%
FDR in the semi-tryptic analysis (Table 5.2) and 1% FDR in the point mutation
analysis (Table 5.3). The X!Tandem patch largely corrects this error in the low FDR
range (Tables 5.4 and 5.5). Of course, it is also possible that, in general, the extent
of statistical bias increases with FDR and in some cases only becomes problematic
when using more lenient thresholds. In practical terms, however, I see no drawbacks
to using a formally corrected model in all cases, including stringent FDR thresholds
for which the statistical bias may be less severe.
In addition to the X!Tandem patch, other methods that maintain the validity of
this null model should also allow accurate decoy FDR calculations on multi-stage
135
search results. However, methods that rely on separate forward and reverse database
searches [104] will not meet this criterion, because the refinement list generated by
the reverse database search will be very different from the one generated by the
forward database search; thus, matches from these two model refinement stages
may not yield accurate FDR estimates (Figures 5.15 and 5.16).
There is also no guarantee that overall score distributions of spectrum matches
will be similar for results from the initial and refinement search stages. The most
reliable way to control the FDR within the refinement stage spectrum matches is to
perform the FDR analysis separately on these matches. This may present problems
for downstream analysis tools that attempt to model the distributions of true and
false matches from all search stages pooled together [31, 108], and can be especially
problematic for applications in which the PTM or nonenzymatic cleavage peptides
are of primary interest. Additionally, the matches from the refinement stage are
technically dependent on the matches from the initial search stage, which violates
assumptions made in some protein-level inference models [146].
Downstream analysis tools for selecting reliable spectrum matches and recon-
structing sample proteins are indispensable to a reliable proteomics analysis pipeline.
However, further consideration of the basic assumptions made in these statistical
models is needed to avoid underestimating the FDR when using a multi-stage search
strategy. A more general strategy, wherein an initial run of a search algorithm and
the downstream analysis are used to determine the set of high-confidence proteins,
followed by subsequent runs of these tools to match the remaining unmatched spec-
tra, is likely to be both statistically valid and widely compatible with other search
algorithms and downstream analysis tools. In other words, each “stage” of the
search strategy could include an independent and rigorous statistical analysis of the
spectrum matches. Such a strategy would also more clearly separate the goals of
136
protein identification and characterization. The validative frameworks developed in
this chapter can be used to empirically test the accuracy of such methods.
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Chapter 6
Conclusions and Future Directions
6.1 Major Contributions in This Work
The inference of biological networks spanning signal transduction and transcrip-
tional regulation remains a critical field of study in genomics research. In this work
I have made several major contributions to this field that will improve the integration
of high-throughput data into a comprehensive framework. The PTM-Switchboard
database addresses a basic need to catalog current knowledge in a structured, search-
able, and machine-readable format. The existing content of this database allows for
validation and benchmarking of computational methods, and provides a platform
for the dissemination of new predictions and experimental results. As of this writ-
ing, PTM-Switchboard has been accessed 1,337 times over a period of 18 months
(averaging approximately 75 hits per month).
While a number of methods exist to infer condition-specific or modulated TF
activity, as reviewed in Chapter 1, many of the regulatory triplets predicted by
these methods involve other classes of TF modulators, such as co-factors and post-
transcriptional regulators. The focused study of TF modulators that function via
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direct post-translational mechanisms can benefit from additional data sources, in-
cluding protein-protein interactions and enzyme substrate-specificity models. To
this end, MoNsTEr is designed to integrate expression data with additional data
sources in a principled and probabilistic framework. I have demonstrated the power
of this probabilistic model-based methodology for integrating heterogeneous data
and inferring complex biological networks encompassing multiple processes. This
work therefore represents a significant step towards a comprehensive model of gene
transcription. MoNsTEr is extremely flexible and can be applied to any of the grow-
ing compendia of high-throughput data describing gene expression, protein-DNA
interactions, and enzyme-substrate interactions.
In particular, MS-based proteomics continues to provide novel methods for study-
ing PTMS and protein modifying enzymes. MS data sources remain largely un-
tapped for integration with transcriptional and other regulatory networks. For this
reason, I have also contributed an improvement to the computational methods for
identifying PTMs by tandem MS. Collectively, the advances presented in this work
can be used to construct a larger-scale data mining and network inference platform,
as discussed in this chapter.
6.2 Mimosa: An Additional Tool for MFG Triplet
Prediction
I have also contributed to the development of another novel algorithm, Mimosa,
for identifying hidden partition structures in expression data, and predicting the
modulators of regulatory interactions [80], described briefly here. In contrast to
other methods that begin by selecting a modulator of interest, Mimosa begins with a
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putative TF-Gene pairwise interaction and finds an appropriate partition structure,
in the expression compendium. In short, a mixture model, described below, is fit to
the coexpression data, such that the TF and target gene are correlated in a subset of
the samples and uncorrelated in the remaining samples. Modulator genes can then
be predicted by testing for differential expression between the inferred partitions.
Following the notation from Chapter 3, for any TF j and putative target gene
i in an expression compendium of samples t, Mimosa can fit the pair of expression
profiles (i, j) to a mixture of correlated and uncorrelated expression models, with
the uncorrelated probability function given by:
pu(git, fjt) =
1
2pi
exp
[−1
2
(
g2it + f
2
jt
)]
(6.1)
And the correlated model probability function given by:
pc(git, fjt) =
exp
[−1
2
(
g2it + f
2
jt + 2ψgitfjt
)
/(1− ψ2)]
2pi
√
1− ψ2 (6.2)
Where−1 ≤ ψ ≤ 1 is a free parameter corresponding to the strength and direction of
the correlated distribution. The observed data is treated as a random sampling from
the two distributions, pu and pc, with mixing parameter ϕ defined as the fraction
of data points that belong to the uncorrelated group, pu. The total likelihood of a
data point (git, fjt) is the mixture of likelihoods under each model:
p(git, fjt) = ϕ pu(git, fjt) + (1− ϕ) pc(git, fjt) (6.3)
In summary, the mixture model has two free parameters, (ϕ, ψ), that determine
the fraction of uncorrelated points in the observed data and the strength of correla-
tion in the remaining points. Parameter estimates are chosen to maximize the log
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likelihood function:
L(f, ψ) ≡
∑
t
ln [p(git, fjt|f, ψ)] . (6.4)
After fitting the mixture model for a selected gene pair (i, j), Mimosa computes the
probability that each sample t belongs to the correlated group:
qt =
(1− ϕ) pc(git, fjt|ψ)
p(git, fjt|ϕ, ψ) . (6.5)
Modulator genes k are then selected based on the correlation between their expres-
sion profile and vector q. See ref. [80] for additional details and validation of this
computational method.
Compared to many of the methods reviewed in Chapter 1, Mimosa reduces the
number of hypotheses that need to be tested, because it first selects informative
TF-Gene pairs before multiplying the possible combinations to predict modula-
tors. The ability to discover conditionally coexpressed genes without an a priori
partition structure provides a unique opportunity to identify novel regulatory inter-
actions, including those involving TF protein modification. Compared to MoNsTEr,
the Mimosa algorithm is far more scalable; the complexity increases only linearly
with more putative TF-Gene pairs or candidate modulators. On the other hand,
Mimosa only analyzes expression data, whereas MoNsTEr is able to integrate ad-
ditional data sources related to the physical interactions underlying the network
structure1. MoNsTEr can integrate data sources in a probabilistic manner that does
not impose strict thresholds on any of the input data, and should be more sensitive
in principle.
1In theory, the tests performed by Mimosa can be further limited to those predicted on other
data sources, such as ChIP-seq (for putative TF-Gene pairs) and protein-protein interactions (for
candidate modulators). However, this is not a particularly principled way to integrate heteroge-
neous data, and requires the selection of additional arbitrary thresholds for each data source.
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Overall, it is likely that Mimosa and MoNsTEr have complimentary strengths. For
example, Mimosa has also been applied in a preliminary analysis of STAT1 activ-
ity in the human B cell expression data [165] used in Chapter 4. Mimosa found a
usable mixture model for 10 of the 25 known target genes compiled in ref. [162],
and thereby predicted 34 candidate modulators for the regulation of these genes
by STAT1 (see ref. [80]). The modifying enzymes predicted in this list are notably
different from those predicted by MoNsTEr. Although Mimosa largely predicted other
classes of TF modulators, it did predict several protein modifying enzymes as mod-
ulators of STAT1 activity. Specifically, the modulator genes GRK5, DUSP1, and
SIK1 were all predicted by Mimosa, and were not predicted by MoNsTEr, despite
being included in the input data used in Chapter 4. None of these modifiers have an
association with STAT1 listed in the STRING database [99] used for TF-Modifier in-
teraction priors, and thus were not predicted by MoNsTEr. However, GRK5 is known
to function upstream of JAK-STAT signaling in general, and therefore represents a
biologically relevant result, at least in terms of indirect STAT1 modulators. Ulti-
mately, Mimosa is capable of testing a much broader array of TF modulators, while
MoNsTEr is specifically designed to predicted direct modifying enzymes of TF-PTMs
when sufficient data is available.
6.3 Approximating Regulator Activities from
Transcript Levels
MoNsTEr and Mimosa both rely on an assumption common to most network inference
methods based on mRNA measurements—that TF and modifier transcript levels
are indicative of their relative activity [12, 22, 112, 134, 204]. The validity of this
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assumption is known to vary widely between different TFs [15], and is also likely to
vary for each modifier. MoNsTEr addresses this problem by improving the estimate
of TF activity through the use of TF-Modifier synergy effects, exemplified by the
results obtained for yeast TFs MSN2 and MSN4. Specifically, MoNsTEr identifies
known targets of MSN2/4 with improved accuracy when using the full model with
TF-Modifier synergistic effects (see Chapter 3).
The initial results also suggest that, when observed over a sufficient number of
conditions, there is substantial biological signal in the expression profiles of modify-
ing enzymes. In the MoNsTEr yeast application (Section 3.5), all input kinases had
at least a 4-fold change in expression across the observed conditions. The expres-
sion level of the known MSN2/4 modifier TPK1 varied 78-fold across the included
conditions. Similarly, expression of JAK1 varied 14-fold across the B cell samples
used in Chapter 4. The median for all STAT1 modifiers predicted by MoNsTEr is a
5-fold range of expression. Although many modifying enzymes are regulated at the
post-translational level, there seems to be significant perturbation occurring at the
transcript level, which is likely to have some effect on their signaling activity, and
which can be used to infer their overall effect on downstream transcription. Thus,
methods for inferring modifier activity from transcript level rely primarily on an
expression compendium encompassing sufficient perturbation to the transcriptional
regulation of the modifier, but can be further aided by the use of additional data
sources, as is the case for MoNsTEr.
Despite the advances achieved by these methods, the results from Chapter 3 in-
dicate that challenges remain for improving the sensitivity of TF-Modifier network
edge prediction. It is possible that modifiers with lower transcript variability may
go undetected by MoNsTEr and other expression-based methods. This reduced vari-
ability in expression can be partly mitigated by having a larger and/or different set
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of expression samples. MoNsTEr can also take advantage of improved accuracy of
TF-Modifier priors, e.g., via new breakthroughs in proteomic methods. Therefore,
the sensitivity of TF-Modifier prediction is reduced, in part, by the available data,
and does not necessarily reflect any inherent limitations of the inference method. In
the rest of this chapter I discuss potential improvements to these methods, as well
as novel data sources—many of which have only become available in the last several
years—that can be used to improve the inference of MFG networks.
6.4 A Comprehensive Tool Set for MFG Triplet
Prediction
The potential uses for Mimosa and MoNsTEr are broad, ranging from large-scale
network inference for elucidating systems-level properties, to focused analysis of a
specific TF under post-translational regulation. These complex inference problems
are unlikely to be solved by a single tool, as evidenced by the fact that Mimosa and
MoNsTEr each identified different known modulators of STAT1 activity from the same
expression compendium. Thus, there is a need to integrate different computational
pipelines to mine existing compendia and analyze new data, in order to guide and
prioritize further experiments. Additionally, there is a broad need to “scale-up” the
applications discussed in this work. In this section, I lay out a general framework
for integrating these and related tools, and discuss some potential improvements to
the computational frameworks of both Mimosa and MoNsTEr.
Scalability remains a major issue for many network inference methods. De-
spite the advances made by Mimosa, the prediction of regulatory triplets still faces
substantial combinatorial complexity. Model complexity for MoNsTEr grows expo-
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nentially with the number of genes, TFs, and modifiers considered, and thus far I
have only applied this method to specific sub-networks of interest. One potential
solution for reducing complexity is to first predict coarse-level network modularity,
then limit these tools to networks or triplets within these modules.
In prior work, I developed a method for identifying clusters in multi-partite
graphs [52] that is of particular interest here. Briefly, this method allows for the
construction of a graph containing different classes of nodes, e.g., genes, regulators,
annotations, etc. Edge sets connecting nodes of different classes are then defined
separately for each pair of classes, based on appropriate data sources. In one of the
applications in ref. [52], I analyzed a graph of TFs, target genes, and tissues, with
an edge set linking TFs to target genes based on PWMs, and two edge sets linking
TFs and target genes to tissues based on a metric of tissue-specific expression [173].
The algorithm developed in this work identifies clusters in the graph containing
nodes from all three classes, such that the density of edges between each class is
significantly higher than background. A particularly novel aspect of the work was
that the significance of density within a cluster was analyzed separately for edge
sets between each pair of classes. This is justified by the different types of data used
for these edges, which have inherently different false positive and negative rates.
To apply this methodology to the prediction of MFG modules, a tri-partite
graph could be used to represent modifiers, TFs, and target genes. TF-Gene edges
would be chosen based on PWM and/or ChIP-seq analyses. Likewise, Modifier-TF
edges would be chosen based on a combination of protein-protein interactions and
enzyme-substrate specificity models—essentially the same data types used as priors
for MoNsTEr. Modifiers could also be linked to target genes based on, for example,
functional associations summarized in STRING [99]. The clustering algorithm could
then be used to identify significant, and potentially overlapping, modules of mod-
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ifiers, TFs, and genes, which would generally be of a reasonable size to model in
finer detail with either Mimosa or MoNsTEr.
Even with a potential reduction in complexity by focusing on modules, there
is still room to improve the statistical and computational framework of MoNsTEr.
For example, I observed that MoNsTEr could not predict STAT1 modifiers without a
high prior probability of connectivity, despite the fact that I did not use any explicit
threshold on the edge priors (see Chapter 4). This is partly a limitation of the model
itself, because the effect of each TF-Modifier interaction in the expression model is
parameterized by a separate γjk variable, whereas the effects of TF-Gene connections
are modeled more robustly by TF-specific βj variables. However, there is a biological
motivation for this model design. While a single TF can often act as both an
activator or repressor in a condition- or promoter-specific manner, TFs tend to have
similar actions across at least a subset of their target gene repertoire. Thus, while the
βj variables may not fully capture the behavior of a TF, they should be sufficient to
identify a substantial subset of the TF expression program on each run of the model-
fitting method. Conversely, the effect of a modifier interaction is highly substrate-
specific. There is no reason to assume, biologically, that a modifier interaction with
one TF will have a mechanistically similar effect to that with another TF. Thus, each
TF-Modifier interaction has its own unique downstream effect in the model. The
result of this model property is that every time a TF-Modifier interaction is removed
from the model during iterative model-fitting, the associated γjk variable defaults
to an uninformative prior (with expected value equal to 0), and the TF-Modifier
interaction is typically only added back into the model by chance, based on its
prior. The end result is that the sensitivity for predicting TF-Modifier interactions is
especially dependent on the prior probabilities derived from non-expression sources,
as observed in the simulation and experimental data analyses. Thus, the current
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method is sufficient for filtering candidate modifiers, predicted by noisier or more
general data sources, down to those which appear to modulate the transcriptional
activity of a TF of interest. This is especially useful in the context of data sources
with high false positive rates such as kinase-substrate PWMs, but is less useful when
analyzing sparse data sets (see Section 3.6).
Additionally, replicate runs of the MoNsTEr algorithm can produce distinct net-
work models given the same input data. In the human B cell application, clustering
of network parameters estimated from individual runs revealed three distinct net-
works. It is possible that all three predicted networks are correct, and capture dis-
tinct biological roles of the TF of interest, STAT1 (see Chapter 4). Thus, there is a
need for a more rigorous statistical framework, in which to compare distinct network
models, and summarize across all model-fitting results. This can also potentially
be ameliorated by alternate model-fitting procedures that inherently address the
multi-modality of the solution space.
Given the apparent biological validity of this model, these limitations can poten-
tially be addressed by alternate model-fitting procedures, i.e., without making any
compromise in the biological motivations of the model itself. Thus, further work
is merited to explore alternate methods for model estimation and summarization
of multiple network structure predictions. Novel model-fitting approaches may in-
crease sensitivity and better summarize multi-modal solution spaces. Briefly, one
possible approach would be to alternate between the selection of candidate network
structures (parameters C and D only), and fitting of all other parameters (set Θ).
The structure selection step would require a novel method for identifying several
candidate network structures, and would benefit from a metric for comparing struc-
tures, such as information criteria [87]. In between network selection steps, the
fitting of other parameters could be solved in the OLS closed form, or iteratively
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sampled for probabilistic estimates.
Regardless of the model-fitting framework, MoNsTEr links modifiers to TFs and
TFs to target genes, but does not provide a direct link between modifiers and target
genes. In theory, the probability of an individual MFG triplet (i, j, k) is the joint
posterior probability P (Cij = 1, Djk = 1|Ξ). However, in the STAT1 network
model, most of the individual network edge posteriors were equal to 1, and thus
the joint probabilities must also be (trivially) equal to 1. To more deeply probe the
dependencies between specific modifiers and target genes, I propose an additional
calculation:
δik =
∑T
t=1
(
ε
{−k}
it
)2
−∑Tt=1 ε2it
∑T
t=1 ε
2
it
(6.6)
Where εit is the residual error observed in the estimated model and ε
(−k)
it is the
adjusted residual error if modifier k is removed from the model. If gene i is par-
ticularly dependent on modifier k in the estimated model, then the residual errors
corresponding to this gene should increase when the modifier is removed, resulting
in a positive value of δik. Reasonable criteria for predicting MFG triplets would
then include a threshold on both the joint posterior stated above, and the value of
δik.
6.5 Improved Integration with Proteomic Data
While tandem MS remains a promising source of information for the methods dis-
cussed above, there is a large amount of data generated from global experiments
characterizing whole cell or organelle proteomes. TF-PTMs are unlikely to be iden-
tified in global proteome experiments because both PTM-forms and TFs tend to
exist below the dynamic range of typical tandem MS experiments. PTMs on non-
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TF proteins cannot be directly integrated into the methods developed in this work,
but can improve models of enzyme substrate-specificity in general [13, 140, 217],
and these models in turn can be applied to TF protein sequences to generate more
informative predictions of TF-Modifier interactions.
As presented in Chapter 5, much of the publicly available tandem MS data has
not been analyzed with consideration for the full range of in vivo PTMs. Most
tandem MS experiments are performed primarily for protein identification and de-
tection of several expected PTM types. However, these experiments often produce
MS2 spectra indicative of unexpected and biologically relevant PTMs that are ig-
nored in the downstream data analysis [147, 150]. Thus, there remains a potential
for data mining efforts to reanalyze much of this data in order to glean additional
predictions of novel PTM sites in general. Multi-stage search strategies, such as the
model refinement option in X!Tandem, are a powerful and useful approach to fully
utilizing MS data, including the identification of PTMs. However, these strategies
require careful consideration before applying the statistical methods currently used
for single-stage search strategies. As demonstrated in Chapter 5, it is useful to make
the required adjustments, rather than tolerate biased statistics or inefficient search
strategies. Additionally, recent developments in proteomics have focused on enrich-
ment, and even quantitation, of specific PTM types. Recent developments in mass
spectrometry [100, 101, 119, 210, 223] and other technologies [56, 128, 157, 194] have
made it possible to assay a much wider range of PTM types with greater sensitivity,
and can further refine computational predictions of enzyme-specific substrates.
Knowledge of in vivo PTM sites can be used to filter the application of predictive
models, rather than blindly scanning entire protein sequences [129]. However, this
is of little help if TF proteins are themselves going undetected in most proteomic
experiments. Another approach is to use the PTMs identified in vivo to improve
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models of enzyme-substrate occurance. This is not a straight-forward task because
tandemMS data does not indicate the enzyme(s) responsible for any identified PTM.
However, it may be possible to use machine-learning and other pattern discovery
methods to identify PTMs in similar sequence motifs/regions with similar physico-
chemical properties. These motifs could be linked to specific modifying enzymes
using additional experiments, such as quantitatively measuring PTM concentrations
after perturbing a specific modifier, or by mining existing protein-protein interaction
data for common interacting partners of substrates containing similar motifs.
Another promising direction is the study of enzyme-substrate interactions in
vitro. For example, protein microarrays [56] have been used to identify novel sub-
strates for protein kinases [157] and an acetyltransferase [128], and can be applied
to a much broader range of protein-modifying enzymes. Turk et al. have developed
a peptide library screening method for determining the specificity of protein ki-
nases [194] that is now broadening our understanding of phosphorylation substrate
specificity [140].
MoNsTEr provides a powerful framework to analyze these and future proteomic
datasets in conjunction with expression and protein-DNA interaction data. MoNsTEr
is extremely flexible and can be applied to any of the growing compendia of high-
throughput data describing gene expression, protein-DNA interactions, and enzyme-
substrate interactions. These collective breakthroughs in PTM research represent a
major opportunity to expand regulatory network models beyond the scope of simple
TF-Gene interactions.
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6.6 Expanding the TF-PTM Knowledge Base
PTM-Switchboard (Chapter 2) is an initial effort to catalog TF-PTMs, with suffi-
cient content for method validation. However, there is a large amount of literature
that remains untapped, and thus there is a need for community curation efforts
and improved text-mining methods. Furthermore, PTM-Switchboard should be ex-
panded to other organisms in the future, especially humans. Mammalian systems
will require a larger, more controlled ontology for describing the cell types and ex-
perimental contexts in which MFG triplets are inferred.
PTM-Switchboard also provides an appropriate database structure in which to
catalog computational predictions and make these searchable and accessible to
molecular biologists. An ideal cycle would populate the database with computa-
tional predictions, followed by validation using the existing literature, and targeted
experimentation in unstudied cases. S. cerevisiae is particularly ripe for genome-
wide application of the computational methods developed in this work. There is a
wide range of in vivo [81] and in vitro [148] binding data available for most TFs in
this yeast species, along with pilot efforts in proteome-wide characterization of sub-
strates for specific kinases and other modifying enzymes [128, 140, 157]. With the
scalability improvements discussed in Section 6.4, it should be possible to predict
MFG triplets in yeast on a genome-wide scale.
Another interesting application for future work is the study of STAT1 PTMs
other than phosphorylation. Although Chapter 4 focused primarily on STAT1
phosphorylation, STAT1 activity is known to be controlled via a variety of PTMs
[117, 163, 180, 207]. This focus was primarily due to the available data in STRING,
which was exceptionally sparse for other classes of modifiers. The methods devel-
oped are not inherently restricted to studying phosphorylation, and can benefit from
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the general proteomic improvements discussed in Section 6.5 to predict candidate
modifiers regulating these PTMs as well.
In Conclusion
Ultimately, cell behavior in both healthy and diseased states is the result of com-
plex interactions between networks of genes. Modeling the structure of biological
networks allows for the generation of novel and testable hypotheses, regarding both
individual gene functions and overall cellular behavior. In this work, I have estab-
lished that it is feasible to model a network with more complexity than just static
TF-Gene interactions, with the benefit of additional biological insight into the inter-
play between cell signaling and transcriptional regulation. Experimental techniques
relevant to network inference are progressing on several fronts, and now more than
ever, there is a significant need for computational methods to integrate heteroge-
neous high-throughput data, and maximize the knowledge extracted from each data
source.
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Appendix A
MoNsTEr Model-Fitting
Procedures
A.1 Derivation of Posterior Distributions
The components of the posterior distribution in Eq 3.6 are further defined as:
P(g|f ,h,C,D,Θ) =
N∏
i=1
T∏
t=1
(2piσ2)−1/2 exp
[−1
2σ2
ε2it
]
P(C|m,b,w) =
N∏
i=1
J∏
j=1
[
b
Cij
ij (1− bij)1−Cij
]wj [
m
Cij
ij (1−mij)1−Cij
]1−wj
P(D|a, s,u) =
J∏
j=1
K∏
k=1
[
a
Djk
jk (1− ajk)1−Djk
]uk [
s
Djk
jk (1− sjk)1−Djk
]1−uk
P(Θ) =
N∏
i=1
(τ 2α)
−1/2 exp
[−1
2τ 2α
α2i
]
∗
J∏
j=1
(τ 2β)
−1/2 exp
[
−1
2τ 2β
β2j
]
∗
J∏
j=1
K∏
k=1
(τ 2γ )
−1/2 exp
[−1
2τ 2γ
γ2jk
]
∗ (σ2)−2 exp
[−1
2σ2
]
Iterative algorithms for estimating model parameters require an individual pos-
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terior distribution for each parameter, i.e., a posterior distribution that can be
computed given the input data and a current instantiaion of all other parameter
values. The necessary distributions for the model in Chapter 3 are derived here.
First, let Θ{−Q} denote the set of all parameters in Θ except some individual
parameter Q. Let ε′it[Q = q] denote the residual error of gene i in sample t when
some model parameter Q is changed to value q. The posterior distribution for a
particular αi given all expression data and all other model parameters is:
P
(
αi = q|Ξ,C,D,Θ{−αi}
) ∝ exp
[
−1
2σ2
T∑
t=1
ε′it[αi = q]
2
]
∗ exp
[−1
2τ 2α
q2
]
(A.1)
This distribution can be sampled as a normal distribution with mean µαi and vari-
ance να:
µαi =
να
σ2
∗
T∑
t=1
ε′it[αi = 0] (A.2)
να = (T/σ
2 + 1/τ 2α)
−1 (A.3)
Alternatively, the value of αi can be chosen to maximize the posterior by setting
αi = µαi . Also note that for an “unregulated” gene, i.e., a gene i such that Cij =
0 ∀j, Eq A.2 simplifies to an estimate of the mean expression for gene i:
µα =
1
T + σ2/τ 2α
T∑
t=1
git
Similarly, the individual posterior for βj is:
P(βj = q|Ξ,C,D,Θ{−βj}) ∝ exp
[
−1
2σ2
N∑
i=1
T∑
t=1
ε′it[βj = q]
2
]
∗ exp
[
−1
2τ 2β
q2
]
(A.4)
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Therefore, βj can be resampled from the normal distribution N(µβj , νβj) with:
µβj =
νβj
σ2
N∑
i=1
T∑
t=1
ε′it[βj = 0] ∗ Cijfjt (A.5)
νβj =
(∑N
i=1
∑T
t=1(Cijfjt)
2
σ2
+
1
τ 2β
)−1
(A.6)
Once again, the posterior can be maximized by setting βj = µβj . Also note
that µβj = 0 and νβj = τ
2
β when Cij = 0 ∀i. In other words, when TF j does
not regulate any genes, its posterior becomes equivalent to its uninformative prior.
Similar equations are derived below for resampling or maximizing the individual
posterior of γjk. In this case, the posterior is equivalent to the the uninformative
prior whenever Cij = 0 ∀i or when Djk = 0.
P(γjk = q|Ξ,C,D,Θ{−γjk}) ∝ exp
[
−1
2σ2
N∑
i=1
T∑
t=1
ε′it[γjk = q]
2
]
∗ exp
[−1
2τ 2γ
q2
]
(A.7)
µγjk =
νγjk
σ2
N∑
i=1
T∑
t=1
ε′it[γjk = 0] ∗ CijDjkΦ(fjt, hkt)
(A.8)
νγjk =
(∑N
i=1
∑T
t=1 (CijDjkΦ(fjt, hkt))
2
σ2
+
1
τ 2γ
)−1
(A.9)
The individual posterior for the model-wide residual error variance σ2, given all
input data and all other parameters is:
P(σ2|Ξ,C,D,Θ{−σ2}) ∝ (σ2)−(
TN
2
+2) ∗ exp
[
−1
2σ2
N∑
i=1
∑
t = 1T ε2it
]
∗ exp
[−1
2σ2
]
(A.10)
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The above equation implies that σ2 can be sampled from a scaled-inverse χ2
distribution with degrees of freedom parameter TN + 2 and scale parameter s2
defined in Eq A.11 below. This posterior can be maximized by setting σ2 = s2.
s2 =
1 +
∑N
i=1
∑T
t=1 ε
2
it
TN + 2
(A.11)
The C and D variables are binary, and therefore the individual posteriors can
be computed from the relative probability of values 1 and 0 for each variable. For
Cij, the individual posterior is given by Eq A.12, with q ∈ {0, 1}:
P(Cij = q|Ξ,C{−Cij},D,Θ) ∝ exp
[
−1
−2σ2
T∑
t=1
ε′it[Cij = q]
2
]
∗ [bqij(1− bij)1−q
]wj ∗ [mqij(1−mij)1−q
]1−wj
(A.12)
To find the exact posteriors for Cij = 0 and Cij = 1, first compute the propor-
tional probability values Z
(Cij)
0 and Z
(Cij)
1 , respectively:
Z
(Cij)
0 = exp
[
−1
−2σ2
T∑
t=1
ε′it[Cij = 0]
2
]
∗ (1− bij)wj(1−mij)1−wj (A.13)
Z
(Cij)
1 = exp
[
−1
−2σ2
T∑
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ε′it[Cij = 1]
2
]
∗ bwjij m1−wjij (A.14)
Therefore, Cij can be resampled by setting Cij = 1 with probability
Z
(Cij)
1
Z
(Cij)
0 +Z
(Cij)
1
and can be maximized by setting Cij = 1 iff Z
(Cij)
1 > Z
(Cij)
0 . Using a similar posterior
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equation for Djk yields ζ
(Djk)
0 and ζ
(Djk)
1 analogous to Z
(Cij)
0 and Z
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1 , respectively:
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The individual posteriors of the weight parameters wj and uk are independent
of the expression data and other parameters, given instantiated values for edge
variables C and D. The individual posterior distributions are calculated as follows:
P(wj|C,b,m) ∝
[∏N
i=1 b
Cij
ij (1− bij)1−Cij
]wj ∗
[∏N
i=1 m
Cij
ij (1−mij)1−Cij
]1−wj
∏N
i=1
[
b
wj
ij m
1−wj
ij + (1− bij)wj(1−mij)1−wj
]
(A.17)
P(uk|D, a, s) ∝
[∏J
j=1 a
Djk
jk (1− ajk)1−Djk
]uk ∗
[∏J
j=1 s
Djk
jk (1− sjk)1−Djk
]1−uk
∏J
j=1
[
aukjk s
1−uk
jk + (1− ajk)uk(1− sjk)1−uk
]
(A.18)
In this work, I used grid sampling to estimate the distributions of wj and uk. I
describe the process here, without loss of generality, for a single parameter wj. First,
let pˆλ = P(wj = λ|C,b,m) from Eq A.17 for all λ values in {0.01, 0.02, . . . , 0.99}.
These values are then normalized to probabilities: pλ = pˆλ/
∑
λ pˆλ. Therefore, wj
can be resampled from all possible values of λ, each with probability pλ. Alterna-
tively, the posterior of wj can be maximized by selecting the wj = argmaxλ (pλ).
157
A.2 Local Estimation Algorithm
Phase 1: Model Initialization
To seed the algorithm, an initial network {C,D} is selected, as summarized in
Box A.1. The simplest way to select this network is deterministically, by setting
a threshold q on the geometric mean prior of each edge, i.e. Cij = 1 if and only
if
√
bijmij ≥ q. This approach is generally appropriate for the first few runs of
the estimation algorithm. For increased exploration of the solution space away
from the most strongly predicted prior network, this initial deterministic starting
network can be perturbed by randomly flipping the state of some fixed proportion of
edges. For a more stochastic starting network, each edge parameter can be randomly
sampled according to the geometric mean of its priors, i.e. P (Cij = 1) =
√
bijmij.
Note that in all cases, using the geometric mean of priors is equivalent to assuming
wj, uk = 0.5 ∀j, k, and these parameters are initialized accordingly.
Given a fixed network {C,D}, the parameters {α,β,γ} can be fit using the
Ordinary Least Squares (OLS) solution to linear regression. To add a stochastic
aspect to the selection of values for these parameters, the best-fit values can be
perturbed by adding noise sampled from a normal distribution with µ = 0 and
small ν (i.e. 0.05). The model-wide variance is always initialized by σ2 = s2 (from
Eq A.11).
Phase 2: Local Maximization
Given initial values for all model parameters, it is possible to compute the individ-
ual posterior of any model variable according to the equations in Appendix A.1. A
hill-climbing algorithm (Box A.2) is run from the starting point computed in Phase
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1, such that each parameter is iteratively reassigned in sequence by maximum like-
lihood. The hill-climbing algorithm is run until the model parameters converge on
an optimal solution. Convergence is determined by tracking the log of the model
likelihood (rather than the model posterior, because the parameter priors are con-
stant), given by Eq A.19 below. Convergence is assumed when ∆ ln(L) < 0.0001
(approximately 0).
ln(L) =
−NT
2
ln
(
2piσ2
)− 1
2σ2
N∑
i=1
T∑
t=1
ε2it
+
N∑
i=1
J∑
j=1
wj [Cij ln(bij) + (1− Cij) ln(1− bij)]
+
N∑
i=1
J∑
j=1
(1− wj) [Cij ln(mij) + (1− Cij) ln(1−mij)]
+
J∑
j=1
K∑
k=1
uk [Djk ln(ajk) + (1−Djk) ln(1− ajk)]
+
J∑
j=1
K∑
k=1
(1− uk) [Djk ln(sjk) + (1−Djk) ln(1− sjk)]
(A.19)
Phase 3: Local Network Estimation
The final phase of the algorithm collects local samples of specific variables of interest,
notably C and D, while leaving other parameters, notably α and β, fixed at the
values identified in Phase 2. This results in a single estimate for each parameter in α
and β, and fixing these variables helps to anchor the subsequent sampling iterations
around the local optimum. The γjk parameters must also be resampled in this
phase, to allow for informative estimation of each corresponding Djk. Specifically,
if a parameter γjk = 0 at the end of Phase 2, and if this value were to remain
fixed, then the posterior for Djk would become equivalent to its prior, and therefore
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uninformative. The variables σ2, w, and u are also resampled, to allow for more
robust resampling of C and D. These variables are resampled in the same order as
they were maximized in Phase 2, using sampling rules derived from the equations
in Appendix A.1. This phase of the algorithm (Box A.3) is repeated a fixed number
of times.
The output of this phase is a set of locally optimal fixed values for parameters α
and β, denoted from here on as αˆ and βˆ, and a fixed number of samples for all other
parameters. To avoid auto-correlation between the samples, a lag is introduced,
such that samples are only used for model inference every ` iterations, and all other
samples are dropped. From here on, let X denote the number of samples used for
model inference, and let x denote a specific sample from 1 to X. In other words,
phase 3 is run for a total of `×X iterations, but only X samples (every `th iteration)
are used for model inference. For the applications discussed in this work, I generally
found that X = 100 and ` = 20 provided an acceptable balance of speed and
accuracy.
A.3 Parameter Estimation and Inference
Using a single run of the algorithm outlined above, it is possible to compute a
maximum a posteriori (MAP) value for each parameter αi and βj from αˆ and βˆ
fixed at the end of Phase 2. Subsequently, the posterior distribution for all other
parameters, given both the input data, and these MAP values can be computed
using the samples from Phase 3:
Pˆ (C,D,γ, σ2,w,u|Ξ, αˆ, βˆ) (A.20)
160
However, it is generally more interesting to marginalize this joint posterior in
order to compute an independent posterior for each parameter. For example, the
estimated probability of a particular TF-Gene edge Cij = Pˆ (Cij|Ξ, αˆ, βˆ). The
marginalized posteriors are computed from the X samples computed in Phase 3,
with [x] denoting the value of a particular parameter in sample x, as follows:
Pˆ
(
Cij = 1|Ξ, αˆ, βˆ
)
= I
(
βˆj 6= 0
) 1
X
X∑
x=1
Cij[x] (A.21)
Pˆ
(
Djk = 1|Ξ, αˆ, βˆ
)
=
1
X
X∑
x=1
I (γjk[x] 6= 0)Djk[x] (A.22)
Eˆ
(
γjk|Ξ, αˆ, βˆ
)
=
1
X
X∑
x=1
I (Djk = 1) γjk[x] (A.23)
Eˆ
(
σ2|Ξ, αˆ, βˆ
)
=
1
X
X∑
x=1
σ2[x] (A.24)
Eˆ
(
wj|Ξ, αˆ, βˆ
)
=
1
X
X∑
x=1
wj[x] (A.25)
Eˆ
(
uk|Ξ, αˆ, βˆ
)
=
1
X
X∑
x=1
uk[x] (A.26)
The function I denotes the identity function, and returns 1 if the specified con-
dition is true, or 0 otherwise. Eq A.21 corresponds to the probability that TF j
regulates gene i. Eq A.22 corresponds to the probability that modifier k has a syn-
ergistic effect on the activity of TF j. Eq A.23 corresponds to the expected value of
γjk for a particular synergistic effect, and the magnitude of this value can be used
as an additional filter to select only those TF-Modifier edges with substantial effects
on target gene expression. In this work, I typically use a threshold of |γjk| ≥ 0.05
to rule out TF-Modifier connections with inconsequential effects on target gene ex-
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pression. In general, βj = 0 (TF j has no influence on target genes) is considered
equivalent to Cij = 0 ∀i (TF j has no target genes), and γjk = 0 (TF j and modifier
k do not have a synergistic effect) is considered equivalent to Djk = 0 (TF j and
modifier k do not interact). These equivalencies are built into the inference calcu-
lations above. Eq A.25 is used to estimate the relative quality of priors for each TF
j, with values of wj > 0.5 favoring b and values of wj < 0.5 favoring m. Likewise,
Eq A.26 estimates the relative quality of priors for each modifier k, with values of
uk > 0.5 favoring a and values of uk < 0.5 favoring s. Thus, given a compendium of
reliable experimental data as input, the parameters of this model can be fit to the
data in order to make inferences about the underlying biological network.
1. Set wj, uk = 0 ∀j, k
2. Select C and D values based on priors {b,m, a, s}
• Deterministically: Cij = 1 iff
√
bijmij ≥ q; Djk = 1 iff √ajksjk ≥ q, or
• Stochastically: sampling Cij = 1 with probability
√
bijmij and
Djk = 1 with probability
√
ajksjk
3. Randomly perturb (flip) fixed proportion of edges in C and D (optional)
4. Fit {α,β,γ} to network by OLS
5. Randomly perturb values in {α,β,γ} by adding noise sampled from N(0, ν)
(optional)
6. Set σ2 = s2 (from Eq A.11)
Box A.1: Parameter initialization procedure for model estimation.
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1. Set each αi = µαi (from Eq A.2)
2. Set each βj = µβj (from Eq A.5)
3. Set each γjk = µγjk (from Eq A.8)
4. Set σ2 = s2 (from Eq A.11)
5. For each Cij:
• Compute Z(Cij)0 , Z(Cij)1 (from Eq A.13, A.14)
• Set Cij = 1 iff Z(Cij)1 > Z(Cij)0 , otherwise set Cij = 0
6. For each Djk:
• Compute ζ(Djk)0 , ζ(Djk)1 (from Eq A.15, A.16)
• Set Djk = 1 iff ζ(Djk)1 > ζ(Djk)0 , otherwise set Djk = 0
7. Set each wj = argmaxλ (pλ) (from Eq A.17).
8. Set each uk = argmaxλ (pλ) (from Eq A.18).
9. Repeat until ∆ ln(L) < 0.0001 (from Eq A.19)
Box A.2: Local maximization procedure for model estimation.
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1. Sample each γjk ∼ N(µγjk , νγjk) (from Eq A.9, A.8)
2. Sample σ2 from the scaled-inverse χ2 distribution with TN + 2 degrees of
freedom and scale parameter s2 (from Eq A.11)
3. Sample each Cij from the Bernoulli distribution with p =
Z
(Cij)
1
Z
(Cij)
1 +Z
(Cij)
0
(from
Eq A.13, A.14)
4. Sample each Djk from the Bernoulli distribution with p =
ζ
(Djk)
1
ζ
(Djk)
1 +ζ
(Djk)
0
(from
Eq A.15, A.16)
5. Sample each wj using grid sampling for Eq A.17
6. Sample each uk using grid sampling for Eq A.18
7. Repeat for `×X iterations
Box A.3: Local sampling procedure for model estimation.
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Appendix B
Derivation of TF-Gene Interaction
Priors from ChIP-seq Data
Where applicable, I used similar methods to those in ref. [22] in order to derive
interaction priors for MoNsTEr. However, Chen et al. did not handle ChIP-seq data,
which is substantially different, mathematically speaking, from the ChIP-chip data
analyzed in ref. [22]. In this work, I used ChIP-seq data in the form of mapped
reads, i.e., short sequence reads that have already been mapped to a unique genomic
location (see ref. [165]). I then assembled the individual reads into peak regions
and assessed the relative confidence of these regions using GLITR [195]. From this
point, I developed a novel method for mapping the output from GLITR to TF-Gene
interaction priors for use with MoNsTEr (Chapter 3).
GLITR outputs a score X ∈ {0, 1, . . . , 100} for each ChIP and Pseudo region,
with 0 corresponding to the highest confidence. The proportion of Pseudo regions
passing a given threshold X ≤ x is used as an estimate of the number of false
positives among the ChIP regions passing this same threshold. Thus, the FDR at
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any threshold x is given by Eq B.1, originally from ref. [195]:
FDR(x) =
Proportion of Pseudo peaks with X ≤ x
Proportion of ChIP peaks with X ≤ x (B.1)
For use in MoNsTEr, each peak score X must be mapped to a prior probability,
rather than an FDR. To map scores X to prior probabilities pX , I rely on the same
assumption as the FDR calculation, namely that the distribution of scores for the
Pseudo peaks is an estimate of the false positives among the ChIP peaks. Thus, I
can derive a reasonable estimate of the desired probability:
px = 1−
(
Proportion of Pseudo peaks with X = x
Proportion of ChIP peaks with X = x
)
(B.2)
Note that pX (Eq B.2) differs from the FDR estimate (Eq B.1) in that it uses
only the proportion of regions at a precise score, rather than all regions passing a
threshold. In practice, the number of regions are under-sampled for some scores, and
therefore the approximation of px is not robust for all x. To adjust for this problem,
I took two basic steps. First, I binned the scores X into bins of size 5, and computed
a more robust probability for the entire bin. In other words, p0 = · · · = p4 = pX∈[0,4],
and so on. The majority of peaks haveX = 100, and so p100 was computed as a single
bin. Second, I assumed that a correct mapping X → pX should be monotonically
decreasing. In other words, if score x1 is better (lower) than another score x2, then
px1 ≥ px2 should be true in all such cases. I enforce monotonicity by iterating
through x from 1..100, and assign px = max(px, px−1). The final mapping from
X → pX for the ChIP-seq data used in Chapter 4 is shown in Figure B.1. Note
that it is desirable that p100 = 0, as these are the majority of the false positives in
the data, and regions with p = 0 can be ignored for subsequent analysis. In this
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Figure B.1: Mapping STAT1 ChIP-seq peak scores to probabilities, based on output from GLITR
algorithm [195]. X = 0 corresponds to the highest confidence peaks.
application, px = 0 ∀x > 64, effectively filtering out most poor-scoring peaks in the
data.
The GLITR algorithm does not explicitly compare Pseudo and ChIP peaks that
overlap in the genome. Such cases may be indicative of regions where DNA is
more accessible, but where there is no actual TF binding site. To account for these
regions, I applied the same mapping X → pX , derived for ChIP peaks, to the scores
for all Pseudo peaks. Let pc be the probability of a particular ChIP peak, and let
pu be the probability of some overlapping Pseudo peak. Let pf denote the final
probability assigned to the ChIP region after consideration of overlapping Pseudo
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regions, calculated by:
pf = max(0, pc −max pu) (B.3)
In other words, simply subtract the probability of the strongest overlapping Pseudo
peak from the probability of the ChIP peak. This essentially enforces a penalty on
ChIP peaks with overlapping Pseudo regions. If the Pseudo peak has probability
greater than or equal to that of the ChIP peak (i.e., max pu ≥ pc) then the ChIP
peak is removed entirely (pf = 0).
The goal of this analysis is to derive prior probabilities for the regulation of target
genes i by TF j, rather than for binding to genomic regions in general. Therefore, I
must also map individual peaks with pf > 0 to proximal genes in order to derive final
values for b. The most reasonable and straightforward way to perform this mapping
is to simply define the presumed promoter regions as a fixed amount of sequence
upstream of each gene start site, then use the maximum pf for all peaks overlapping
the presumed promoter. In this analysis, I defined the presumed promoter as the
1kb region upstream of each gene start site as defined in RefSeq [156]. Thus, for
the analysis in Chapter 4, j = STAT1, and bij = max pf using all peaks overlapping
the designated 1kb upstream region for each gene i.
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List of Abbreviated Terms
ARACNE Algorithm for the Reconstruction of Gene Regulatory Networks
AUC Area Under the Curve
BP Biological Process
cAMP Cyclic Adenosine Monophosphate
CBP CREB Binding Protein
ChIP Chromatin Immunoprecipitation
CI Confidence Interval
CID Collision-Induced Dissociation
CLR Context Likelihood of Relatedness
COGRIM Clustering of Genes into Regulons using Integrated Modeling
CRE cAMP Response Element
CREB cAMP Response Element-Binding
Da Dalton (m/z unit)
DNA Deoxyribonucleic Acid
FDR False Discovery Rate
FOCI First-Order Conditional Independence
GAS Interferon-γ-Activated Site
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GEO Gene Expression Omnibus
GLITR Global Identifier of Target Regions
GO Gene Ontology
GRAM Gene Regulatory Modules
IAA Iodoacetamide
IFN Interferon
ISRE Interferon-Stimulated Response Element
JAK Janus Kinase
KEGG Kyoto Encyclopedia of Genes and Genomes
LC Liquid Chromatography
MAPK Mitogen-Activated Protein Kinase
MFG Modifier-TF-Gene
MINDY Modulator Inference by Network Dynamics
MoNsTEr Modification-dependent Network-based Transcriptional Estimator
mRNA Messenger Ribonucleic Acid
MS Mass Spectrometry
ORF Open Reading Frame
PAINT Promoter Analysis and Interaction Network Toolset
PIC Pre-Initiation Complex
PKA Protein Kinase A
PTM Post-Translational Modification
PWM Positional Weight Matrix
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ROC Receiver Operating Characteristic
RIPK Receptor-Interacting Protein Kinase
RNA Ribonucleic Acid
RNAPII RNA Polymerase II
SELEX Systematic Evolution of Ligands by Exponential Enrichment
SGD Saccharomyces Genome Database
SST Somatostatin
STAT Signal Transducer and Activator of Transcription
TF Transcription Factor
TNF Tumor Necrosis Factor
TNFR Tumor Necrosis Factor Receptor
TPP Trans-Proteomic Pipeline
TSS Transcription Start Site
UPS Universal Proteomics Standard
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